BIOSAMPLE_ACCESSION	DESCRIPTION	NAME	PLANNED_VISIT_ACCESSION	STUDY_ACCESSION	STUDY_TIME_COLLECTED	STUDY_TIME_COLLECTED_UNIT	STUDY_TIME_T0_EVENT	STUDY_TIME_T0_EVENT_SPECIFY	SUBJECT_ACCESSION	SUBTYPE	TYPE	WORKSPACE_ID
BS630798	Before vaccine		PV1834	SDY80	0	Days	Time of initial vaccine administration		SUB114454		RNA	2771
BS630803	Before vaccine		PV1834	SDY80	0	Days	Time of initial vaccine administration		SUB114459		RNA	2771
BS630806	Before vaccine		PV1834	SDY80	0	Days	Time of initial vaccine administration		SUB114462		RNA	2771
BS630813	Before vaccine		PV1834	SDY80	0	Days	Time of initial vaccine administration		SUB114469		RNA	2771
BS630815	Before vaccine		PV1834	SDY80	0	Days	Time of initial vaccine administration		SUB114471		RNA	2771
BS630816	Before vaccine		PV1834	SDY80	0	Days	Time of initial vaccine administration		SUB114472		RNA	2771
BS630822	Before vaccine		PV1834	SDY80	0	Days	Time of initial vaccine administration		SUB114478		RNA	2771
BS630833	Before vaccine		PV1834	SDY80	0	Days	Time of initial vaccine administration		SUB114489		RNA	2771
BS630836	Before vaccine		PV1834	SDY80	0	Days	Time of initial vaccine administration		SUB114492		RNA	2771
BS630841	Before vaccine		PV1834	SDY80	0	Days	Time of initial vaccine administration		SUB114497		RNA	2771
BS630847	Before vaccine		PV1834	SDY80	0	Days	Time of initial vaccine administration		SUB114503		RNA	2771
BS630849	Before vaccine		PV1834	SDY80	0	Days	Time of initial vaccine administration		SUB114505		RNA	2771
BS630858	After vaccine		PV1835	SDY80	1	Days	Time of initial vaccine administration		SUB114451		RNA	2771
BS630863	After vaccine		PV1835	SDY80	1	Days	Time of initial vaccine administration		SUB114456		RNA	2771
BS630869	After vaccine		PV1835	SDY80	1	Days	Time of initial vaccine administration		SUB114462		RNA	2771
BS630881	After vaccine		PV1835	SDY80	1	Days	Time of initial vaccine administration		SUB114474		RNA	2771
BS630897	After vaccine		PV1835	SDY80	1	Days	Time of initial vaccine administration		SUB114490		RNA	2771
BS630908	After vaccine		PV1835	SDY80	1	Days	Time of initial vaccine administration		SUB114501		RNA	2771
BS630914	After vaccine		PV1835	SDY80	1	Days	Time of initial vaccine administration		SUB114507		RNA	2771
BS806193			PV4267	SDY80	-7	Days	Time of initial vaccine administration		SUB114472		Serum	2771
BS806207			PV4268	SDY80	7	Days	Time of initial vaccine administration		SUB114475		Serum	2771
BS806226			PV1835	SDY80	1	Days	Time of initial vaccine administration		SUB114480		Serum	2771
BS806229			PV1834	SDY80	0	Days	Time of initial vaccine administration		SUB114481		Serum	2771
BS806237			PV4267	SDY80	-7	Days	Time of initial vaccine administration		SUB114482		Serum	2771
BS806249			PV4268	SDY80	7	Days	Time of initial vaccine administration		SUB114485		Serum	2771
BS806274			PV4267	SDY80	-7	Days	Time of initial vaccine administration		SUB114490		Serum	2771
BS806281			PV1834	SDY80	0	Days	Time of initial vaccine administration		SUB114492		Serum	2771
BS806283			PV4268	SDY80	7	Days	Time of initial vaccine administration		SUB114492		Serum	2771
BS806284			PV4267	SDY80	-7	Days	Time of initial vaccine administration		SUB114492		Serum	2771
BS806289			PV4267	SDY80	-7	Days	Time of initial vaccine administration		SUB114493		Serum	2771
BS806291			PV1834	SDY80	0	Days	Time of initial vaccine administration		SUB114494		Serum	2771
BS806303			PV1835	SDY80	1	Days	Time of initial vaccine administration		SUB114497		Serum	2771
BS806308			PV1835	SDY80	1	Days	Time of initial vaccine administration		SUB114498		Serum	2771
BS806309			PV4268	SDY80	7	Days	Time of initial vaccine administration		SUB114498		Serum	2771
BS806314			PV4268	SDY80	7	Days	Time of initial vaccine administration		SUB114499		Serum	2771
BS806318			PV1835	SDY80	1	Days	Time of initial vaccine administration		SUB114500		Serum	2771
BS806322			PV1834	SDY80	0	Days	Time of initial vaccine administration		SUB114501		Serum	2771
BS806336			PV4269	SDY80	70	Days	Time of initial vaccine administration		SUB114503		Serum	2771
BS806341			PV4267	SDY80	-7	Days	Time of initial vaccine administration		SUB114505		Serum	2771
BS806344			PV4268	SDY80	7	Days	Time of initial vaccine administration		SUB114506		Serum	2771
BS806350			PV4269	SDY80	70	Days	Time of initial vaccine administration		SUB114507		Serum	2771
BS806356			PV1834	SDY80	0	Days	Time of initial vaccine administration		SUB114509		Serum	2771
BS806374			PV4267	SDY80	-7	Days	Time of initial vaccine administration		SUB114512		Serum	2771
BS807761	Cryopreserved PBMCs were thawed, washed twice and the number of viable cells enumerated with an automated FACS based instrument (Millipore). A portion of the PBMCs were examined by flow cytometry using CD19, CD20, CD27, CD21, CD10 and CD95 or CD19, CD20, IgM, IgD, IgG and IgA for immunophenotyping of B cell markers and normalization of B cell numbers		PV4268	SDY80	7	Days	Time of initial vaccine administration		SUB114502		PBMC	2771
BS807764	Cryopreserved PBMCs were thawed, washed twice and the number of viable cells enumerated with an automated FACS based instrument (Millipore). A portion of the PBMCs were examined by flow cytometry using CD19, CD20, CD27, CD21, CD10 and CD95 or CD19, CD20, IgM, IgD, IgG and IgA for immunophenotyping of B cell markers and normalization of B cell numbers		PV4268	SDY80	7	Days	Time of initial vaccine administration		SUB114497		PBMC	2771
BS807767	Cryopreserved PBMCs were thawed, washed twice and the number of viable cells enumerated with an automated FACS based instrument (Millipore). A portion of the PBMCs were examined by flow cytometry using CD19, CD20, CD27, CD21, CD10 and CD95 or CD19, CD20, IgM, IgD, IgG and IgA for immunophenotyping of B cell markers and normalization of B cell numbers		PV4268	SDY80	7	Days	Time of initial vaccine administration		SUB114466		PBMC	2771
BS807769	Cryopreserved PBMCs were thawed, washed twice and the number of viable cells enumerated with an automated FACS based instrument (Millipore). A portion of the PBMCs were examined by flow cytometry using CD19, CD20, CD27, CD21, CD10 and CD95 or CD19, CD20, IgM, IgD, IgG and IgA for immunophenotyping of B cell markers and normalization of B cell numbers		PV1834	SDY80	0	Days	Time of initial vaccine administration		SUB114506		PBMC	2771
BS807786	Cryopreserved PBMCs were thawed, washed twice and the number of viable cells enumerated with an automated FACS based instrument (Millipore). A portion of the PBMCs were examined by flow cytometry using CD19, CD20, CD27, CD21, CD10 and CD95 or CD19, CD20, IgM, IgD, IgG and IgA for immunophenotyping of B cell markers and normalization of B cell numbers		PV1834	SDY80	0	Days	Time of initial vaccine administration		SUB114494		PBMC	2771
BS807800	Cryopreserved PBMCs were thawed, washed twice and the number of viable cells enumerated with an automated FACS based instrument (Millipore). A portion of the PBMCs were examined by flow cytometry using CD19, CD20, CD27, CD21, CD10 and CD95 or CD19, CD20, IgM, IgD, IgG and IgA for immunophenotyping of B cell markers and normalization of B cell numbers		PV1834	SDY80	0	Days	Time of initial vaccine administration		SUB114507		PBMC	2771
BS807824	Cryopreserved PBMCs were thawed, washed twice and the number of viable cells enumerated with an automated FACS based instrument (Millipore). A portion of the PBMCs were examined by flow cytometry using CD19, CD20, CD27, CD21, CD10 and CD95 or CD19, CD20, IgM, IgD, IgG and IgA for immunophenotyping of B cell markers and normalization of B cell numbers		PV1834	SDY80	0	Days	Time of initial vaccine administration		SUB114489		PBMC	2771
BS807826	Cryopreserved PBMCs were thawed, washed twice and the number of viable cells enumerated with an automated FACS based instrument (Millipore). A portion of the PBMCs were examined by flow cytometry using CD19, CD20, CD27, CD21, CD10 and CD95 or CD19, CD20, IgM, IgD, IgG and IgA for immunophenotyping of B cell markers and normalization of B cell numbers		PV1834	SDY80	0	Days	Time of initial vaccine administration		SUB114455		PBMC	2771
BS807828	Cryopreserved PBMCs were thawed, washed twice and the number of viable cells enumerated with an automated FACS based instrument (Millipore). A portion of the PBMCs were examined by flow cytometry using CD19, CD20, CD27, CD21, CD10 and CD95 or CD19, CD20, IgM, IgD, IgG and IgA for immunophenotyping of B cell markers and normalization of B cell numbers		PV4268	SDY80	7	Days	Time of initial vaccine administration		SUB114493		PBMC	2771
BS807838	Cryopreserved PBMCs were thawed, washed twice and the number of viable cells enumerated with an automated FACS based instrument (Millipore). A portion of the PBMCs were examined by flow cytometry using CD19, CD20, CD27, CD21, CD10 and CD95 or CD19, CD20, IgM, IgD, IgG and IgA for immunophenotyping of B cell markers and normalization of B cell numbers		PV4268	SDY80	7	Days	Time of initial vaccine administration		SUB114487		PBMC	2771
BS807845	Cryopreserved PBMCs were thawed, washed twice and the number of viable cells enumerated with an automated FACS based instrument (Millipore). A portion of the PBMCs were examined by flow cytometry using CD19, CD20, CD27, CD21, CD10 and CD95 or CD19, CD20, IgM, IgD, IgG and IgA for immunophenotyping of B cell markers and normalization of B cell numbers		PV4268	SDY80	7	Days	Time of initial vaccine administration		SUB114489		PBMC	2771
BS807850			PV4268	SDY80	7	Days	Time of initial vaccine administration		SUB114450		PBMC	2771
BS807862			PV4269	SDY80	70	Days	Time of initial vaccine administration		SUB114452		PBMC	2771
BS807864			PV1835	SDY80	1	Days	Time of initial vaccine administration		SUB114453		PBMC	2771
BS807872			PV4269	SDY80	70	Days	Time of initial vaccine administration		SUB114454		PBMC	2771
BS807873			PV1835	SDY80	1	Days	Time of initial vaccine administration		SUB114455		PBMC	2771
BS807880			PV4269	SDY80	70	Days	Time of initial vaccine administration		SUB114456		PBMC	2771
BS807908			PV4269	SDY80	70	Days	Time of initial vaccine administration		SUB114462		PBMC	2771
BS807914			PV1834	SDY80	0	Days	Time of initial vaccine administration		SUB114464		PBMC	2771
BS807921			PV4268	SDY80	7	Days	Time of initial vaccine administration		SUB114465		PBMC	2771
BS807929			PV1834	SDY80	0	Days	Time of initial vaccine administration		SUB114468		PBMC	2771
BS807931			PV4268	SDY80	7	Days	Time of initial vaccine administration		SUB114468		PBMC	2771
BS807949			PV4268	SDY80	7	Days	Time of initial vaccine administration		SUB114472		PBMC	2771
BS807953			PV4268	SDY80	7	Days	Time of initial vaccine administration		SUB114473		PBMC	2771
BS807972			PV1835	SDY80	1	Days	Time of initial vaccine administration		SUB114478		PBMC	2771
BS807987			PV4267	SDY80	-7	Days	Time of initial vaccine administration		SUB114482		PBMC	2771
BS807993			PV4269	SDY80	70	Days	Time of initial vaccine administration		SUB114483		PBMC	2771
BS807997			PV4267	SDY80	-7	Days	Time of initial vaccine administration		SUB114485		PBMC	2771
BS808003			PV1834	SDY80	0	Days	Time of initial vaccine administration		SUB114487		PBMC	2771
BS808006			PV4269	SDY80	70	Days	Time of initial vaccine administration		SUB114487		PBMC	2771
BS808009			PV4268	SDY80	7	Days	Time of initial vaccine administration		SUB114488		PBMC	2771
BS808025			PV4267	SDY80	-7	Days	Time of initial vaccine administration		SUB114493		PBMC	2771
BS808042			PV4267	SDY80	-7	Days	Time of initial vaccine administration		SUB114497		PBMC	2771
BS808046			PV4269	SDY80	70	Days	Time of initial vaccine administration		SUB114498		PBMC	2771
BS808048			PV4267	SDY80	-7	Days	Time of initial vaccine administration		SUB114499		PBMC	2771
BS808049			PV1834	SDY80	0	Days	Time of initial vaccine administration		SUB114500		PBMC	2771
BS808050			PV1835	SDY80	1	Days	Time of initial vaccine administration		SUB114500		PBMC	2771
BS808057			PV4267	SDY80	-7	Days	Time of initial vaccine administration		SUB114502		PBMC	2771
BS808062			PV4267	SDY80	-7	Days	Time of initial vaccine administration		SUB114503		PBMC	2771
BS808066			PV4268	SDY80	7	Days	Time of initial vaccine administration		SUB114504		PBMC	2771
BS808080			PV4269	SDY80	70	Days	Time of initial vaccine administration		SUB114508		PBMC	2771
BS808083			PV1834	SDY80	0	Days	Time of initial vaccine administration		SUB114511		PBMC	2771
BS808085			PV4268	SDY80	7	Days	Time of initial vaccine administration		SUB114511		PBMC	2771
BS808086			PV4267	SDY80	-7	Days	Time of initial vaccine administration		SUB114511		PBMC	2771
BS808090			PV4268	SDY80	7	Days	Time of initial vaccine administration		SUB114512		PBMC	2771
BS808098	Cryopreserved PBMCs were thawed, washed twice and the number of viable cells enumerated with an automated FACS based instrument (Millipore). A portion of the PBMCs were examined by flow cytometry using CD19, CD20, CD27, CD21, CD10 and CD95 or CD19, CD20, IgM, IgD, IgG and IgA for immunophenotyping of B cell markers and normalization of B cell numbers		PV1834	SDY80	0	Days	Time of initial vaccine administration		SUB114454		PBMC	2771
BS808104	Cryopreserved PBMCs were thawed, washed twice and the number of viable cells enumerated with an automated FACS based instrument (Millipore). A portion of the PBMCs were examined by flow cytometry using CD19, CD20, CD27, CD21, CD10 and CD95 or CD19, CD20, IgM, IgD, IgG and IgA for immunophenotyping of B cell markers and normalization of B cell numbers		PV1834	SDY80	0	Days	Time of initial vaccine administration		SUB114486		PBMC	2771
BS808107	Cryopreserved PBMCs were thawed, washed twice and the number of viable cells enumerated with an automated FACS based instrument (Millipore). A portion of the PBMCs were examined by flow cytometry using CD19, CD20, CD27, CD21, CD10 and CD95 or CD19, CD20, IgM, IgD, IgG and IgA for immunophenotyping of B cell markers and normalization of B cell numbers		PV1834	SDY80	0	Days	Time of initial vaccine administration		SUB114498		PBMC	2771
BS808126	Cryopreserved PBMCs were thawed, washed twice and the number of viable cells enumerated with an automated FACS based instrument (Millipore). A portion of the PBMCs were examined by flow cytometry using CD19, CD20, CD27, CD21, CD10 and CD95 or CD19, CD20, IgM, IgD, IgG and IgA for immunophenotyping of B cell markers and normalization of B cell numbers		PV4267	SDY80	-7	Days	Time of initial vaccine administration		SUB114490		PBMC	2771
BS808130	Cryopreserved PBMCs were thawed, washed twice and the number of viable cells enumerated with an automated FACS based instrument (Millipore). A portion of the PBMCs were examined by flow cytometry using CD19, CD20, CD27, CD21, CD10 and CD95 or CD19, CD20, IgM, IgD, IgG and IgA for immunophenotyping of B cell markers and normalization of B cell numbers		PV1834	SDY80	0	Days	Time of initial vaccine administration		SUB114499		PBMC	2771
BS808144	Cryopreserved PBMCs were thawed, washed twice and the number of viable cells enumerated with an automated FACS based instrument (Millipore). A portion of the PBMCs were examined by flow cytometry using CD19, CD20, CD27, CD21, CD10 and CD95 or CD19, CD20, IgM, IgD, IgG and IgA for immunophenotyping of B cell markers and normalization of B cell numbers		PV1834	SDY80	0	Days	Time of initial vaccine administration		SUB114460		PBMC	2771
BS808155	Cryopreserved PBMCs were thawed, washed twice and the number of viable cells enumerated with an automated FACS based instrument (Millipore). A portion of the PBMCs were examined by flow cytometry using CD19, CD20, CD27, CD21, CD10 and CD95 or CD19, CD20, IgM, IgD, IgG and IgA for immunophenotyping of B cell markers and normalization of B cell numbers		PV1834	SDY80	0	Days	Time of initial vaccine administration		SUB114505		PBMC	2771
BS808170	Cryopreserved PBMCs were thawed, washed twice and the number of viable cells enumerated with an automated FACS based instrument (Millipore). A portion of the PBMCs were examined by flow cytometry using CD19, CD20, CD27, CD21, CD10 and CD95 or CD19, CD20, IgM, IgD, IgG and IgA for immunophenotyping of B cell markers and normalization of B cell numbers		PV1834	SDY80	0	Days	Time of initial vaccine administration		SUB114493		PBMC	2771
BS808171	Cryopreserved PBMCs were thawed, washed twice and the number of viable cells enumerated with an automated FACS based instrument (Millipore). A portion of the PBMCs were examined by flow cytometry using CD19, CD20, CD27, CD21, CD10 and CD95 or CD19, CD20, IgM, IgD, IgG and IgA for immunophenotyping of B cell markers and normalization of B cell numbers		PV4267	SDY80	-7	Days	Time of initial vaccine administration		SUB114472		PBMC	2771
BS808174	Cryopreserved PBMCs were thawed, washed twice and the number of viable cells enumerated with an automated FACS based instrument (Millipore). A portion of the PBMCs were examined by flow cytometry using CD19, CD20, CD27, CD21, CD10 and CD95 or CD19, CD20, IgM, IgD, IgG and IgA for immunophenotyping of B cell markers and normalization of B cell numbers		PV4267	SDY80	-7	Days	Time of initial vaccine administration		SUB114465		PBMC	2771
BS808192	Cryopreserved PBMCs were thawed, washed twice and the number of viable cells enumerated with an automated FACS based instrument (Millipore). A portion of the PBMCs were examined by flow cytometry using CD19, CD20, CD27, CD21, CD10 and CD95 or CD19, CD20, IgM, IgD, IgG and IgA for immunophenotyping of B cell markers and normalization of B cell numbers		PV4267	SDY80	-7	Days	Time of initial vaccine administration		SUB114512		PBMC	2771
BS808196	Cryopreserved PBMCs were thawed, washed twice and the number of viable cells enumerated with an automated FACS based instrument (Millipore). A portion of the PBMCs were examined by flow cytometry using CD19, CD20, CD27, CD21, CD10 and CD95 or CD19, CD20, IgM, IgD, IgG and IgA for immunophenotyping of B cell markers and normalization of B cell numbers		PV4267	SDY80	-7	Days	Time of initial vaccine administration		SUB114487		PBMC	2771
BS808210		206_day-7	PV4267	SDY80	-7	Days	Time of initial vaccine administration		SUB114455	206.Blood.RNA-MicroArray.PV4267	RNA	2771
BS808228		233_day-7	PV4267	SDY80	-7	Days	Time of initial vaccine administration		SUB114473	233.Blood.RNA-MicroArray.PV4267	RNA	2771
BS808232		241_day-7	PV4267	SDY80	-7	Days	Time of initial vaccine administration		SUB114478	241.Blood.RNA-MicroArray.PV4267	RNA	2771
BS808239		250_day-7	PV4267	SDY80	-7	Days	Time of initial vaccine administration		SUB114487	250.Blood.RNA-MicroArray.PV4267	RNA	2771
BS808241		252_day-7	PV4267	SDY80	-7	Days	Time of initial vaccine administration		SUB114489	252.Blood.RNA-MicroArray.PV4267	RNA	2771
BS808251		267_day-7	PV4267	SDY80	-7	Days	Time of initial vaccine administration		SUB114499	267.Blood.RNA-MicroArray.PV4267	RNA	2771
BS808277		222_day7	PV4268	SDY80	7	Days	Time of initial vaccine administration		SUB114464	222.Blood.RNA-MicroArray.PV4268	RNA	2771
BS808282		229_day7	PV4268	SDY80	7	Days	Time of initial vaccine administration		SUB114469	229.Blood.RNA-MicroArray.PV4268	RNA	2771
BS808294		244_day7	PV4268	SDY80	7	Days	Time of initial vaccine administration		SUB114481	244.Blood.RNA-MicroArray.PV4268	RNA	2771
BS808314		272_day7	PV4268	SDY80	7	Days	Time of initial vaccine administration		SUB114502	272.Blood.RNA-MicroArray.PV4268	RNA	2771
BS808341		230_day70	PV4269	SDY80	70	Days	Time of initial vaccine administration		SUB114470	230.Blood.RNA-MicroArray.PV4269	RNA	2771
BS808349		242_day70	PV4269	SDY80	70	Days	Time of initial vaccine administration		SUB114479	242.Blood.RNA-MicroArray.PV4269	RNA	2771
BS806085			PV1835	SDY80	1	Days	Time of initial vaccine administration		SUB114450		Serum	2771
BS806087			PV4267	SDY80	-7	Days	Time of initial vaccine administration		SUB114450		Serum	2771
BS806111			PV4268	SDY80	7	Days	Time of initial vaccine administration		SUB114455		Serum	2771
BS806125			PV4267	SDY80	-7	Days	Time of initial vaccine administration		SUB114458		Serum	2771
BS806126			PV4269	SDY80	70	Days	Time of initial vaccine administration		SUB114458		Serum	2771
BS806135			PV4267	SDY80	-7	Days	Time of initial vaccine administration		SUB114460		Serum	2771
BS806148			PV1835	SDY80	1	Days	Time of initial vaccine administration		SUB114463		Serum	2771
BS806157			PV4268	SDY80	7	Days	Time of initial vaccine administration		SUB114465		Serum	2771
BS806168			PV4267	SDY80	-7	Days	Time of initial vaccine administration		SUB114467		Serum	2771
BS806169			PV4269	SDY80	70	Days	Time of initial vaccine administration		SUB114467		Serum	2771
BS806176			PV1835	SDY80	1	Days	Time of initial vaccine administration		SUB114469		Serum	2771
BS806183			PV4267	SDY80	-7	Days	Time of initial vaccine administration		SUB114470		Serum	2771
BS808352		245_day70	PV4269	SDY80	70	Days	Time of initial vaccine administration		SUB114482	245.Blood.RNA-MicroArray.PV4269	RNA	2771
BS808374		279_day70	PV4269	SDY80	70	Days	Time of initial vaccine administration		SUB114507	279.Blood.RNA-MicroArray.PV4269	RNA	2771
BS808378		283_day70	PV4269	SDY80	70	Days	Time of initial vaccine administration		SUB114511	283.Blood.RNA-MicroArray.PV4269	RNA	2771
BS807737	Cryopreserved PBMCs were thawed, washed twice and the number of viable cells enumerated with an automated FACS based instrument (Millipore). A portion of the PBMCs were examined by flow cytometry using CD19, CD20, CD27, CD21, CD10 and CD95 or CD19, CD20, IgM, IgD, IgG and IgA for immunophenotyping of B cell markers and normalization of B cell numbers		PV4268	SDY80	7	Days	Time of initial vaccine administration		SUB114495		PBMC	2771
BS807740	Cryopreserved PBMCs were thawed, washed twice and the number of viable cells enumerated with an automated FACS based instrument (Millipore). A portion of the PBMCs were examined by flow cytometry using CD19, CD20, CD27, CD21, CD10 and CD95 or CD19, CD20, IgM, IgD, IgG and IgA for immunophenotyping of B cell markers and normalization of B cell numbers		PV1834	SDY80	0	Days	Time of initial vaccine administration		SUB114454		PBMC	2771
BS807747	Cryopreserved PBMCs were thawed, washed twice and the number of viable cells enumerated with an automated FACS based instrument (Millipore). A portion of the PBMCs were examined by flow cytometry using CD19, CD20, CD27, CD21, CD10 and CD95 or CD19, CD20, IgM, IgD, IgG and IgA for immunophenotyping of B cell markers and normalization of B cell numbers		PV4268	SDY80	7	Days	Time of initial vaccine administration		SUB114469		PBMC	2771
BS807751	Cryopreserved PBMCs were thawed, washed twice and the number of viable cells enumerated with an automated FACS based instrument (Millipore). A portion of the PBMCs were examined by flow cytometry using CD19, CD20, CD27, CD21, CD10 and CD95 or CD19, CD20, IgM, IgD, IgG and IgA for immunophenotyping of B cell markers and normalization of B cell numbers		PV4268	SDY80	7	Days	Time of initial vaccine administration		SUB114482		PBMC	2771
BS953283			PV1834	SDY80	0	Days	Time of initial vaccine administration		SUB114479		Serum	2771
BS953288			PV6192	SDY80	28	Days	Time of initial vaccine administration		SUB114485		Serum	2771
BS953289			PV1834	SDY80	0	Days	Time of initial vaccine administration		SUB114496		Serum	2771
BS953309			PV6192	SDY80	28	Days	Time of initial vaccine administration		SUB114467		Serum	2771
BS953317			PV6192	SDY80	28	Days	Time of initial vaccine administration		SUB114475		Serum	2771
BS953319			PV6192	SDY80	28	Days	Time of initial vaccine administration		SUB114477		Serum	2771
BS953320			PV6192	SDY80	28	Days	Time of initial vaccine administration		SUB114478		Serum	2771
BS953323			PV6192	SDY80	28	Days	Time of initial vaccine administration		SUB114483		Serum	2771
BS953326			PV6192	SDY80	28	Days	Time of initial vaccine administration		SUB114487		Serum	2771
BS953331			PV6192	SDY80	28	Days	Time of initial vaccine administration		SUB114492		Serum	2771
BS953333			PV6192	SDY80	28	Days	Time of initial vaccine administration		SUB114494		Serum	2771
BS953339			PV6192	SDY80	28	Days	Time of initial vaccine administration		SUB114502		Serum	2771
BS630796	Before vaccine		PV1834	SDY80	0	Days	Time of initial vaccine administration		SUB114452		RNA	2771
BS630804	Before vaccine		PV1834	SDY80	0	Days	Time of initial vaccine administration		SUB114460		RNA	2771
BS630820	Before vaccine		PV1834	SDY80	0	Days	Time of initial vaccine administration		SUB114476		RNA	2771
BS630832	Before vaccine		PV1834	SDY80	0	Days	Time of initial vaccine administration		SUB114488		RNA	2771
BS630835	Before vaccine		PV1834	SDY80	0	Days	Time of initial vaccine administration		SUB114491		RNA	2771
BS630840	Before vaccine		PV1834	SDY80	0	Days	Time of initial vaccine administration		SUB114496		RNA	2771
BS630856	Before vaccine		PV1834	SDY80	0	Days	Time of initial vaccine administration		SUB114512		RNA	2771
BS630859	After vaccine		PV1835	SDY80	1	Days	Time of initial vaccine administration		SUB114452		RNA	2771
BS630861	After vaccine		PV1835	SDY80	1	Days	Time of initial vaccine administration		SUB114454		RNA	2771
BS630862	After vaccine		PV1835	SDY80	1	Days	Time of initial vaccine administration		SUB114455		RNA	2771
BS630892	After vaccine		PV1835	SDY80	1	Days	Time of initial vaccine administration		SUB114485		RNA	2771
BS630906	After vaccine		PV1835	SDY80	1	Days	Time of initial vaccine administration		SUB114499		RNA	2771
BS630909	After vaccine		PV1835	SDY80	1	Days	Time of initial vaccine administration		SUB114502		RNA	2771
BS630919	After vaccine		PV1835	SDY80	1	Days	Time of initial vaccine administration		SUB114512		RNA	2771
BS806200			PV1834	SDY80	0	Days	Time of initial vaccine administration		SUB114474		Serum	2771
BS806222			PV4269	SDY80	70	Days	Time of initial vaccine administration		SUB114478		Serum	2771
BS806225			PV4269	SDY80	70	Days	Time of initial vaccine administration		SUB114479		Serum	2771
BS806232			PV4267	SDY80	-7	Days	Time of initial vaccine administration		SUB114481		Serum	2771
BS806233			PV4269	SDY80	70	Days	Time of initial vaccine administration		SUB114481		Serum	2771
BS806235			PV1835	SDY80	1	Days	Time of initial vaccine administration		SUB114482		Serum	2771
BS806242			PV4267	SDY80	-7	Days	Time of initial vaccine administration		SUB114483		Serum	2771
BS806254			PV4267	SDY80	-7	Days	Time of initial vaccine administration		SUB114486		Serum	2771
BS806262			PV1835	SDY80	1	Days	Time of initial vaccine administration		SUB114488		Serum	2771
BS806264			PV4267	SDY80	-7	Days	Time of initial vaccine administration		SUB114488		Serum	2771
BS806273			PV4268	SDY80	7	Days	Time of initial vaccine administration		SUB114490		Serum	2771
BS806277			PV1835	SDY80	1	Days	Time of initial vaccine administration		SUB114491		Serum	2771
BS806280			PV4269	SDY80	70	Days	Time of initial vaccine administration		SUB114491		Serum	2771
BS806311			PV4269	SDY80	70	Days	Time of initial vaccine administration		SUB114498		Serum	2771
BS806320			PV4267	SDY80	-7	Days	Time of initial vaccine administration		SUB114500		Serum	2771
BS806349			PV4267	SDY80	-7	Days	Time of initial vaccine administration		SUB114507		Serum	2771
BS806351			PV1834	SDY80	0	Days	Time of initial vaccine administration		SUB114508		Serum	2771
BS806360			PV4269	SDY80	70	Days	Time of initial vaccine administration		SUB114509		Serum	2771
BS806366			PV1834	SDY80	0	Days	Time of initial vaccine administration		SUB114511		Serum	2771
BS806367			PV1835	SDY80	1	Days	Time of initial vaccine administration		SUB114511		Serum	2771
BS806373			PV4268	SDY80	7	Days	Time of initial vaccine administration		SUB114512		Serum	2771
BS807763	Cryopreserved PBMCs were thawed, washed twice and the number of viable cells enumerated with an automated FACS based instrument (Millipore). A portion of the PBMCs were examined by flow cytometry using CD19, CD20, CD27, CD21, CD10 and CD95 or CD19, CD20, IgM, IgD, IgG and IgA for immunophenotyping of B cell markers and normalization of B cell numbers		PV1834	SDY80	0	Days	Time of initial vaccine administration		SUB114478		PBMC	2771
BS807784	Cryopreserved PBMCs were thawed, washed twice and the number of viable cells enumerated with an automated FACS based instrument (Millipore). A portion of the PBMCs were examined by flow cytometry using CD19, CD20, CD27, CD21, CD10 and CD95 or CD19, CD20, IgM, IgD, IgG and IgA for immunophenotyping of B cell markers and normalization of B cell numbers		PV4268	SDY80	7	Days	Time of initial vaccine administration		SUB114471		PBMC	2771
BS807792	Cryopreserved PBMCs were thawed, washed twice and the number of viable cells enumerated with an automated FACS based instrument (Millipore). A portion of the PBMCs were examined by flow cytometry using CD19, CD20, CD27, CD21, CD10 and CD95 or CD19, CD20, IgM, IgD, IgG and IgA for immunophenotyping of B cell markers and normalization of B cell numbers		PV4268	SDY80	7	Days	Time of initial vaccine administration		SUB114478		PBMC	2771
BS807794	Cryopreserved PBMCs were thawed, washed twice and the number of viable cells enumerated with an automated FACS based instrument (Millipore). A portion of the PBMCs were examined by flow cytometry using CD19, CD20, CD27, CD21, CD10 and CD95 or CD19, CD20, IgM, IgD, IgG and IgA for immunophenotyping of B cell markers and normalization of B cell numbers		PV1834	SDY80	0	Days	Time of initial vaccine administration		SUB114476		PBMC	2771
BS807802	Cryopreserved PBMCs were thawed, washed twice and the number of viable cells enumerated with an automated FACS based instrument (Millipore). A portion of the PBMCs were examined by flow cytometry using CD19, CD20, CD27, CD21, CD10 and CD95 or CD19, CD20, IgM, IgD, IgG and IgA for immunophenotyping of B cell markers and normalization of B cell numbers		PV4268	SDY80	7	Days	Time of initial vaccine administration		SUB114459		PBMC	2771
BS807803	Cryopreserved PBMCs were thawed, washed twice and the number of viable cells enumerated with an automated FACS based instrument (Millipore). A portion of the PBMCs were examined by flow cytometry using CD19, CD20, CD27, CD21, CD10 and CD95 or CD19, CD20, IgM, IgD, IgG and IgA for immunophenotyping of B cell markers and normalization of B cell numbers		PV1834	SDY80	0	Days	Time of initial vaccine administration		SUB114473		PBMC	2771
BS807806	Cryopreserved PBMCs were thawed, washed twice and the number of viable cells enumerated with an automated FACS based instrument (Millipore). A portion of the PBMCs were examined by flow cytometry using CD19, CD20, CD27, CD21, CD10 and CD95 or CD19, CD20, IgM, IgD, IgG and IgA for immunophenotyping of B cell markers and normalization of B cell numbers		PV4268	SDY80	7	Days	Time of initial vaccine administration		SUB114475		PBMC	2771
BS807810	Cryopreserved PBMCs were thawed, washed twice and the number of viable cells enumerated with an automated FACS based instrument (Millipore). A portion of the PBMCs were examined by flow cytometry using CD19, CD20, CD27, CD21, CD10 and CD95 or CD19, CD20, IgM, IgD, IgG and IgA for immunophenotyping of B cell markers and normalization of B cell numbers		PV1834	SDY80	0	Days	Time of initial vaccine administration		SUB114471		PBMC	2771
BS807815	Cryopreserved PBMCs were thawed, washed twice and the number of viable cells enumerated with an automated FACS based instrument (Millipore). A portion of the PBMCs were examined by flow cytometry using CD19, CD20, CD27, CD21, CD10 and CD95 or CD19, CD20, IgM, IgD, IgG and IgA for immunophenotyping of B cell markers and normalization of B cell numbers		PV4268	SDY80	7	Days	Time of initial vaccine administration		SUB114472		PBMC	2771
BS807821	Cryopreserved PBMCs were thawed, washed twice and the number of viable cells enumerated with an automated FACS based instrument (Millipore). A portion of the PBMCs were examined by flow cytometry using CD19, CD20, CD27, CD21, CD10 and CD95 or CD19, CD20, IgM, IgD, IgG and IgA for immunophenotyping of B cell markers and normalization of B cell numbers		PV1834	SDY80	0	Days	Time of initial vaccine administration		SUB114483		PBMC	2771
BS807835	Cryopreserved PBMCs were thawed, washed twice and the number of viable cells enumerated with an automated FACS based instrument (Millipore). A portion of the PBMCs were examined by flow cytometry using CD19, CD20, CD27, CD21, CD10 and CD95 or CD19, CD20, IgM, IgD, IgG and IgA for immunophenotyping of B cell markers and normalization of B cell numbers		PV4268	SDY80	7	Days	Time of initial vaccine administration		SUB114460		PBMC	2771
BS807851			PV4267	SDY80	-7	Days	Time of initial vaccine administration		SUB114450		PBMC	2771
BS807871			PV4267	SDY80	-7	Days	Time of initial vaccine administration		SUB114454		PBMC	2771
BS807874			PV4268	SDY80	7	Days	Time of initial vaccine administration		SUB114455		PBMC	2771
BS807883			PV4268	SDY80	7	Days	Time of initial vaccine administration		SUB114457		PBMC	2771
BS807886			PV1834	SDY80	0	Days	Time of initial vaccine administration		SUB114458		PBMC	2771
BS807889			PV4267	SDY80	-7	Days	Time of initial vaccine administration		SUB114458		PBMC	2771
BS807898			PV4268	SDY80	7	Days	Time of initial vaccine administration		SUB114460		PBMC	2771
BS807906			PV1835	SDY80	1	Days	Time of initial vaccine administration		SUB114462		PBMC	2771
BS807950			PV4267	SDY80	-7	Days	Time of initial vaccine administration		SUB114472		PBMC	2771
BS807952			PV1835	SDY80	1	Days	Time of initial vaccine administration		SUB114473		PBMC	2771
BS807977			PV1835	SDY80	1	Days	Time of initial vaccine administration		SUB114479		PBMC	2771
BS807980			PV4269	SDY80	70	Days	Time of initial vaccine administration		SUB114479		PBMC	2771
BS807988			PV4269	SDY80	70	Days	Time of initial vaccine administration		SUB114482		PBMC	2771
BS808000			PV4268	SDY80	7	Days	Time of initial vaccine administration		SUB114486		PBMC	2771
BS808007			PV1834	SDY80	0	Days	Time of initial vaccine administration		SUB114488		PBMC	2771
BS808008			PV1835	SDY80	1	Days	Time of initial vaccine administration		SUB114488		PBMC	2771
BS808012			PV1835	SDY80	1	Days	Time of initial vaccine administration		SUB114490		PBMC	2771
BS808023			PV1834	SDY80	0	Days	Time of initial vaccine administration		SUB114493		PBMC	2771
BS808038			PV4268	SDY80	7	Days	Time of initial vaccine administration		SUB114496		PBMC	2771
BS808055			PV1835	SDY80	1	Days	Time of initial vaccine administration		SUB114502		PBMC	2771
BS808087			PV4269	SDY80	70	Days	Time of initial vaccine administration		SUB114511		PBMC	2771
BS808089			PV1835	SDY80	1	Days	Time of initial vaccine administration		SUB114512		PBMC	2771
BS808105	Cryopreserved PBMCs were thawed, washed twice and the number of viable cells enumerated with an automated FACS based instrument (Millipore). A portion of the PBMCs were examined by flow cytometry using CD19, CD20, CD27, CD21, CD10 and CD95 or CD19, CD20, IgM, IgD, IgG and IgA for immunophenotyping of B cell markers and normalization of B cell numbers		PV1834	SDY80	0	Days	Time of initial vaccine administration		SUB114489		PBMC	2771
BS808118	Cryopreserved PBMCs were thawed, washed twice and the number of viable cells enumerated with an automated FACS based instrument (Millipore). A portion of the PBMCs were examined by flow cytometry using CD19, CD20, CD27, CD21, CD10 and CD95 or CD19, CD20, IgM, IgD, IgG and IgA for immunophenotyping of B cell markers and normalization of B cell numbers		PV1834	SDY80	0	Days	Time of initial vaccine administration		SUB114468		PBMC	2771
BS808129	Cryopreserved PBMCs were thawed, washed twice and the number of viable cells enumerated with an automated FACS based instrument (Millipore). A portion of the PBMCs were examined by flow cytometry using CD19, CD20, CD27, CD21, CD10 and CD95 or CD19, CD20, IgM, IgD, IgG and IgA for immunophenotyping of B cell markers and normalization of B cell numbers		PV1834	SDY80	0	Days	Time of initial vaccine administration		SUB114501		PBMC	2771
BS808133	Cryopreserved PBMCs were thawed, washed twice and the number of viable cells enumerated with an automated FACS based instrument (Millipore). A portion of the PBMCs were examined by flow cytometry using CD19, CD20, CD27, CD21, CD10 and CD95 or CD19, CD20, IgM, IgD, IgG and IgA for immunophenotyping of B cell markers and normalization of B cell numbers		PV4267	SDY80	-7	Days	Time of initial vaccine administration		SUB114461		PBMC	2771
BS808142	Cryopreserved PBMCs were thawed, washed twice and the number of viable cells enumerated with an automated FACS based instrument (Millipore). A portion of the PBMCs were examined by flow cytometry using CD19, CD20, CD27, CD21, CD10 and CD95 or CD19, CD20, IgM, IgD, IgG and IgA for immunophenotyping of B cell markers and normalization of B cell numbers		PV4268	SDY80	7	Days	Time of initial vaccine administration		SUB114477		PBMC	2771
BS808145	Cryopreserved PBMCs were thawed, washed twice and the number of viable cells enumerated with an automated FACS based instrument (Millipore). A portion of the PBMCs were examined by flow cytometry using CD19, CD20, CD27, CD21, CD10 and CD95 or CD19, CD20, IgM, IgD, IgG and IgA for immunophenotyping of B cell markers and normalization of B cell numbers		PV4267	SDY80	-7	Days	Time of initial vaccine administration		SUB114494		PBMC	2771
BS808147	Cryopreserved PBMCs were thawed, washed twice and the number of viable cells enumerated with an automated FACS based instrument (Millipore). A portion of the PBMCs were examined by flow cytometry using CD19, CD20, CD27, CD21, CD10 and CD95 or CD19, CD20, IgM, IgD, IgG and IgA for immunophenotyping of B cell markers and normalization of B cell numbers		PV4267	SDY80	-7	Days	Time of initial vaccine administration		SUB114451		PBMC	2771
BS808156	Cryopreserved PBMCs were thawed, washed twice and the number of viable cells enumerated with an automated FACS based instrument (Millipore). A portion of the PBMCs were examined by flow cytometry using CD19, CD20, CD27, CD21, CD10 and CD95 or CD19, CD20, IgM, IgD, IgG and IgA for immunophenotyping of B cell markers and normalization of B cell numbers		PV1834	SDY80	0	Days	Time of initial vaccine administration		SUB114471		PBMC	2771
BS808162	Cryopreserved PBMCs were thawed, washed twice and the number of viable cells enumerated with an automated FACS based instrument (Millipore). A portion of the PBMCs were examined by flow cytometry using CD19, CD20, CD27, CD21, CD10 and CD95 or CD19, CD20, IgM, IgD, IgG and IgA for immunophenotyping of B cell markers and normalization of B cell numbers		PV1834	SDY80	0	Days	Time of initial vaccine administration		SUB114490		PBMC	2771
BS808163	Cryopreserved PBMCs were thawed, washed twice and the number of viable cells enumerated with an automated FACS based instrument (Millipore). A portion of the PBMCs were examined by flow cytometry using CD19, CD20, CD27, CD21, CD10 and CD95 or CD19, CD20, IgM, IgD, IgG and IgA for immunophenotyping of B cell markers and normalization of B cell numbers		PV4267	SDY80	-7	Days	Time of initial vaccine administration		SUB114511		PBMC	2771
BS808183	Cryopreserved PBMCs were thawed, washed twice and the number of viable cells enumerated with an automated FACS based instrument (Millipore). A portion of the PBMCs were examined by flow cytometry using CD19, CD20, CD27, CD21, CD10 and CD95 or CD19, CD20, IgM, IgD, IgG and IgA for immunophenotyping of B cell markers and normalization of B cell numbers		PV4267	SDY80	-7	Days	Time of initial vaccine administration		SUB114466		PBMC	2771
BS808187	Cryopreserved PBMCs were thawed, washed twice and the number of viable cells enumerated with an automated FACS based instrument (Millipore). A portion of the PBMCs were examined by flow cytometry using CD19, CD20, CD27, CD21, CD10 and CD95 or CD19, CD20, IgM, IgD, IgG and IgA for immunophenotyping of B cell markers and normalization of B cell numbers		PV4267	SDY80	-7	Days	Time of initial vaccine administration		SUB114452		PBMC	2771
BS808188	Cryopreserved PBMCs were thawed, washed twice and the number of viable cells enumerated with an automated FACS based instrument (Millipore). A portion of the PBMCs were examined by flow cytometry using CD19, CD20, CD27, CD21, CD10 and CD95 or CD19, CD20, IgM, IgD, IgG and IgA for immunophenotyping of B cell markers and normalization of B cell numbers		PV4267	SDY80	-7	Days	Time of initial vaccine administration		SUB114468		PBMC	2771
BS808190	Cryopreserved PBMCs were thawed, washed twice and the number of viable cells enumerated with an automated FACS based instrument (Millipore). A portion of the PBMCs were examined by flow cytometry using CD19, CD20, CD27, CD21, CD10 and CD95 or CD19, CD20, IgM, IgD, IgG and IgA for immunophenotyping of B cell markers and normalization of B cell numbers		PV4267	SDY80	-7	Days	Time of initial vaccine administration		SUB114491		PBMC	2771
BS808195	Cryopreserved PBMCs were thawed, washed twice and the number of viable cells enumerated with an automated FACS based instrument (Millipore). A portion of the PBMCs were examined by flow cytometry using CD19, CD20, CD27, CD21, CD10 and CD95 or CD19, CD20, IgM, IgD, IgG and IgA for immunophenotyping of B cell markers and normalization of B cell numbers		PV4267	SDY80	-7	Days	Time of initial vaccine administration		SUB114459		PBMC	2771
BS808198	Cryopreserved PBMCs were thawed, washed twice and the number of viable cells enumerated with an automated FACS based instrument (Millipore). A portion of the PBMCs were examined by flow cytometry using CD19, CD20, CD27, CD21, CD10 and CD95 or CD19, CD20, IgM, IgD, IgG and IgA for immunophenotyping of B cell markers and normalization of B cell numbers		PV4267	SDY80	-7	Days	Time of initial vaccine administration		SUB114474		PBMC	2771
BS808200	Cryopreserved PBMCs were thawed, washed twice and the number of viable cells enumerated with an automated FACS based instrument (Millipore). A portion of the PBMCs were examined by flow cytometry using CD19, CD20, CD27, CD21, CD10 and CD95 or CD19, CD20, IgM, IgD, IgG and IgA for immunophenotyping of B cell markers and normalization of B cell numbers		PV4267	SDY80	-7	Days	Time of initial vaccine administration		SUB114470		PBMC	2771
BS808205		200_day-7	PV4267	SDY80	-7	Days	Time of initial vaccine administration		SUB114450	200.Blood.RNA-MicroArray.PV4267	RNA	2771
BS808208		204_day-7	PV4267	SDY80	-7	Days	Time of initial vaccine administration		SUB114453	204.Blood.RNA-MicroArray.PV4267	RNA	2771
BS808209		205_day-7	PV4267	SDY80	-7	Days	Time of initial vaccine administration		SUB114454	205.Blood.RNA-MicroArray.PV4267	RNA	2771
BS808217		218_day-7	PV4267	SDY80	-7	Days	Time of initial vaccine administration		SUB114462	218.Blood.RNA-MicroArray.PV4267	RNA	2771
BS808227		232_day-7	PV4267	SDY80	-7	Days	Time of initial vaccine administration		SUB114472	232.Blood.RNA-MicroArray.PV4267	RNA	2771
BS808230		235_day-7	PV4267	SDY80	-7	Days	Time of initial vaccine administration		SUB114475	235.Blood.RNA-MicroArray.PV4267	RNA	2771
BS808234		245_day-7	PV4267	SDY80	-7	Days	Time of initial vaccine administration		SUB114482	245.Blood.RNA-MicroArray.PV4267	RNA	2771
BS808242		254_day-7	PV4267	SDY80	-7	Days	Time of initial vaccine administration		SUB114490	254.Blood.RNA-MicroArray.PV4267	RNA	2771
BS808254		272_day-7	PV4267	SDY80	-7	Days	Time of initial vaccine administration		SUB114502	272.Blood.RNA-MicroArray.PV4267	RNA	2771
BS808256		274_day-7	PV4267	SDY80	-7	Days	Time of initial vaccine administration		SUB114504	274.Blood.RNA-MicroArray.PV4267	RNA	2771
BS808268		204_day7	PV4268	SDY80	7	Days	Time of initial vaccine administration		SUB114453	204.Blood.RNA-MicroArray.PV4268	RNA	2771
BS808285		232_day7	PV4268	SDY80	7	Days	Time of initial vaccine administration		SUB114472	232.Blood.RNA-MicroArray.PV4268	RNA	2771
BS808288		235_day7	PV4268	SDY80	7	Days	Time of initial vaccine administration		SUB114475	235.Blood.RNA-MicroArray.PV4268	RNA	2771
BS808295		245_day7	PV4268	SDY80	7	Days	Time of initial vaccine administration		SUB114482	245.Blood.RNA-MicroArray.PV4268	RNA	2771
BS808304		256_day7	PV4268	SDY80	7	Days	Time of initial vaccine administration		SUB114491	256.Blood.RNA-MicroArray.PV4268	RNA	2771
BS808316		277_day7	PV4268	SDY80	7	Days	Time of initial vaccine administration		SUB114506	277.Blood.RNA-MicroArray.PV4268	RNA	2771
BS808321		284_day7	PV4268	SDY80	7	Days	Time of initial vaccine administration		SUB114512	284.Blood.RNA-MicroArray.PV4268	RNA	2771
BS808330		212_day70	PV4269	SDY80	70	Days	Time of initial vaccine administration		SUB114458	212.Blood.RNA-MicroArray.PV4269	RNA	2771
BS808336		224_day70	PV4269	SDY80	70	Days	Time of initial vaccine administration		SUB114465	224.Blood.RNA-MicroArray.PV4269	RNA	2771
BS808340		229_day70	PV4269	SDY80	70	Days	Time of initial vaccine administration		SUB114469	229.Blood.RNA-MicroArray.PV4269	RNA	2771
BS808345		234_day70	PV4269	SDY80	70	Days	Time of initial vaccine administration		SUB114474	234.Blood.RNA-MicroArray.PV4269	RNA	2771
BS808346		235_day70	PV4269	SDY80	70	Days	Time of initial vaccine administration		SUB114475	235.Blood.RNA-MicroArray.PV4269	RNA	2771
BS808347		236_day70	PV4269	SDY80	70	Days	Time of initial vaccine administration		SUB114476	236.Blood.RNA-MicroArray.PV4269	RNA	2771
BS806095			PV1835	SDY80	1	Days	Time of initial vaccine administration		SUB114452		Serum	2771
BS806096			PV4268	SDY80	7	Days	Time of initial vaccine administration		SUB114452		Serum	2771
BS806098			PV4269	SDY80	70	Days	Time of initial vaccine administration		SUB114452		Serum	2771
BS806100			PV1835	SDY80	1	Days	Time of initial vaccine administration		SUB114453		Serum	2771
BS806101			PV4268	SDY80	7	Days	Time of initial vaccine administration		SUB114453		Serum	2771
BS806106			PV4268	SDY80	7	Days	Time of initial vaccine administration		SUB114454		Serum	2771
BS806107			PV4267	SDY80	-7	Days	Time of initial vaccine administration		SUB114454		Serum	2771
BS806120			PV4267	SDY80	-7	Days	Time of initial vaccine administration		SUB114457		Serum	2771
BS806128			PV1835	SDY80	1	Days	Time of initial vaccine administration		SUB114459		Serum	2771
BS806134			PV4268	SDY80	7	Days	Time of initial vaccine administration		SUB114460		Serum	2771
BS806149			PV4268	SDY80	7	Days	Time of initial vaccine administration		SUB114463		Serum	2771
BS806150			PV4267	SDY80	-7	Days	Time of initial vaccine administration		SUB114463		Serum	2771
BS806151			PV1834	SDY80	0	Days	Time of initial vaccine administration		SUB114464		Serum	2771
BS806152			PV1835	SDY80	1	Days	Time of initial vaccine administration		SUB114464		Serum	2771
BS806153			PV4268	SDY80	7	Days	Time of initial vaccine administration		SUB114464		Serum	2771
BS806163			PV4267	SDY80	-7	Days	Time of initial vaccine administration		SUB114466		Serum	2771
BS806164			PV4269	SDY80	70	Days	Time of initial vaccine administration		SUB114466		Serum	2771
BS806167			PV4268	SDY80	7	Days	Time of initial vaccine administration		SUB114467		Serum	2771
BS806180			PV1834	SDY80	0	Days	Time of initial vaccine administration		SUB114470		Serum	2771
BS806182			PV4268	SDY80	7	Days	Time of initial vaccine administration		SUB114470		Serum	2771
BS806184			PV4269	SDY80	70	Days	Time of initial vaccine administration		SUB114470		Serum	2771
BS806186			PV1835	SDY80	1	Days	Time of initial vaccine administration		SUB114471		Serum	2771
BS806187			PV4268	SDY80	7	Days	Time of initial vaccine administration		SUB114471		Serum	2771
BS808355		249_day70	PV4269	SDY80	70	Days	Time of initial vaccine administration		SUB114486	249.Blood.RNA-MicroArray.PV4269	RNA	2771
BS808358		252_day70	PV4269	SDY80	70	Days	Time of initial vaccine administration		SUB114489	252.Blood.RNA-MicroArray.PV4269	RNA	2771
BS808365		263_day70	PV4269	SDY80	70	Days	Time of initial vaccine administration		SUB114497	263.Blood.RNA-MicroArray.PV4269	RNA	2771
BS808371		273_day70	PV4269	SDY80	70	Days	Time of initial vaccine administration		SUB114503	273.Blood.RNA-MicroArray.PV4269	RNA	2771
BS808372		274_day70	PV4269	SDY80	70	Days	Time of initial vaccine administration		SUB114504	274.Blood.RNA-MicroArray.PV4269	RNA	2771
BS808377		282_day70	PV4269	SDY80	70	Days	Time of initial vaccine administration		SUB114510	282.Blood.RNA-MicroArray.PV4269	RNA	2771
BS808379		284_day70	PV4269	SDY80	70	Days	Time of initial vaccine administration		SUB114512	284.Blood.RNA-MicroArray.PV4269	RNA	2771
BS807754	Cryopreserved PBMCs were thawed, washed twice and the number of viable cells enumerated with an automated FACS based instrument (Millipore). A portion of the PBMCs were examined by flow cytometry using CD19, CD20, CD27, CD21, CD10 and CD95 or CD19, CD20, IgM, IgD, IgG and IgA for immunophenotyping of B cell markers and normalization of B cell numbers		PV1834	SDY80	0	Days	Time of initial vaccine administration		SUB114505		PBMC	2771
BS953294			PV6192	SDY80	28	Days	Time of initial vaccine administration		SUB114451		Serum	2771
BS953300			PV6192	SDY80	28	Days	Time of initial vaccine administration		SUB114457		Serum	2771
BS953304			PV6192	SDY80	28	Days	Time of initial vaccine administration		SUB114461		Serum	2771
BS953313			PV6192	SDY80	28	Days	Time of initial vaccine administration		SUB114471		Serum	2771
BS953314			PV6192	SDY80	28	Days	Time of initial vaccine administration		SUB114472		Serum	2771
BS953321			PV6192	SDY80	28	Days	Time of initial vaccine administration		SUB114481		Serum	2771
BS953348			PV6192	SDY80	28	Days	Time of initial vaccine administration		SUB114512		Serum	2771
BS630797	Before vaccine		PV1834	SDY80	0	Days	Time of initial vaccine administration		SUB114453		RNA	2771
BS630801	Before vaccine		PV1834	SDY80	0	Days	Time of initial vaccine administration		SUB114457		RNA	2771
BS630812	Before vaccine		PV1834	SDY80	0	Days	Time of initial vaccine administration		SUB114468		RNA	2771
BS630821	Before vaccine		PV1834	SDY80	0	Days	Time of initial vaccine administration		SUB114477		RNA	2771
BS630844	Before vaccine		PV1834	SDY80	0	Days	Time of initial vaccine administration		SUB114500		RNA	2771
BS630866	After vaccine		PV1835	SDY80	1	Days	Time of initial vaccine administration		SUB114459		RNA	2771
BS630873	After vaccine		PV1835	SDY80	1	Days	Time of initial vaccine administration		SUB114466		RNA	2771
BS630894	After vaccine		PV1835	SDY80	1	Days	Time of initial vaccine administration		SUB114487		RNA	2771
BS630904	After vaccine		PV1835	SDY80	1	Days	Time of initial vaccine administration		SUB114497		RNA	2771
BS630917	After vaccine		PV1835	SDY80	1	Days	Time of initial vaccine administration		SUB114510		RNA	2771
BS630918	After vaccine		PV1835	SDY80	1	Days	Time of initial vaccine administration		SUB114511		RNA	2771
BS806197			PV4268	SDY80	7	Days	Time of initial vaccine administration		SUB114473		Serum	2771
BS806201			PV1835	SDY80	1	Days	Time of initial vaccine administration		SUB114474		Serum	2771
BS806209			PV4269	SDY80	70	Days	Time of initial vaccine administration		SUB114475		Serum	2771
BS806223			PV1835	SDY80	1	Days	Time of initial vaccine administration		SUB114479		Serum	2771
BS806224			PV4268	SDY80	7	Days	Time of initial vaccine administration		SUB114479		Serum	2771
BS806231			PV4268	SDY80	7	Days	Time of initial vaccine administration		SUB114481		Serum	2771
BS806238			PV4269	SDY80	70	Days	Time of initial vaccine administration		SUB114482		Serum	2771
BS806245			PV1835	SDY80	1	Days	Time of initial vaccine administration		SUB114484		Serum	2771
BS806258			PV4268	SDY80	7	Days	Time of initial vaccine administration		SUB114487		Serum	2771
BS806265			PV4269	SDY80	70	Days	Time of initial vaccine administration		SUB114488		Serum	2771
BS806267			PV1835	SDY80	1	Days	Time of initial vaccine administration		SUB114489		Serum	2771
BS806278			PV4268	SDY80	7	Days	Time of initial vaccine administration		SUB114491		Serum	2771
BS806293			PV4268	SDY80	7	Days	Time of initial vaccine administration		SUB114494		Serum	2771
BS806294			PV4267	SDY80	-7	Days	Time of initial vaccine administration		SUB114494		Serum	2771
BS806300			PV4269	SDY80	70	Days	Time of initial vaccine administration		SUB114495		Serum	2771
BS806316			PV4269	SDY80	70	Days	Time of initial vaccine administration		SUB114499		Serum	2771
BS806319			PV4268	SDY80	7	Days	Time of initial vaccine administration		SUB114500		Serum	2771
BS806324			PV4268	SDY80	7	Days	Time of initial vaccine administration		SUB114501		Serum	2771
BS806328			PV1835	SDY80	1	Days	Time of initial vaccine administration		SUB114502		Serum	2771
BS806330			PV4267	SDY80	-7	Days	Time of initial vaccine administration		SUB114502		Serum	2771
BS806332			PV1834	SDY80	0	Days	Time of initial vaccine administration		SUB114503		Serum	2771
BS806338			PV4269	SDY80	70	Days	Time of initial vaccine administration		SUB114504		Serum	2771
BS806343			PV1835	SDY80	1	Days	Time of initial vaccine administration		SUB114506		Serum	2771
BS806345			PV4267	SDY80	-7	Days	Time of initial vaccine administration		SUB114506		Serum	2771
BS807771	Cryopreserved PBMCs were thawed, washed twice and the number of viable cells enumerated with an automated FACS based instrument (Millipore). A portion of the PBMCs were examined by flow cytometry using CD19, CD20, CD27, CD21, CD10 and CD95 or CD19, CD20, IgM, IgD, IgG and IgA for immunophenotyping of B cell markers and normalization of B cell numbers		PV4268	SDY80	7	Days	Time of initial vaccine administration		SUB114467		PBMC	2771
BS807772	Cryopreserved PBMCs were thawed, washed twice and the number of viable cells enumerated with an automated FACS based instrument (Millipore). A portion of the PBMCs were examined by flow cytometry using CD19, CD20, CD27, CD21, CD10 and CD95 or CD19, CD20, IgM, IgD, IgG and IgA for immunophenotyping of B cell markers and normalization of B cell numbers		PV1834	SDY80	0	Days	Time of initial vaccine administration		SUB114451		PBMC	2771
BS807774	Cryopreserved PBMCs were thawed, washed twice and the number of viable cells enumerated with an automated FACS based instrument (Millipore). A portion of the PBMCs were examined by flow cytometry using CD19, CD20, CD27, CD21, CD10 and CD95 or CD19, CD20, IgM, IgD, IgG and IgA for immunophenotyping of B cell markers and normalization of B cell numbers		PV4268	SDY80	7	Days	Time of initial vaccine administration		SUB114468		PBMC	2771
BS807775	Cryopreserved PBMCs were thawed, washed twice and the number of viable cells enumerated with an automated FACS based instrument (Millipore). A portion of the PBMCs were examined by flow cytometry using CD19, CD20, CD27, CD21, CD10 and CD95 or CD19, CD20, IgM, IgD, IgG and IgA for immunophenotyping of B cell markers and normalization of B cell numbers		PV1834	SDY80	0	Days	Time of initial vaccine administration		SUB114492		PBMC	2771
BS807779	Cryopreserved PBMCs were thawed, washed twice and the number of viable cells enumerated with an automated FACS based instrument (Millipore). A portion of the PBMCs were examined by flow cytometry using CD19, CD20, CD27, CD21, CD10 and CD95 or CD19, CD20, IgM, IgD, IgG and IgA for immunophenotyping of B cell markers and normalization of B cell numbers		PV4268	SDY80	7	Days	Time of initial vaccine administration		SUB114494		PBMC	2771
BS807780	Cryopreserved PBMCs were thawed, washed twice and the number of viable cells enumerated with an automated FACS based instrument (Millipore). A portion of the PBMCs were examined by flow cytometry using CD19, CD20, CD27, CD21, CD10 and CD95 or CD19, CD20, IgM, IgD, IgG and IgA for immunophenotyping of B cell markers and normalization of B cell numbers		PV1834	SDY80	0	Days	Time of initial vaccine administration		SUB114477		PBMC	2771
BS807790	Cryopreserved PBMCs were thawed, washed twice and the number of viable cells enumerated with an automated FACS based instrument (Millipore). A portion of the PBMCs were examined by flow cytometry using CD19, CD20, CD27, CD21, CD10 and CD95 or CD19, CD20, IgM, IgD, IgG and IgA for immunophenotyping of B cell markers and normalization of B cell numbers		PV1834	SDY80	0	Days	Time of initial vaccine administration		SUB114459		PBMC	2771
BS807796	Cryopreserved PBMCs were thawed, washed twice and the number of viable cells enumerated with an automated FACS based instrument (Millipore). A portion of the PBMCs were examined by flow cytometry using CD19, CD20, CD27, CD21, CD10 and CD95 or CD19, CD20, IgM, IgD, IgG and IgA for immunophenotyping of B cell markers and normalization of B cell numbers		PV1834	SDY80	0	Days	Time of initial vaccine administration		SUB114472		PBMC	2771
BS807797	Cryopreserved PBMCs were thawed, washed twice and the number of viable cells enumerated with an automated FACS based instrument (Millipore). A portion of the PBMCs were examined by flow cytometry using CD19, CD20, CD27, CD21, CD10 and CD95 or CD19, CD20, IgM, IgD, IgG and IgA for immunophenotyping of B cell markers and normalization of B cell numbers		PV4268	SDY80	7	Days	Time of initial vaccine administration		SUB114481		PBMC	2771
BS807813	Cryopreserved PBMCs were thawed, washed twice and the number of viable cells enumerated with an automated FACS based instrument (Millipore). A portion of the PBMCs were examined by flow cytometry using CD19, CD20, CD27, CD21, CD10 and CD95 or CD19, CD20, IgM, IgD, IgG and IgA for immunophenotyping of B cell markers and normalization of B cell numbers		PV4268	SDY80	7	Days	Time of initial vaccine administration		SUB114464		PBMC	2771
BS807817	Cryopreserved PBMCs were thawed, washed twice and the number of viable cells enumerated with an automated FACS based instrument (Millipore). A portion of the PBMCs were examined by flow cytometry using CD19, CD20, CD27, CD21, CD10 and CD95 or CD19, CD20, IgM, IgD, IgG and IgA for immunophenotyping of B cell markers and normalization of B cell numbers		PV4268	SDY80	7	Days	Time of initial vaccine administration		SUB114452		PBMC	2771
BS807831	Cryopreserved PBMCs were thawed, washed twice and the number of viable cells enumerated with an automated FACS based instrument (Millipore). A portion of the PBMCs were examined by flow cytometry using CD19, CD20, CD27, CD21, CD10 and CD95 or CD19, CD20, IgM, IgD, IgG and IgA for immunophenotyping of B cell markers and normalization of B cell numbers		PV4268	SDY80	7	Days	Time of initial vaccine administration		SUB114498		PBMC	2771
BS807839	Cryopreserved PBMCs were thawed, washed twice and the number of viable cells enumerated with an automated FACS based instrument (Millipore). A portion of the PBMCs were examined by flow cytometry using CD19, CD20, CD27, CD21, CD10 and CD95 or CD19, CD20, IgM, IgD, IgG and IgA for immunophenotyping of B cell markers and normalization of B cell numbers		PV1834	SDY80	0	Days	Time of initial vaccine administration		SUB114493		PBMC	2771
BS807855			PV4268	SDY80	7	Days	Time of initial vaccine administration		SUB114451		PBMC	2771
BS807861			PV4267	SDY80	-7	Days	Time of initial vaccine administration		SUB114452		PBMC	2771
BS807901			PV1834	SDY80	0	Days	Time of initial vaccine administration		SUB114461		PBMC	2771
BS807912			PV4267	SDY80	-7	Days	Time of initial vaccine administration		SUB114463		PBMC	2771
BS807924			PV1834	SDY80	0	Days	Time of initial vaccine administration		SUB114467		PBMC	2771
BS807933			PV4269	SDY80	70	Days	Time of initial vaccine administration		SUB114468		PBMC	2771
BS807941			PV4268	SDY80	7	Days	Time of initial vaccine administration		SUB114470		PBMC	2771
BS807962			PV1834	SDY80	0	Days	Time of initial vaccine administration		SUB114476		PBMC	2771
BS807965			PV4269	SDY80	70	Days	Time of initial vaccine administration		SUB114476		PBMC	2771
BS807976			PV1834	SDY80	0	Days	Time of initial vaccine administration		SUB114479		PBMC	2771
BS807983			PV4267	SDY80	-7	Days	Time of initial vaccine administration		SUB114481		PBMC	2771
BS807991			PV4268	SDY80	7	Days	Time of initial vaccine administration		SUB114483		PBMC	2771
BS807996			PV4268	SDY80	7	Days	Time of initial vaccine administration		SUB114485		PBMC	2771
BS808004			PV1835	SDY80	1	Days	Time of initial vaccine administration		SUB114487		PBMC	2771
BS808019			PV1834	SDY80	0	Days	Time of initial vaccine administration		SUB114492		PBMC	2771
BS808020			PV1835	SDY80	1	Days	Time of initial vaccine administration		SUB114492		PBMC	2771
BS808022			PV4269	SDY80	70	Days	Time of initial vaccine administration		SUB114492		PBMC	2771
BS808039			PV4267	SDY80	-7	Days	Time of initial vaccine administration		SUB114496		PBMC	2771
BS808045			PV4267	SDY80	-7	Days	Time of initial vaccine administration		SUB114498		PBMC	2771
BS808047			PV1834	SDY80	0	Days	Time of initial vaccine administration		SUB114499		PBMC	2771
BS808058			PV4269	SDY80	70	Days	Time of initial vaccine administration		SUB114502		PBMC	2771
BS808059			PV1834	SDY80	0	Days	Time of initial vaccine administration		SUB114503		PBMC	2771
BS808075			PV4267	SDY80	-7	Days	Time of initial vaccine administration		SUB114507		PBMC	2771
BS808077			PV1834	SDY80	0	Days	Time of initial vaccine administration		SUB114508		PBMC	2771
BS808078			PV4268	SDY80	7	Days	Time of initial vaccine administration		SUB114508		PBMC	2771
BS808092			PV4269	SDY80	70	Days	Time of initial vaccine administration		SUB114512		PBMC	2771
BS808094	Cryopreserved PBMCs were thawed, washed twice and the number of viable cells enumerated with an automated FACS based instrument (Millipore). A portion of the PBMCs were examined by flow cytometry using CD19, CD20, CD27, CD21, CD10 and CD95 or CD19, CD20, IgM, IgD, IgG and IgA for immunophenotyping of B cell markers and normalization of B cell numbers		PV1834	SDY80	0	Days	Time of initial vaccine administration		SUB114463		PBMC	2771
BS808097	Cryopreserved PBMCs were thawed, washed twice and the number of viable cells enumerated with an automated FACS based instrument (Millipore). A portion of the PBMCs were examined by flow cytometry using CD19, CD20, CD27, CD21, CD10 and CD95 or CD19, CD20, IgM, IgD, IgG and IgA for immunophenotyping of B cell markers and normalization of B cell numbers		PV1834	SDY80	0	Days	Time of initial vaccine administration		SUB114464		PBMC	2771
BS808108	Cryopreserved PBMCs were thawed, washed twice and the number of viable cells enumerated with an automated FACS based instrument (Millipore). A portion of the PBMCs were examined by flow cytometry using CD19, CD20, CD27, CD21, CD10 and CD95 or CD19, CD20, IgM, IgD, IgG and IgA for immunophenotyping of B cell markers and normalization of B cell numbers		PV1834	SDY80	0	Days	Time of initial vaccine administration		SUB114459		PBMC	2771
BS808110	Cryopreserved PBMCs were thawed, washed twice and the number of viable cells enumerated with an automated FACS based instrument (Millipore). A portion of the PBMCs were examined by flow cytometry using CD19, CD20, CD27, CD21, CD10 and CD95 or CD19, CD20, IgM, IgD, IgG and IgA for immunophenotyping of B cell markers and normalization of B cell numbers		PV1834	SDY80	0	Days	Time of initial vaccine administration		SUB114509		PBMC	2771
BS808112	Cryopreserved PBMCs were thawed, washed twice and the number of viable cells enumerated with an automated FACS based instrument (Millipore). A portion of the PBMCs were examined by flow cytometry using CD19, CD20, CD27, CD21, CD10 and CD95 or CD19, CD20, IgM, IgD, IgG and IgA for immunophenotyping of B cell markers and normalization of B cell numbers		PV4267	SDY80	-7	Days	Time of initial vaccine administration		SUB114484		PBMC	2771
BS808114	Cryopreserved PBMCs were thawed, washed twice and the number of viable cells enumerated with an automated FACS based instrument (Millipore). A portion of the PBMCs were examined by flow cytometry using CD19, CD20, CD27, CD21, CD10 and CD95 or CD19, CD20, IgM, IgD, IgG and IgA for immunophenotyping of B cell markers and normalization of B cell numbers		PV1834	SDY80	0	Days	Time of initial vaccine administration		SUB114484		PBMC	2771
BS808121	Cryopreserved PBMCs were thawed, washed twice and the number of viable cells enumerated with an automated FACS based instrument (Millipore). A portion of the PBMCs were examined by flow cytometry using CD19, CD20, CD27, CD21, CD10 and CD95 or CD19, CD20, IgM, IgD, IgG and IgA for immunophenotyping of B cell markers and normalization of B cell numbers		PV1834	SDY80	0	Days	Time of initial vaccine administration		SUB114451		PBMC	2771
BS808127	Cryopreserved PBMCs were thawed, washed twice and the number of viable cells enumerated with an automated FACS based instrument (Millipore). A portion of the PBMCs were examined by flow cytometry using CD19, CD20, CD27, CD21, CD10 and CD95 or CD19, CD20, IgM, IgD, IgG and IgA for immunophenotyping of B cell markers and normalization of B cell numbers		PV1834	SDY80	0	Days	Time of initial vaccine administration		SUB114452		PBMC	2771
BS808132	Cryopreserved PBMCs were thawed, washed twice and the number of viable cells enumerated with an automated FACS based instrument (Millipore). A portion of the PBMCs were examined by flow cytometry using CD19, CD20, CD27, CD21, CD10 and CD95 or CD19, CD20, IgM, IgD, IgG and IgA for immunophenotyping of B cell markers and normalization of B cell numbers		PV1834	SDY80	0	Days	Time of initial vaccine administration		SUB114503		PBMC	2771
BS808137	Cryopreserved PBMCs were thawed, washed twice and the number of viable cells enumerated with an automated FACS based instrument (Millipore). A portion of the PBMCs were examined by flow cytometry using CD19, CD20, CD27, CD21, CD10 and CD95 or CD19, CD20, IgM, IgD, IgG and IgA for immunophenotyping of B cell markers and normalization of B cell numbers		PV1834	SDY80	0	Days	Time of initial vaccine administration		SUB114511		PBMC	2771
BS808153	Cryopreserved PBMCs were thawed, washed twice and the number of viable cells enumerated with an automated FACS based instrument (Millipore). A portion of the PBMCs were examined by flow cytometry using CD19, CD20, CD27, CD21, CD10 and CD95 or CD19, CD20, IgM, IgD, IgG and IgA for immunophenotyping of B cell markers and normalization of B cell numbers		PV4269	SDY80	70	Days	Time of initial vaccine administration		SUB114480		PBMC	2771
BS808154	Cryopreserved PBMCs were thawed, washed twice and the number of viable cells enumerated with an automated FACS based instrument (Millipore). A portion of the PBMCs were examined by flow cytometry using CD19, CD20, CD27, CD21, CD10 and CD95 or CD19, CD20, IgM, IgD, IgG and IgA for immunophenotyping of B cell markers and normalization of B cell numbers		PV1834	SDY80	0	Days	Time of initial vaccine administration		SUB114487		PBMC	2771
BS808157	Cryopreserved PBMCs were thawed, washed twice and the number of viable cells enumerated with an automated FACS based instrument (Millipore). A portion of the PBMCs were examined by flow cytometry using CD19, CD20, CD27, CD21, CD10 and CD95 or CD19, CD20, IgM, IgD, IgG and IgA for immunophenotyping of B cell markers and normalization of B cell numbers		PV4267	SDY80	-7	Days	Time of initial vaccine administration		SUB114467		PBMC	2771
BS808158	Cryopreserved PBMCs were thawed, washed twice and the number of viable cells enumerated with an automated FACS based instrument (Millipore). A portion of the PBMCs were examined by flow cytometry using CD19, CD20, CD27, CD21, CD10 and CD95 or CD19, CD20, IgM, IgD, IgG and IgA for immunophenotyping of B cell markers and normalization of B cell numbers		PV4267	SDY80	-7	Days	Time of initial vaccine administration		SUB114455		PBMC	2771
BS808166	Cryopreserved PBMCs were thawed, washed twice and the number of viable cells enumerated with an automated FACS based instrument (Millipore). A portion of the PBMCs were examined by flow cytometry using CD19, CD20, CD27, CD21, CD10 and CD95 or CD19, CD20, IgM, IgD, IgG and IgA for immunophenotyping of B cell markers and normalization of B cell numbers		PV4267	SDY80	-7	Days	Time of initial vaccine administration		SUB114473		PBMC	2771
BS808173	Cryopreserved PBMCs were thawed, washed twice and the number of viable cells enumerated with an automated FACS based instrument (Millipore). A portion of the PBMCs were examined by flow cytometry using CD19, CD20, CD27, CD21, CD10 and CD95 or CD19, CD20, IgM, IgD, IgG and IgA for immunophenotyping of B cell markers and normalization of B cell numbers		PV1834	SDY80	0	Days	Time of initial vaccine administration		SUB114497		PBMC	2771
BS808178	Cryopreserved PBMCs were thawed, washed twice and the number of viable cells enumerated with an automated FACS based instrument (Millipore). A portion of the PBMCs were examined by flow cytometry using CD19, CD20, CD27, CD21, CD10 and CD95 or CD19, CD20, IgM, IgD, IgG and IgA for immunophenotyping of B cell markers and normalization of B cell numbers		PV4267	SDY80	-7	Days	Time of initial vaccine administration		SUB114458		PBMC	2771
BS808206		201_day-7	PV4267	SDY80	-7	Days	Time of initial vaccine administration		SUB114451	201.Blood.RNA-MicroArray.PV4267	RNA	2771
BS808207		202_day-7	PV4267	SDY80	-7	Days	Time of initial vaccine administration		SUB114452	202.Blood.RNA-MicroArray.PV4267	RNA	2771
BS808212		209_day-7	PV4267	SDY80	-7	Days	Time of initial vaccine administration		SUB114457	209.Blood.RNA-MicroArray.PV4267	RNA	2771
BS808218		221_day-7	PV4267	SDY80	-7	Days	Time of initial vaccine administration		SUB114463	221.Blood.RNA-MicroArray.PV4267	RNA	2771
BS808220		224_day-7	PV4267	SDY80	-7	Days	Time of initial vaccine administration		SUB114465	224.Blood.RNA-MicroArray.PV4267	RNA	2771
BS808221		226_day-7	PV4267	SDY80	-7	Days	Time of initial vaccine administration		SUB114466	226.Blood.RNA-MicroArray.PV4267	RNA	2771
BS808225		230_day-7	PV4267	SDY80	-7	Days	Time of initial vaccine administration		SUB114470	230.Blood.RNA-MicroArray.PV4267	RNA	2771
BS808249		263_day-7	PV4267	SDY80	-7	Days	Time of initial vaccine administration		SUB114497	263.Blood.RNA-MicroArray.PV4267	RNA	2771
BS808266		201_day7	PV4268	SDY80	7	Days	Time of initial vaccine administration		SUB114451	201.Blood.RNA-MicroArray.PV4268	RNA	2771
BS808270		206_day7	PV4268	SDY80	7	Days	Time of initial vaccine administration		SUB114455	206.Blood.RNA-MicroArray.PV4268	RNA	2771
BS808283		230_day7	PV4268	SDY80	7	Days	Time of initial vaccine administration		SUB114470	230.Blood.RNA-MicroArray.PV4268	RNA	2771
BS808291		241_day7	PV4268	SDY80	7	Days	Time of initial vaccine administration		SUB114478	241.Blood.RNA-MicroArray.PV4268	RNA	2771
BS808306		259_day7	PV4268	SDY80	7	Days	Time of initial vaccine administration		SUB114493	259.Blood.RNA-MicroArray.PV4268	RNA	2771
BS808311		267_day7	PV4268	SDY80	7	Days	Time of initial vaccine administration		SUB114499	267.Blood.RNA-MicroArray.PV4268	RNA	2771
BS808326		205_day70	PV4269	SDY80	70	Days	Time of initial vaccine administration		SUB114454	205.Blood.RNA-MicroArray.PV4269	RNA	2771
BS808328		207_day70	PV4269	SDY80	70	Days	Time of initial vaccine administration		SUB114456	207.Blood.RNA-MicroArray.PV4269	RNA	2771
BS808343		232_day70	PV4269	SDY80	70	Days	Time of initial vaccine administration		SUB114472	232.Blood.RNA-MicroArray.PV4269	RNA	2771
BS806084			PV1834	SDY80	0	Days	Time of initial vaccine administration		SUB114450		Serum	2771
BS806090			PV1835	SDY80	1	Days	Time of initial vaccine administration		SUB114451		Serum	2771
BS806103			PV4269	SDY80	70	Days	Time of initial vaccine administration		SUB114453		Serum	2771
BS806105			PV1835	SDY80	1	Days	Time of initial vaccine administration		SUB114454		Serum	2771
BS806109			PV1834	SDY80	0	Days	Time of initial vaccine administration		SUB114455		Serum	2771
BS806114			PV1834	SDY80	0	Days	Time of initial vaccine administration		SUB114456		Serum	2771
BS806123			PV1835	SDY80	1	Days	Time of initial vaccine administration		SUB114458		Serum	2771
BS806129			PV4268	SDY80	7	Days	Time of initial vaccine administration		SUB114459		Serum	2771
BS806133			PV1835	SDY80	1	Days	Time of initial vaccine administration		SUB114460		Serum	2771
BS806136			PV4269	SDY80	70	Days	Time of initial vaccine administration		SUB114460		Serum	2771
BS806146			PV4269	SDY80	70	Days	Time of initial vaccine administration		SUB114462		Serum	2771
BS806171			PV1835	SDY80	1	Days	Time of initial vaccine administration		SUB114468		Serum	2771
BS806185			PV1834	SDY80	0	Days	Time of initial vaccine administration		SUB114471		Serum	2771
BS808350		243_day70	PV4269	SDY80	70	Days	Time of initial vaccine administration		SUB114480	243.Blood.RNA-MicroArray.PV4269	RNA	2771
BS808359		254_day70	PV4269	SDY80	70	Days	Time of initial vaccine administration		SUB114490	254.Blood.RNA-MicroArray.PV4269	RNA	2771
BS808376		281_day70	PV4269	SDY80	70	Days	Time of initial vaccine administration		SUB114509	281.Blood.RNA-MicroArray.PV4269	RNA	2771
BS807735	Cryopreserved PBMCs were thawed, washed twice and the number of viable cells enumerated with an automated FACS based instrument (Millipore). A portion of the PBMCs were examined by flow cytometry using CD19, CD20, CD27, CD21, CD10 and CD95 or CD19, CD20, IgM, IgD, IgG and IgA for immunophenotyping of B cell markers and normalization of B cell numbers		PV1834	SDY80	0	Days	Time of initial vaccine administration		SUB114458		PBMC	2771
BS807741	Cryopreserved PBMCs were thawed, washed twice and the number of viable cells enumerated with an automated FACS based instrument (Millipore). A portion of the PBMCs were examined by flow cytometry using CD19, CD20, CD27, CD21, CD10 and CD95 or CD19, CD20, IgM, IgD, IgG and IgA for immunophenotyping of B cell markers and normalization of B cell numbers		PV4268	SDY80	7	Days	Time of initial vaccine administration		SUB114503		PBMC	2771
BS807748	Cryopreserved PBMCs were thawed, washed twice and the number of viable cells enumerated with an automated FACS based instrument (Millipore). A portion of the PBMCs were examined by flow cytometry using CD19, CD20, CD27, CD21, CD10 and CD95 or CD19, CD20, IgM, IgD, IgG and IgA for immunophenotyping of B cell markers and normalization of B cell numbers		PV1834	SDY80	0	Days	Time of initial vaccine administration		SUB114469		PBMC	2771
BS807750	Cryopreserved PBMCs were thawed, washed twice and the number of viable cells enumerated with an automated FACS based instrument (Millipore). A portion of the PBMCs were examined by flow cytometry using CD19, CD20, CD27, CD21, CD10 and CD95 or CD19, CD20, IgM, IgD, IgG and IgA for immunophenotyping of B cell markers and normalization of B cell numbers		PV1834	SDY80	0	Days	Time of initial vaccine administration		SUB114474		PBMC	2771
BS953290			PV6192	SDY80	28	Days	Time of initial vaccine administration		SUB114496		Serum	2771
BS953301			PV6192	SDY80	28	Days	Time of initial vaccine administration		SUB114458		Serum	2771
BS953328			PV6192	SDY80	28	Days	Time of initial vaccine administration		SUB114489		Serum	2771
BS953340			PV6192	SDY80	28	Days	Time of initial vaccine administration		SUB114503		Serum	2771
BS953346			PV6192	SDY80	28	Days	Time of initial vaccine administration		SUB114510		Serum	2771
BS630807	Before vaccine		PV1834	SDY80	0	Days	Time of initial vaccine administration		SUB114463		RNA	2771
BS630811	Before vaccine		PV1834	SDY80	0	Days	Time of initial vaccine administration		SUB114467		RNA	2771
BS630814	Before vaccine		PV1834	SDY80	0	Days	Time of initial vaccine administration		SUB114470		RNA	2771
BS630817	Before vaccine		PV1834	SDY80	0	Days	Time of initial vaccine administration		SUB114473		RNA	2771
BS630824	Before vaccine		PV1834	SDY80	0	Days	Time of initial vaccine administration		SUB114480		RNA	2771
BS630827	Before vaccine		PV1834	SDY80	0	Days	Time of initial vaccine administration		SUB114483		RNA	2771
BS630839	Before vaccine		PV1834	SDY80	0	Days	Time of initial vaccine administration		SUB114495		RNA	2771
BS630845	Before vaccine		PV1834	SDY80	0	Days	Time of initial vaccine administration		SUB114501		RNA	2771
BS630867	After vaccine		PV1835	SDY80	1	Days	Time of initial vaccine administration		SUB114460		RNA	2771
BS630877	After vaccine		PV1835	SDY80	1	Days	Time of initial vaccine administration		SUB114470		RNA	2771
BS630878	After vaccine		PV1835	SDY80	1	Days	Time of initial vaccine administration		SUB114471		RNA	2771
BS630882	After vaccine		PV1835	SDY80	1	Days	Time of initial vaccine administration		SUB114475		RNA	2771
BS630883	After vaccine		PV1835	SDY80	1	Days	Time of initial vaccine administration		SUB114476		RNA	2771
BS630888	After vaccine		PV1835	SDY80	1	Days	Time of initial vaccine administration		SUB114481		RNA	2771
BS630891	After vaccine		PV1835	SDY80	1	Days	Time of initial vaccine administration		SUB114484		RNA	2771
BS630900	After vaccine		PV1835	SDY80	1	Days	Time of initial vaccine administration		SUB114493		RNA	2771
BS630905	After vaccine		PV1835	SDY80	1	Days	Time of initial vaccine administration		SUB114498		RNA	2771
BS806199			PV4269	SDY80	70	Days	Time of initial vaccine administration		SUB114473		Serum	2771
BS806211			PV1835	SDY80	1	Days	Time of initial vaccine administration		SUB114476		Serum	2771
BS806215			PV1835	SDY80	1	Days	Time of initial vaccine administration		SUB114477		Serum	2771
BS806217			PV4267	SDY80	-7	Days	Time of initial vaccine administration		SUB114477		Serum	2771
BS806236			PV4268	SDY80	7	Days	Time of initial vaccine administration		SUB114482		Serum	2771
BS806243			PV4269	SDY80	70	Days	Time of initial vaccine administration		SUB114483		Serum	2771
BS806246			PV4268	SDY80	7	Days	Time of initial vaccine administration		SUB114484		Serum	2771
BS806247			PV4267	SDY80	-7	Days	Time of initial vaccine administration		SUB114484		Serum	2771
BS806251			PV1834	SDY80	0	Days	Time of initial vaccine administration		SUB114486		Serum	2771
BS806252			PV1835	SDY80	1	Days	Time of initial vaccine administration		SUB114486		Serum	2771
BS806253			PV4268	SDY80	7	Days	Time of initial vaccine administration		SUB114486		Serum	2771
BS806255			PV4269	SDY80	70	Days	Time of initial vaccine administration		SUB114486		Serum	2771
BS806256			PV1834	SDY80	0	Days	Time of initial vaccine administration		SUB114487		Serum	2771
BS806260			PV4269	SDY80	70	Days	Time of initial vaccine administration		SUB114487		Serum	2771
BS806270			PV4269	SDY80	70	Days	Time of initial vaccine administration		SUB114489		Serum	2771
BS806285			PV4269	SDY80	70	Days	Time of initial vaccine administration		SUB114492		Serum	2771
BS806298			PV4268	SDY80	7	Days	Time of initial vaccine administration		SUB114495		Serum	2771
BS806299			PV4267	SDY80	-7	Days	Time of initial vaccine administration		SUB114495		Serum	2771
BS806302			PV1834	SDY80	0	Days	Time of initial vaccine administration		SUB114497		Serum	2771
BS806325			PV4267	SDY80	-7	Days	Time of initial vaccine administration		SUB114501		Serum	2771
BS806327			PV1834	SDY80	0	Days	Time of initial vaccine administration		SUB114502		Serum	2771
BS806333			PV1835	SDY80	1	Days	Time of initial vaccine administration		SUB114503		Serum	2771
BS806347			PV1834	SDY80	0	Days	Time of initial vaccine administration		SUB114507		Serum	2771
BS806369			PV4267	SDY80	-7	Days	Time of initial vaccine administration		SUB114511		Serum	2771
BS806371			PV1834	SDY80	0	Days	Time of initial vaccine administration		SUB114512		Serum	2771
BS806372			PV1835	SDY80	1	Days	Time of initial vaccine administration		SUB114512		Serum	2771
BS806375			PV4269	SDY80	70	Days	Time of initial vaccine administration		SUB114512		Serum	2771
BS807781	Cryopreserved PBMCs were thawed, washed twice and the number of viable cells enumerated with an automated FACS based instrument (Millipore). A portion of the PBMCs were examined by flow cytometry using CD19, CD20, CD27, CD21, CD10 and CD95 or CD19, CD20, IgM, IgD, IgG and IgA for immunophenotyping of B cell markers and normalization of B cell numbers		PV4268	SDY80	7	Days	Time of initial vaccine administration		SUB114499		PBMC	2771
BS807785	Cryopreserved PBMCs were thawed, washed twice and the number of viable cells enumerated with an automated FACS based instrument (Millipore). A portion of the PBMCs were examined by flow cytometry using CD19, CD20, CD27, CD21, CD10 and CD95 or CD19, CD20, IgM, IgD, IgG and IgA for immunophenotyping of B cell markers and normalization of B cell numbers		PV1834	SDY80	0	Days	Time of initial vaccine administration		SUB114491		PBMC	2771
BS807787	Cryopreserved PBMCs were thawed, washed twice and the number of viable cells enumerated with an automated FACS based instrument (Millipore). A portion of the PBMCs were examined by flow cytometry using CD19, CD20, CD27, CD21, CD10 and CD95 or CD19, CD20, IgM, IgD, IgG and IgA for immunophenotyping of B cell markers and normalization of B cell numbers		PV1834	SDY80	0	Days	Time of initial vaccine administration		SUB114499		PBMC	2771
BS807791	Cryopreserved PBMCs were thawed, washed twice and the number of viable cells enumerated with an automated FACS based instrument (Millipore). A portion of the PBMCs were examined by flow cytometry using CD19, CD20, CD27, CD21, CD10 and CD95 or CD19, CD20, IgM, IgD, IgG and IgA for immunophenotyping of B cell markers and normalization of B cell numbers		PV1834	SDY80	0	Days	Time of initial vaccine administration		SUB114463		PBMC	2771
BS807798	Cryopreserved PBMCs were thawed, washed twice and the number of viable cells enumerated with an automated FACS based instrument (Millipore). A portion of the PBMCs were examined by flow cytometry using CD19, CD20, CD27, CD21, CD10 and CD95 or CD19, CD20, IgM, IgD, IgG and IgA for immunophenotyping of B cell markers and normalization of B cell numbers		PV4268	SDY80	7	Days	Time of initial vaccine administration		SUB114450		PBMC	2771
BS807801	Cryopreserved PBMCs were thawed, washed twice and the number of viable cells enumerated with an automated FACS based instrument (Millipore). A portion of the PBMCs were examined by flow cytometry using CD19, CD20, CD27, CD21, CD10 and CD95 or CD19, CD20, IgM, IgD, IgG and IgA for immunophenotyping of B cell markers and normalization of B cell numbers		PV4268	SDY80	7	Days	Time of initial vaccine administration		SUB114473		PBMC	2771
BS807811	Cryopreserved PBMCs were thawed, washed twice and the number of viable cells enumerated with an automated FACS based instrument (Millipore). A portion of the PBMCs were examined by flow cytometry using CD19, CD20, CD27, CD21, CD10 and CD95 or CD19, CD20, IgM, IgD, IgG and IgA for immunophenotyping of B cell markers and normalization of B cell numbers		PV1834	SDY80	0	Days	Time of initial vaccine administration		SUB114509		PBMC	2771
BS807814	Cryopreserved PBMCs were thawed, washed twice and the number of viable cells enumerated with an automated FACS based instrument (Millipore). A portion of the PBMCs were examined by flow cytometry using CD19, CD20, CD27, CD21, CD10 and CD95 or CD19, CD20, IgM, IgD, IgG and IgA for immunophenotyping of B cell markers and normalization of B cell numbers		PV1834	SDY80	0	Days	Time of initial vaccine administration		SUB114450		PBMC	2771
BS807816	Cryopreserved PBMCs were thawed, washed twice and the number of viable cells enumerated with an automated FACS based instrument (Millipore). A portion of the PBMCs were examined by flow cytometry using CD19, CD20, CD27, CD21, CD10 and CD95 or CD19, CD20, IgM, IgD, IgG and IgA for immunophenotyping of B cell markers and normalization of B cell numbers		PV1834	SDY80	0	Days	Time of initial vaccine administration		SUB114462		PBMC	2771
BS807827	Cryopreserved PBMCs were thawed, washed twice and the number of viable cells enumerated with an automated FACS based instrument (Millipore). A portion of the PBMCs were examined by flow cytometry using CD19, CD20, CD27, CD21, CD10 and CD95 or CD19, CD20, IgM, IgD, IgG and IgA for immunophenotyping of B cell markers and normalization of B cell numbers		PV4268	SDY80	7	Days	Time of initial vaccine administration		SUB114511		PBMC	2771
BS807846	Cryopreserved PBMCs were thawed, washed twice and the number of viable cells enumerated with an automated FACS based instrument (Millipore). A portion of the PBMCs were examined by flow cytometry using CD19, CD20, CD27, CD21, CD10 and CD95 or CD19, CD20, IgM, IgD, IgG and IgA for immunophenotyping of B cell markers and normalization of B cell numbers		PV1834	SDY80	0	Days	Time of initial vaccine administration		SUB114488		PBMC	2771
BS807847	Cryopreserved PBMCs were thawed, washed twice and the number of viable cells enumerated with an automated FACS based instrument (Millipore). A portion of the PBMCs were examined by flow cytometry using CD19, CD20, CD27, CD21, CD10 and CD95 or CD19, CD20, IgM, IgD, IgG and IgA for immunophenotyping of B cell markers and normalization of B cell numbers		PV4268	SDY80	7	Days	Time of initial vaccine administration		SUB114488		PBMC	2771
BS807849			PV1835	SDY80	1	Days	Time of initial vaccine administration		SUB114450		PBMC	2771
BS807869			PV1835	SDY80	1	Days	Time of initial vaccine administration		SUB114454		PBMC	2771
BS807879			PV4267	SDY80	-7	Days	Time of initial vaccine administration		SUB114456		PBMC	2771
BS807891			PV1834	SDY80	0	Days	Time of initial vaccine administration		SUB114459		PBMC	2771
BS807893			PV4268	SDY80	7	Days	Time of initial vaccine administration		SUB114459		PBMC	2771
BS807896			PV1834	SDY80	0	Days	Time of initial vaccine administration		SUB114460		PBMC	2771
BS807902			PV1835	SDY80	1	Days	Time of initial vaccine administration		SUB114461		PBMC	2771
BS807911			PV4268	SDY80	7	Days	Time of initial vaccine administration		SUB114463		PBMC	2771
BS807915			PV1835	SDY80	1	Days	Time of initial vaccine administration		SUB114464		PBMC	2771
BS807923			PV4269	SDY80	70	Days	Time of initial vaccine administration		SUB114465		PBMC	2771
BS807925			PV1835	SDY80	1	Days	Time of initial vaccine administration		SUB114467		PBMC	2771
BS807926			PV4268	SDY80	7	Days	Time of initial vaccine administration		SUB114467		PBMC	2771
BS807928			PV4269	SDY80	70	Days	Time of initial vaccine administration		SUB114467		PBMC	2771
BS807937			PV4267	SDY80	-7	Days	Time of initial vaccine administration		SUB114469		PBMC	2771
BS807939			PV1834	SDY80	0	Days	Time of initial vaccine administration		SUB114470		PBMC	2771
BS807951			PV1834	SDY80	0	Days	Time of initial vaccine administration		SUB114473		PBMC	2771
BS807960			PV4268	SDY80	7	Days	Time of initial vaccine administration		SUB114475		PBMC	2771
BS807978			PV4268	SDY80	7	Days	Time of initial vaccine administration		SUB114479		PBMC	2771
BS807985			PV1835	SDY80	1	Days	Time of initial vaccine administration		SUB114482		PBMC	2771
BS807992			PV4267	SDY80	-7	Days	Time of initial vaccine administration		SUB114483		PBMC	2771
BS807995			PV1835	SDY80	1	Days	Time of initial vaccine administration		SUB114485		PBMC	2771
BS808005			PV4268	SDY80	7	Days	Time of initial vaccine administration		SUB114487		PBMC	2771
BS808016			PV1835	SDY80	1	Days	Time of initial vaccine administration		SUB114491		PBMC	2771
BS808021			PV4267	SDY80	-7	Days	Time of initial vaccine administration		SUB114492		PBMC	2771
BS808029			PV4267	SDY80	-7	Days	Time of initial vaccine administration		SUB114494		PBMC	2771
BS808030			PV4269	SDY80	70	Days	Time of initial vaccine administration		SUB114494		PBMC	2771
BS808044			PV1835	SDY80	1	Days	Time of initial vaccine administration		SUB114498		PBMC	2771
BS808053			PV4269	SDY80	70	Days	Time of initial vaccine administration		SUB114500		PBMC	2771
BS808060			PV1835	SDY80	1	Days	Time of initial vaccine administration		SUB114503		PBMC	2771
BS808068			PV4269	SDY80	70	Days	Time of initial vaccine administration		SUB114504		PBMC	2771
BS808069			PV1834	SDY80	0	Days	Time of initial vaccine administration		SUB114506		PBMC	2771
BS808070			PV1835	SDY80	1	Days	Time of initial vaccine administration		SUB114506		PBMC	2771
BS808071			PV4268	SDY80	7	Days	Time of initial vaccine administration		SUB114506		PBMC	2771
BS808073			PV4269	SDY80	70	Days	Time of initial vaccine administration		SUB114506		PBMC	2771
BS808076			PV4269	SDY80	70	Days	Time of initial vaccine administration		SUB114507		PBMC	2771
BS808081			PV4268	SDY80	7	Days	Time of initial vaccine administration		SUB114510		PBMC	2771
BS808093	Cryopreserved PBMCs were thawed, washed twice and the number of viable cells enumerated with an automated FACS based instrument (Millipore). A portion of the PBMCs were examined by flow cytometry using CD19, CD20, CD27, CD21, CD10 and CD95 or CD19, CD20, IgM, IgD, IgG and IgA for immunophenotyping of B cell markers and normalization of B cell numbers		PV1834	SDY80	0	Days	Time of initial vaccine administration		SUB114495		PBMC	2771
BS808100	Cryopreserved PBMCs were thawed, washed twice and the number of viable cells enumerated with an automated FACS based instrument (Millipore). A portion of the PBMCs were examined by flow cytometry using CD19, CD20, CD27, CD21, CD10 and CD95 or CD19, CD20, IgM, IgD, IgG and IgA for immunophenotyping of B cell markers and normalization of B cell numbers		PV4267	SDY80	-7	Days	Time of initial vaccine administration		SUB114469		PBMC	2771
BS808113	Cryopreserved PBMCs were thawed, washed twice and the number of viable cells enumerated with an automated FACS based instrument (Millipore). A portion of the PBMCs were examined by flow cytometry using CD19, CD20, CD27, CD21, CD10 and CD95 or CD19, CD20, IgM, IgD, IgG and IgA for immunophenotyping of B cell markers and normalization of B cell numbers		PV4269	SDY80	70	Days	Time of initial vaccine administration		SUB114476		PBMC	2771
BS808120	Cryopreserved PBMCs were thawed, washed twice and the number of viable cells enumerated with an automated FACS based instrument (Millipore). A portion of the PBMCs were examined by flow cytometry using CD19, CD20, CD27, CD21, CD10 and CD95 or CD19, CD20, IgM, IgD, IgG and IgA for immunophenotyping of B cell markers and normalization of B cell numbers		PV1834	SDY80	0	Days	Time of initial vaccine administration		SUB114492		PBMC	2771
BS808125	Cryopreserved PBMCs were thawed, washed twice and the number of viable cells enumerated with an automated FACS based instrument (Millipore). A portion of the PBMCs were examined by flow cytometry using CD19, CD20, CD27, CD21, CD10 and CD95 or CD19, CD20, IgM, IgD, IgG and IgA for immunophenotyping of B cell markers and normalization of B cell numbers		PV1834	SDY80	0	Days	Time of initial vaccine administration		SUB114483		PBMC	2771
BS808134	Cryopreserved PBMCs were thawed, washed twice and the number of viable cells enumerated with an automated FACS based instrument (Millipore). A portion of the PBMCs were examined by flow cytometry using CD19, CD20, CD27, CD21, CD10 and CD95 or CD19, CD20, IgM, IgD, IgG and IgA for immunophenotyping of B cell markers and normalization of B cell numbers		PV1834	SDY80	0	Days	Time of initial vaccine administration		SUB114512		PBMC	2771
BS808135	Cryopreserved PBMCs were thawed, washed twice and the number of viable cells enumerated with an automated FACS based instrument (Millipore). A portion of the PBMCs were examined by flow cytometry using CD19, CD20, CD27, CD21, CD10 and CD95 or CD19, CD20, IgM, IgD, IgG and IgA for immunophenotyping of B cell markers and normalization of B cell numbers		PV1834	SDY80	0	Days	Time of initial vaccine administration		SUB114472		PBMC	2771
BS808136	Cryopreserved PBMCs were thawed, washed twice and the number of viable cells enumerated with an automated FACS based instrument (Millipore). A portion of the PBMCs were examined by flow cytometry using CD19, CD20, CD27, CD21, CD10 and CD95 or CD19, CD20, IgM, IgD, IgG and IgA for immunophenotyping of B cell markers and normalization of B cell numbers		PV1834	SDY80	0	Days	Time of initial vaccine administration		SUB114474		PBMC	2771
BS808141	Cryopreserved PBMCs were thawed, washed twice and the number of viable cells enumerated with an automated FACS based instrument (Millipore). A portion of the PBMCs were examined by flow cytometry using CD19, CD20, CD27, CD21, CD10 and CD95 or CD19, CD20, IgM, IgD, IgG and IgA for immunophenotyping of B cell markers and normalization of B cell numbers		PV1834	SDY80	0	Days	Time of initial vaccine administration		SUB114488		PBMC	2771
BS808151	Cryopreserved PBMCs were thawed, washed twice and the number of viable cells enumerated with an automated FACS based instrument (Millipore). A portion of the PBMCs were examined by flow cytometry using CD19, CD20, CD27, CD21, CD10 and CD95 or CD19, CD20, IgM, IgD, IgG and IgA for immunophenotyping of B cell markers and normalization of B cell numbers		PV4267	SDY80	-7	Days	Time of initial vaccine administration		SUB114509		PBMC	2771
BS808161	Cryopreserved PBMCs were thawed, washed twice and the number of viable cells enumerated with an automated FACS based instrument (Millipore). A portion of the PBMCs were examined by flow cytometry using CD19, CD20, CD27, CD21, CD10 and CD95 or CD19, CD20, IgM, IgD, IgG and IgA for immunophenotyping of B cell markers and normalization of B cell numbers		PV1834	SDY80	0	Days	Time of initial vaccine administration		SUB114456		PBMC	2771
BS808165	Cryopreserved PBMCs were thawed, washed twice and the number of viable cells enumerated with an automated FACS based instrument (Millipore). A portion of the PBMCs were examined by flow cytometry using CD19, CD20, CD27, CD21, CD10 and CD95 or CD19, CD20, IgM, IgD, IgG and IgA for immunophenotyping of B cell markers and normalization of B cell numbers		PV1834	SDY80	0	Days	Time of initial vaccine administration		SUB114481		PBMC	2771
BS808177	Cryopreserved PBMCs were thawed, washed twice and the number of viable cells enumerated with an automated FACS based instrument (Millipore). A portion of the PBMCs were examined by flow cytometry using CD19, CD20, CD27, CD21, CD10 and CD95 or CD19, CD20, IgM, IgD, IgG and IgA for immunophenotyping of B cell markers and normalization of B cell numbers		PV4267	SDY80	-7	Days	Time of initial vaccine administration		SUB114499		PBMC	2771
BS808179	Cryopreserved PBMCs were thawed, washed twice and the number of viable cells enumerated with an automated FACS based instrument (Millipore). A portion of the PBMCs were examined by flow cytometry using CD19, CD20, CD27, CD21, CD10 and CD95 or CD19, CD20, IgM, IgD, IgG and IgA for immunophenotyping of B cell markers and normalization of B cell numbers		PV4267	SDY80	-7	Days	Time of initial vaccine administration		SUB114501		PBMC	2771
BS808180	Cryopreserved PBMCs were thawed, washed twice and the number of viable cells enumerated with an automated FACS based instrument (Millipore). A portion of the PBMCs were examined by flow cytometry using CD19, CD20, CD27, CD21, CD10 and CD95 or CD19, CD20, IgM, IgD, IgG and IgA for immunophenotyping of B cell markers and normalization of B cell numbers		PV4267	SDY80	-7	Days	Time of initial vaccine administration		SUB114488		PBMC	2771
BS808191	Cryopreserved PBMCs were thawed, washed twice and the number of viable cells enumerated with an automated FACS based instrument (Millipore). A portion of the PBMCs were examined by flow cytometry using CD19, CD20, CD27, CD21, CD10 and CD95 or CD19, CD20, IgM, IgD, IgG and IgA for immunophenotyping of B cell markers and normalization of B cell numbers		PV4267	SDY80	-7	Days	Time of initial vaccine administration		SUB114502		PBMC	2771
BS808197	Cryopreserved PBMCs were thawed, washed twice and the number of viable cells enumerated with an automated FACS based instrument (Millipore). A portion of the PBMCs were examined by flow cytometry using CD19, CD20, CD27, CD21, CD10 and CD95 or CD19, CD20, IgM, IgD, IgG and IgA for immunophenotyping of B cell markers and normalization of B cell numbers		PV4268	SDY80	7	Days	Time of initial vaccine administration		SUB114463		PBMC	2771
BS808226		231_day-7	PV4267	SDY80	-7	Days	Time of initial vaccine administration		SUB114471	231.Blood.RNA-MicroArray.PV4267	RNA	2771
BS808240		251_day-7	PV4267	SDY80	-7	Days	Time of initial vaccine administration		SUB114488	251.Blood.RNA-MicroArray.PV4267	RNA	2771
BS808246		260_day-7	PV4267	SDY80	-7	Days	Time of initial vaccine administration		SUB114494	260.Blood.RNA-MicroArray.PV4267	RNA	2771
BS808257		275_day-7	PV4267	SDY80	-7	Days	Time of initial vaccine administration		SUB114505	275.Blood.RNA-MicroArray.PV4267	RNA	2771
BS808259		279_day-7	PV4267	SDY80	-7	Days	Time of initial vaccine administration		SUB114507	279.Blood.RNA-MicroArray.PV4267	RNA	2771
BS808261		281_day-7	PV4267	SDY80	-7	Days	Time of initial vaccine administration		SUB114509	281.Blood.RNA-MicroArray.PV4267	RNA	2771
BS808262		282_day-7	PV4267	SDY80	-7	Days	Time of initial vaccine administration		SUB114510	282.Blood.RNA-MicroArray.PV4267	RNA	2771
BS808263		283_day-7	PV4267	SDY80	-7	Days	Time of initial vaccine administration		SUB114511	283.Blood.RNA-MicroArray.PV4267	RNA	2771
BS808267		202_day7	PV4268	SDY80	7	Days	Time of initial vaccine administration		SUB114452	202.Blood.RNA-MicroArray.PV4268	RNA	2771
BS808269		205_day7	PV4268	SDY80	7	Days	Time of initial vaccine administration		SUB114454	205.Blood.RNA-MicroArray.PV4268	RNA	2771
BS808271		212_day7	PV4268	SDY80	7	Days	Time of initial vaccine administration		SUB114458	212.Blood.RNA-MicroArray.PV4268	RNA	2771
BS808276		221_day7	PV4268	SDY80	7	Days	Time of initial vaccine administration		SUB114463	221.Blood.RNA-MicroArray.PV4268	RNA	2771
BS808279		226_day7	PV4268	SDY80	7	Days	Time of initial vaccine administration		SUB114466	226.Blood.RNA-MicroArray.PV4268	RNA	2771
BS808302		252_day7	PV4268	SDY80	7	Days	Time of initial vaccine administration		SUB114489	252.Blood.RNA-MicroArray.PV4268	RNA	2771
BS808317		280_day7	PV4268	SDY80	7	Days	Time of initial vaccine administration		SUB114508	280.Blood.RNA-MicroArray.PV4268	RNA	2771
BS808324		202_day70	PV4269	SDY80	70	Days	Time of initial vaccine administration		SUB114452	202.Blood.RNA-MicroArray.PV4269	RNA	2771
BS808325		204_day70	PV4269	SDY80	70	Days	Time of initial vaccine administration		SUB114453	204.Blood.RNA-MicroArray.PV4269	RNA	2771
BS808344		233_day70	PV4269	SDY80	70	Days	Time of initial vaccine administration		SUB114473	233.Blood.RNA-MicroArray.PV4269	RNA	2771
BS806088			PV4269	SDY80	70	Days	Time of initial vaccine administration		SUB114450		Serum	2771
BS806089			PV1834	SDY80	0	Days	Time of initial vaccine administration		SUB114451		Serum	2771
BS806094			PV1834	SDY80	0	Days	Time of initial vaccine administration		SUB114452		Serum	2771
BS806139			PV4268	SDY80	7	Days	Time of initial vaccine administration		SUB114461		Serum	2771
BS806141			PV4269	SDY80	70	Days	Time of initial vaccine administration		SUB114461		Serum	2771
BS806147			PV1834	SDY80	0	Days	Time of initial vaccine administration		SUB114463		Serum	2771
BS806172			PV4268	SDY80	7	Days	Time of initial vaccine administration		SUB114468		Serum	2771
BS806175			PV1834	SDY80	0	Days	Time of initial vaccine administration		SUB114469		Serum	2771
BS806179			PV4269	SDY80	70	Days	Time of initial vaccine administration		SUB114469		Serum	2771
BS806188			PV4267	SDY80	-7	Days	Time of initial vaccine administration		SUB114471		Serum	2771
BS808351		244_day70	PV4269	SDY80	70	Days	Time of initial vaccine administration		SUB114481	244.Blood.RNA-MicroArray.PV4269	RNA	2771
BS808353		246_day70	PV4269	SDY80	70	Days	Time of initial vaccine administration		SUB114483	246.Blood.RNA-MicroArray.PV4269	RNA	2771
BS808373		277_day70	PV4269	SDY80	70	Days	Time of initial vaccine administration		SUB114506	277.Blood.RNA-MicroArray.PV4269	RNA	2771
BS807738	Cryopreserved PBMCs were thawed, washed twice and the number of viable cells enumerated with an automated FACS based instrument (Millipore). A portion of the PBMCs were examined by flow cytometry using CD19, CD20, CD27, CD21, CD10 and CD95 or CD19, CD20, IgM, IgD, IgG and IgA for immunophenotyping of B cell markers and normalization of B cell numbers		PV1834	SDY80	0	Days	Time of initial vaccine administration		SUB114457		PBMC	2771
BS807744	Cryopreserved PBMCs were thawed, washed twice and the number of viable cells enumerated with an automated FACS based instrument (Millipore). A portion of the PBMCs were examined by flow cytometry using CD19, CD20, CD27, CD21, CD10 and CD95 or CD19, CD20, IgM, IgD, IgG and IgA for immunophenotyping of B cell markers and normalization of B cell numbers		PV1834	SDY80	0	Days	Time of initial vaccine administration		SUB114466		PBMC	2771
BS953282			PV6192	SDY80	28	Days	Time of initial vaccine administration		SUB114465		Serum	2771
BS953297			PV6192	SDY80	28	Days	Time of initial vaccine administration		SUB114454		Serum	2771
BS953310			PV6192	SDY80	28	Days	Time of initial vaccine administration		SUB114468		Serum	2771
BS953330			PV6192	SDY80	28	Days	Time of initial vaccine administration		SUB114491		Serum	2771
BS953335			PV6192	SDY80	28	Days	Time of initial vaccine administration		SUB114497		Serum	2771
BS953343			PV6192	SDY80	28	Days	Time of initial vaccine administration		SUB114507		Serum	2771
BS953345			PV6192	SDY80	28	Days	Time of initial vaccine administration		SUB114509		Serum	2771
BS630805	Before vaccine		PV1834	SDY80	0	Days	Time of initial vaccine administration		SUB114461		RNA	2771
BS630808	Before vaccine		PV1834	SDY80	0	Days	Time of initial vaccine administration		SUB114464		RNA	2771
BS630829	Before vaccine		PV1834	SDY80	0	Days	Time of initial vaccine administration		SUB114485		RNA	2771
BS630842	Before vaccine		PV1834	SDY80	0	Days	Time of initial vaccine administration		SUB114498		RNA	2771
BS630854	Before vaccine		PV1834	SDY80	0	Days	Time of initial vaccine administration		SUB114510		RNA	2771
BS630855	Before vaccine		PV1834	SDY80	0	Days	Time of initial vaccine administration		SUB114511		RNA	2771
BS630870	After vaccine		PV1835	SDY80	1	Days	Time of initial vaccine administration		SUB114463		RNA	2771
BS630874	After vaccine		PV1835	SDY80	1	Days	Time of initial vaccine administration		SUB114467		RNA	2771
BS630884	After vaccine		PV1835	SDY80	1	Days	Time of initial vaccine administration		SUB114477		RNA	2771
BS630889	After vaccine		PV1835	SDY80	1	Days	Time of initial vaccine administration		SUB114482		RNA	2771
BS630896	After vaccine		PV1835	SDY80	1	Days	Time of initial vaccine administration		SUB114489		RNA	2771
BS630898	After vaccine		PV1835	SDY80	1	Days	Time of initial vaccine administration		SUB114491		RNA	2771
BS630902	After vaccine		PV1835	SDY80	1	Days	Time of initial vaccine administration		SUB114495		RNA	2771
BS630913	After vaccine		PV1835	SDY80	1	Days	Time of initial vaccine administration		SUB114506		RNA	2771
BS806192			PV4268	SDY80	7	Days	Time of initial vaccine administration		SUB114472		Serum	2771
BS806196			PV1835	SDY80	1	Days	Time of initial vaccine administration		SUB114473		Serum	2771
BS806198			PV4267	SDY80	-7	Days	Time of initial vaccine administration		SUB114473		Serum	2771
BS806204			PV4269	SDY80	70	Days	Time of initial vaccine administration		SUB114474		Serum	2771
BS806206			PV1835	SDY80	1	Days	Time of initial vaccine administration		SUB114475		Serum	2771
BS806241			PV4268	SDY80	7	Days	Time of initial vaccine administration		SUB114483		Serum	2771
BS806248			PV4269	SDY80	70	Days	Time of initial vaccine administration		SUB114484		Serum	2771
BS806259			PV4267	SDY80	-7	Days	Time of initial vaccine administration		SUB114487		Serum	2771
BS806263			PV4268	SDY80	7	Days	Time of initial vaccine administration		SUB114488		Serum	2771
BS806276			PV1834	SDY80	0	Days	Time of initial vaccine administration		SUB114491		Serum	2771
BS806296			PV1834	SDY80	0	Days	Time of initial vaccine administration		SUB114495		Serum	2771
BS806301			PV4267	SDY80	-7	Days	Time of initial vaccine administration		SUB114496		Serum	2771
BS806306			PV4269	SDY80	70	Days	Time of initial vaccine administration		SUB114497		Serum	2771
BS806310			PV4267	SDY80	-7	Days	Time of initial vaccine administration		SUB114498		Serum	2771
BS806313			PV1835	SDY80	1	Days	Time of initial vaccine administration		SUB114499		Serum	2771
BS806315			PV4267	SDY80	-7	Days	Time of initial vaccine administration		SUB114499		Serum	2771
BS806329			PV4268	SDY80	7	Days	Time of initial vaccine administration		SUB114502		Serum	2771
BS806331			PV4269	SDY80	70	Days	Time of initial vaccine administration		SUB114502		Serum	2771
BS806340			PV1835	SDY80	1	Days	Time of initial vaccine administration		SUB114505		Serum	2771
BS806342			PV1834	SDY80	0	Days	Time of initial vaccine administration		SUB114506		Serum	2771
BS806348			PV1835	SDY80	1	Days	Time of initial vaccine administration		SUB114507		Serum	2771
BS806352			PV1835	SDY80	1	Days	Time of initial vaccine administration		SUB114508		Serum	2771
BS806359			PV4267	SDY80	-7	Days	Time of initial vaccine administration		SUB114509		Serum	2771
BS806364			PV4267	SDY80	-7	Days	Time of initial vaccine administration		SUB114510		Serum	2771
BS807760	Cryopreserved PBMCs were thawed, washed twice and the number of viable cells enumerated with an automated FACS based instrument (Millipore). A portion of the PBMCs were examined by flow cytometry using CD19, CD20, CD27, CD21, CD10 and CD95 or CD19, CD20, IgM, IgD, IgG and IgA for immunophenotyping of B cell markers and normalization of B cell numbers		PV4268	SDY80	7	Days	Time of initial vaccine administration		SUB114454		PBMC	2771
BS807765	Cryopreserved PBMCs were thawed, washed twice and the number of viable cells enumerated with an automated FACS based instrument (Millipore). A portion of the PBMCs were examined by flow cytometry using CD19, CD20, CD27, CD21, CD10 and CD95 or CD19, CD20, IgM, IgD, IgG and IgA for immunophenotyping of B cell markers and normalization of B cell numbers		PV4268	SDY80	7	Days	Time of initial vaccine administration		SUB114451		PBMC	2771
BS807782	Cryopreserved PBMCs were thawed, washed twice and the number of viable cells enumerated with an automated FACS based instrument (Millipore). A portion of the PBMCs were examined by flow cytometry using CD19, CD20, CD27, CD21, CD10 and CD95 or CD19, CD20, IgM, IgD, IgG and IgA for immunophenotyping of B cell markers and normalization of B cell numbers		PV4267	SDY80	-7	Days	Time of initial vaccine administration		SUB114456		PBMC	2771
BS807783	Cryopreserved PBMCs were thawed, washed twice and the number of viable cells enumerated with an automated FACS based instrument (Millipore). A portion of the PBMCs were examined by flow cytometry using CD19, CD20, CD27, CD21, CD10 and CD95 or CD19, CD20, IgM, IgD, IgG and IgA for immunophenotyping of B cell markers and normalization of B cell numbers		PV1834	SDY80	0	Days	Time of initial vaccine administration		SUB114497		PBMC	2771
BS807789	Cryopreserved PBMCs were thawed, washed twice and the number of viable cells enumerated with an automated FACS based instrument (Millipore). A portion of the PBMCs were examined by flow cytometry using CD19, CD20, CD27, CD21, CD10 and CD95 or CD19, CD20, IgM, IgD, IgG and IgA for immunophenotyping of B cell markers and normalization of B cell numbers		PV4267	SDY80	-7	Days	Time of initial vaccine administration		SUB114507		PBMC	2771
BS807808	Cryopreserved PBMCs were thawed, washed twice and the number of viable cells enumerated with an automated FACS based instrument (Millipore). A portion of the PBMCs were examined by flow cytometry using CD19, CD20, CD27, CD21, CD10 and CD95 or CD19, CD20, IgM, IgD, IgG and IgA for immunophenotyping of B cell markers and normalization of B cell numbers		PV4268	SDY80	7	Days	Time of initial vaccine administration		SUB114509		PBMC	2771
BS807812	Cryopreserved PBMCs were thawed, washed twice and the number of viable cells enumerated with an automated FACS based instrument (Millipore). A portion of the PBMCs were examined by flow cytometry using CD19, CD20, CD27, CD21, CD10 and CD95 or CD19, CD20, IgM, IgD, IgG and IgA for immunophenotyping of B cell markers and normalization of B cell numbers		PV1834	SDY80	0	Days	Time of initial vaccine administration		SUB114481		PBMC	2771
BS807818	Cryopreserved PBMCs were thawed, washed twice and the number of viable cells enumerated with an automated FACS based instrument (Millipore). A portion of the PBMCs were examined by flow cytometry using CD19, CD20, CD27, CD21, CD10 and CD95 or CD19, CD20, IgM, IgD, IgG and IgA for immunophenotyping of B cell markers and normalization of B cell numbers		PV4268	SDY80	7	Days	Time of initial vaccine administration		SUB114461		PBMC	2771
BS807820	Cryopreserved PBMCs were thawed, washed twice and the number of viable cells enumerated with an automated FACS based instrument (Millipore). A portion of the PBMCs were examined by flow cytometry using CD19, CD20, CD27, CD21, CD10 and CD95 or CD19, CD20, IgM, IgD, IgG and IgA for immunophenotyping of B cell markers and normalization of B cell numbers		PV4268	SDY80	7	Days	Time of initial vaccine administration		SUB114462		PBMC	2771
BS807829	Cryopreserved PBMCs were thawed, washed twice and the number of viable cells enumerated with an automated FACS based instrument (Millipore). A portion of the PBMCs were examined by flow cytometry using CD19, CD20, CD27, CD21, CD10 and CD95 or CD19, CD20, IgM, IgD, IgG and IgA for immunophenotyping of B cell markers and normalization of B cell numbers		PV4268	SDY80	7	Days	Time of initial vaccine administration		SUB114453		PBMC	2771
BS807832	Cryopreserved PBMCs were thawed, washed twice and the number of viable cells enumerated with an automated FACS based instrument (Millipore). A portion of the PBMCs were examined by flow cytometry using CD19, CD20, CD27, CD21, CD10 and CD95 or CD19, CD20, IgM, IgD, IgG and IgA for immunophenotyping of B cell markers and normalization of B cell numbers		PV1834	SDY80	0	Days	Time of initial vaccine administration		SUB114511		PBMC	2771
BS807834	Cryopreserved PBMCs were thawed, washed twice and the number of viable cells enumerated with an automated FACS based instrument (Millipore). A portion of the PBMCs were examined by flow cytometry using CD19, CD20, CD27, CD21, CD10 and CD95 or CD19, CD20, IgM, IgD, IgG and IgA for immunophenotyping of B cell markers and normalization of B cell numbers		PV4268	SDY80	7	Days	Time of initial vaccine administration		SUB114470		PBMC	2771
BS807853			PV1834	SDY80	0	Days	Time of initial vaccine administration		SUB114451		PBMC	2771
BS807875			PV4267	SDY80	-7	Days	Time of initial vaccine administration		SUB114455		PBMC	2771
BS807892			PV1835	SDY80	1	Days	Time of initial vaccine administration		SUB114459		PBMC	2771
BS807895			PV4269	SDY80	70	Days	Time of initial vaccine administration		SUB114459		PBMC	2771
BS807899			PV4267	SDY80	-7	Days	Time of initial vaccine administration		SUB114460		PBMC	2771
BS807907			PV4268	SDY80	7	Days	Time of initial vaccine administration		SUB114462		PBMC	2771
BS807919			PV1834	SDY80	0	Days	Time of initial vaccine administration		SUB114465		PBMC	2771
BS807932			PV4267	SDY80	-7	Days	Time of initial vaccine administration		SUB114468		PBMC	2771
BS807936			PV4268	SDY80	7	Days	Time of initial vaccine administration		SUB114469		PBMC	2771
BS807956			PV1834	SDY80	0	Days	Time of initial vaccine administration		SUB114474		PBMC	2771
BS807959			PV1834	SDY80	0	Days	Time of initial vaccine administration		SUB114475		PBMC	2771
BS807961			PV4267	SDY80	-7	Days	Time of initial vaccine administration		SUB114475		PBMC	2771
BS807969			PV4267	SDY80	-7	Days	Time of initial vaccine administration		SUB114477		PBMC	2771
BS807970			PV4269	SDY80	70	Days	Time of initial vaccine administration		SUB114477		PBMC	2771
BS807974			PV4267	SDY80	-7	Days	Time of initial vaccine administration		SUB114478		PBMC	2771
BS807986			PV4268	SDY80	7	Days	Time of initial vaccine administration		SUB114482		PBMC	2771
BS807998			PV4269	SDY80	70	Days	Time of initial vaccine administration		SUB114485		PBMC	2771
BS808001			PV4267	SDY80	-7	Days	Time of initial vaccine administration		SUB114486		PBMC	2771
BS808010			PV4267	SDY80	-7	Days	Time of initial vaccine administration		SUB114488		PBMC	2771
BS808014			PV4269	SDY80	70	Days	Time of initial vaccine administration		SUB114490		PBMC	2771
BS808018			PV4269	SDY80	70	Days	Time of initial vaccine administration		SUB114491		PBMC	2771
BS808027			PV1835	SDY80	1	Days	Time of initial vaccine administration		SUB114494		PBMC	2771
BS808036			PV1834	SDY80	0	Days	Time of initial vaccine administration		SUB114496		PBMC	2771
BS808037			PV1835	SDY80	1	Days	Time of initial vaccine administration		SUB114496		PBMC	2771
BS808040			PV4269	SDY80	70	Days	Time of initial vaccine administration		SUB114496		PBMC	2771
BS808041			PV1835	SDY80	1	Days	Time of initial vaccine administration		SUB114497		PBMC	2771
BS808052			PV4267	SDY80	-7	Days	Time of initial vaccine administration		SUB114500		PBMC	2771
BS808056			PV4268	SDY80	7	Days	Time of initial vaccine administration		SUB114502		PBMC	2771
BS808064			PV1834	SDY80	0	Days	Time of initial vaccine administration		SUB114504		PBMC	2771
BS808065			PV1835	SDY80	1	Days	Time of initial vaccine administration		SUB114504		PBMC	2771
BS808074			PV1834	SDY80	0	Days	Time of initial vaccine administration		SUB114507		PBMC	2771
BS808084			PV1835	SDY80	1	Days	Time of initial vaccine administration		SUB114511		PBMC	2771
BS808091			PV4267	SDY80	-7	Days	Time of initial vaccine administration		SUB114512		PBMC	2771
BS808096	Cryopreserved PBMCs were thawed, washed twice and the number of viable cells enumerated with an automated FACS based instrument (Millipore). A portion of the PBMCs were examined by flow cytometry using CD19, CD20, CD27, CD21, CD10 and CD95 or CD19, CD20, IgM, IgD, IgG and IgA for immunophenotyping of B cell markers and normalization of B cell numbers		PV1834	SDY80	0	Days	Time of initial vaccine administration		SUB114469		PBMC	2771
BS808101	Cryopreserved PBMCs were thawed, washed twice and the number of viable cells enumerated with an automated FACS based instrument (Millipore). A portion of the PBMCs were examined by flow cytometry using CD19, CD20, CD27, CD21, CD10 and CD95 or CD19, CD20, IgM, IgD, IgG and IgA for immunophenotyping of B cell markers and normalization of B cell numbers		PV1834	SDY80	0	Days	Time of initial vaccine administration		SUB114458		PBMC	2771
BS808122	Cryopreserved PBMCs were thawed, washed twice and the number of viable cells enumerated with an automated FACS based instrument (Millipore). A portion of the PBMCs were examined by flow cytometry using CD19, CD20, CD27, CD21, CD10 and CD95 or CD19, CD20, IgM, IgD, IgG and IgA for immunophenotyping of B cell markers and normalization of B cell numbers		PV1834	SDY80	0	Days	Time of initial vaccine administration		SUB114494		PBMC	2771
BS808123	Cryopreserved PBMCs were thawed, washed twice and the number of viable cells enumerated with an automated FACS based instrument (Millipore). A portion of the PBMCs were examined by flow cytometry using CD19, CD20, CD27, CD21, CD10 and CD95 or CD19, CD20, IgM, IgD, IgG and IgA for immunophenotyping of B cell markers and normalization of B cell numbers		PV1834	SDY80	0	Days	Time of initial vaccine administration		SUB114491		PBMC	2771
BS808131	Cryopreserved PBMCs were thawed, washed twice and the number of viable cells enumerated with an automated FACS based instrument (Millipore). A portion of the PBMCs were examined by flow cytometry using CD19, CD20, CD27, CD21, CD10 and CD95 or CD19, CD20, IgM, IgD, IgG and IgA for immunophenotyping of B cell markers and normalization of B cell numbers		PV4267	SDY80	-7	Days	Time of initial vaccine administration		SUB114500		PBMC	2771
BS808140	Cryopreserved PBMCs were thawed, washed twice and the number of viable cells enumerated with an automated FACS based instrument (Millipore). A portion of the PBMCs were examined by flow cytometry using CD19, CD20, CD27, CD21, CD10 and CD95 or CD19, CD20, IgM, IgD, IgG and IgA for immunophenotyping of B cell markers and normalization of B cell numbers		PV4267	SDY80	-7	Days	Time of initial vaccine administration		SUB114489		PBMC	2771
BS808159	Cryopreserved PBMCs were thawed, washed twice and the number of viable cells enumerated with an automated FACS based instrument (Millipore). A portion of the PBMCs were examined by flow cytometry using CD19, CD20, CD27, CD21, CD10 and CD95 or CD19, CD20, IgM, IgD, IgG and IgA for immunophenotyping of B cell markers and normalization of B cell numbers		PV4267	SDY80	-7	Days	Time of initial vaccine administration		SUB114498		PBMC	2771
BS808172	Cryopreserved PBMCs were thawed, washed twice and the number of viable cells enumerated with an automated FACS based instrument (Millipore). A portion of the PBMCs were examined by flow cytometry using CD19, CD20, CD27, CD21, CD10 and CD95 or CD19, CD20, IgM, IgD, IgG and IgA for immunophenotyping of B cell markers and normalization of B cell numbers		PV4267	SDY80	-7	Days	Time of initial vaccine administration		SUB114492		PBMC	2771
BS808181	Cryopreserved PBMCs were thawed, washed twice and the number of viable cells enumerated with an automated FACS based instrument (Millipore). A portion of the PBMCs were examined by flow cytometry using CD19, CD20, CD27, CD21, CD10 and CD95 or CD19, CD20, IgM, IgD, IgG and IgA for immunophenotyping of B cell markers and normalization of B cell numbers		PV4267	SDY80	-7	Days	Time of initial vaccine administration		SUB114506		PBMC	2771
BS808182	Cryopreserved PBMCs were thawed, washed twice and the number of viable cells enumerated with an automated FACS based instrument (Millipore). A portion of the PBMCs were examined by flow cytometry using CD19, CD20, CD27, CD21, CD10 and CD95 or CD19, CD20, IgM, IgD, IgG and IgA for immunophenotyping of B cell markers and normalization of B cell numbers		PV4267	SDY80	-7	Days	Time of initial vaccine administration		SUB114481		PBMC	2771
BS808186	Cryopreserved PBMCs were thawed, washed twice and the number of viable cells enumerated with an automated FACS based instrument (Millipore). A portion of the PBMCs were examined by flow cytometry using CD19, CD20, CD27, CD21, CD10 and CD95 or CD19, CD20, IgM, IgD, IgG and IgA for immunophenotyping of B cell markers and normalization of B cell numbers		PV4267	SDY80	-7	Days	Time of initial vaccine administration		SUB114462		PBMC	2771
BS808194	Cryopreserved PBMCs were thawed, washed twice and the number of viable cells enumerated with an automated FACS based instrument (Millipore). A portion of the PBMCs were examined by flow cytometry using CD19, CD20, CD27, CD21, CD10 and CD95 or CD19, CD20, IgM, IgD, IgG and IgA for immunophenotyping of B cell markers and normalization of B cell numbers		PV4267	SDY80	-7	Days	Time of initial vaccine administration		SUB114460		PBMC	2771
BS808203	Cryopreserved PBMCs were thawed, washed twice and the number of viable cells enumerated with an automated FACS based instrument (Millipore). A portion of the PBMCs were examined by flow cytometry using CD19, CD20, CD27, CD21, CD10 and CD95 or CD19, CD20, IgM, IgD, IgG and IgA for immunophenotyping of B cell markers and normalization of B cell numbers		PV4267	SDY80	-7	Days	Time of initial vaccine administration		SUB114453		PBMC	2771
BS808211		207_day-7	PV4267	SDY80	-7	Days	Time of initial vaccine administration		SUB114456	207.Blood.RNA-MicroArray.PV4267	RNA	2771
BS808213		212_day-7	PV4267	SDY80	-7	Days	Time of initial vaccine administration		SUB114458	212.Blood.RNA-MicroArray.PV4267	RNA	2771
BS808214		213_day-7	PV4267	SDY80	-7	Days	Time of initial vaccine administration		SUB114459	213.Blood.RNA-MicroArray.PV4267	RNA	2771
BS808229		234_day-7	PV4267	SDY80	-7	Days	Time of initial vaccine administration		SUB114474	234.Blood.RNA-MicroArray.PV4267	RNA	2771
BS808237		248_day-7	PV4267	SDY80	-7	Days	Time of initial vaccine administration		SUB114485	248.Blood.RNA-MicroArray.PV4267	RNA	2771
BS808244		257_day-7	PV4267	SDY80	-7	Days	Time of initial vaccine administration		SUB114492	257.Blood.RNA-MicroArray.PV4267	RNA	2771
BS808248		262_day-7	PV4267	SDY80	-7	Days	Time of initial vaccine administration		SUB114496	262.Blood.RNA-MicroArray.PV4267	RNA	2771
BS808258		277_day-7	PV4267	SDY80	-7	Days	Time of initial vaccine administration		SUB114506	277.Blood.RNA-MicroArray.PV4267	RNA	2771
BS808260		280_day-7	PV4267	SDY80	-7	Days	Time of initial vaccine administration		SUB114508	280.Blood.RNA-MicroArray.PV4267	RNA	2771
BS808278		224_day7	PV4268	SDY80	7	Days	Time of initial vaccine administration		SUB114465	224.Blood.RNA-MicroArray.PV4268	RNA	2771
BS808286		233_day7	PV4268	SDY80	7	Days	Time of initial vaccine administration		SUB114473	233.Blood.RNA-MicroArray.PV4268	RNA	2771
BS808293		243_day7	PV4268	SDY80	7	Days	Time of initial vaccine administration		SUB114480	243.Blood.RNA-MicroArray.PV4268	RNA	2771
BS808305		257_day7	PV4268	SDY80	7	Days	Time of initial vaccine administration		SUB114492	257.Blood.RNA-MicroArray.PV4268	RNA	2771
BS808309		263_day7	PV4268	SDY80	7	Days	Time of initial vaccine administration		SUB114497	263.Blood.RNA-MicroArray.PV4268	RNA	2771
BS808315		273_day7	PV4268	SDY80	7	Days	Time of initial vaccine administration		SUB114503	273.Blood.RNA-MicroArray.PV4268	RNA	2771
BS808319		282_day7	PV4268	SDY80	7	Days	Time of initial vaccine administration		SUB114510	282.Blood.RNA-MicroArray.PV4268	RNA	2771
BS808327		206_day70	PV4269	SDY80	70	Days	Time of initial vaccine administration		SUB114455	206.Blood.RNA-MicroArray.PV4269	RNA	2771
BS808334		218_day70	PV4269	SDY80	70	Days	Time of initial vaccine administration		SUB114462	218.Blood.RNA-MicroArray.PV4269	RNA	2771
BS808342		231_day70	PV4269	SDY80	70	Days	Time of initial vaccine administration		SUB114471	231.Blood.RNA-MicroArray.PV4269	RNA	2771
BS806115			PV1835	SDY80	1	Days	Time of initial vaccine administration		SUB114456		Serum	2771
BS806116			PV4267	SDY80	-7	Days	Time of initial vaccine administration		SUB114456		Serum	2771
BS806117			PV4269	SDY80	70	Days	Time of initial vaccine administration		SUB114456		Serum	2771
BS806127			PV1834	SDY80	0	Days	Time of initial vaccine administration		SUB114459		Serum	2771
BS806130			PV4267	SDY80	-7	Days	Time of initial vaccine administration		SUB114459		Serum	2771
BS806137			PV1834	SDY80	0	Days	Time of initial vaccine administration		SUB114461		Serum	2771
BS806140			PV4267	SDY80	-7	Days	Time of initial vaccine administration		SUB114461		Serum	2771
BS806156			PV1835	SDY80	1	Days	Time of initial vaccine administration		SUB114465		Serum	2771
BS806161			PV1835	SDY80	1	Days	Time of initial vaccine administration		SUB114466		Serum	2771
BS806181			PV1835	SDY80	1	Days	Time of initial vaccine administration		SUB114470		Serum	2771
BS808357		251_day70	PV4269	SDY80	70	Days	Time of initial vaccine administration		SUB114488	251.Blood.RNA-MicroArray.PV4269	RNA	2771
BS808369		270_day70	PV4269	SDY80	70	Days	Time of initial vaccine administration		SUB114501	270.Blood.RNA-MicroArray.PV4269	RNA	2771
BS807736	Cryopreserved PBMCs were thawed, washed twice and the number of viable cells enumerated with an automated FACS based instrument (Millipore). A portion of the PBMCs were examined by flow cytometry using CD19, CD20, CD27, CD21, CD10 and CD95 or CD19, CD20, IgM, IgD, IgG and IgA for immunophenotyping of B cell markers and normalization of B cell numbers		PV1834	SDY80	0	Days	Time of initial vaccine administration		SUB114495		PBMC	2771
BS807745	Cryopreserved PBMCs were thawed, washed twice and the number of viable cells enumerated with an automated FACS based instrument (Millipore). A portion of the PBMCs were examined by flow cytometry using CD19, CD20, CD27, CD21, CD10 and CD95 or CD19, CD20, IgM, IgD, IgG and IgA for immunophenotyping of B cell markers and normalization of B cell numbers		PV4268	SDY80	7	Days	Time of initial vaccine administration		SUB114506		PBMC	2771
BS807749	Cryopreserved PBMCs were thawed, washed twice and the number of viable cells enumerated with an automated FACS based instrument (Millipore). A portion of the PBMCs were examined by flow cytometry using CD19, CD20, CD27, CD21, CD10 and CD95 or CD19, CD20, IgM, IgD, IgG and IgA for immunophenotyping of B cell markers and normalization of B cell numbers		PV4268	SDY80	7	Days	Time of initial vaccine administration		SUB114479		PBMC	2771
BS953281			PV1834	SDY80	0	Days	Time of initial vaccine administration		SUB114465		Serum	2771
BS953292			PV6192	SDY80	28	Days	Time of initial vaccine administration		SUB114504		Serum	2771
BS953293			PV6192	SDY80	28	Days	Time of initial vaccine administration		SUB114450		Serum	2771
BS953303			PV6192	SDY80	28	Days	Time of initial vaccine administration		SUB114460		Serum	2771
BS953307			PV6192	SDY80	28	Days	Time of initial vaccine administration		SUB114464		Serum	2771
BS953312			PV6192	SDY80	28	Days	Time of initial vaccine administration		SUB114470		Serum	2771
BS953316			PV6192	SDY80	28	Days	Time of initial vaccine administration		SUB114474		Serum	2771
BS953322			PV6192	SDY80	28	Days	Time of initial vaccine administration		SUB114482		Serum	2771
BS953325			PV6192	SDY80	28	Days	Time of initial vaccine administration		SUB114486		Serum	2771
BS953338			PV6192	SDY80	28	Days	Time of initial vaccine administration		SUB114501		Serum	2771
BS953344			PV6192	SDY80	28	Days	Time of initial vaccine administration		SUB114508		Serum	2771
BS630799	Before vaccine		PV1834	SDY80	0	Days	Time of initial vaccine administration		SUB114455		RNA	2771
BS630800	Before vaccine		PV1834	SDY80	0	Days	Time of initial vaccine administration		SUB114456		RNA	2771
BS630819	Before vaccine		PV1834	SDY80	0	Days	Time of initial vaccine administration		SUB114475		RNA	2771
BS630826	Before vaccine		PV1834	SDY80	0	Days	Time of initial vaccine administration		SUB114482		RNA	2771
BS630838	Before vaccine		PV1834	SDY80	0	Days	Time of initial vaccine administration		SUB114494		RNA	2771
BS630893	After vaccine		PV1835	SDY80	1	Days	Time of initial vaccine administration		SUB114486		RNA	2771
BS630899	After vaccine		PV1835	SDY80	1	Days	Time of initial vaccine administration		SUB114492		RNA	2771
BS630907	After vaccine		PV1835	SDY80	1	Days	Time of initial vaccine administration		SUB114500		RNA	2771
BS630912	After vaccine		PV1835	SDY80	1	Days	Time of initial vaccine administration		SUB114505		RNA	2771
BS806195			PV1834	SDY80	0	Days	Time of initial vaccine administration		SUB114473		Serum	2771
BS806203			PV4267	SDY80	-7	Days	Time of initial vaccine administration		SUB114474		Serum	2771
BS806205			PV1834	SDY80	0	Days	Time of initial vaccine administration		SUB114475		Serum	2771
BS806208			PV4267	SDY80	-7	Days	Time of initial vaccine administration		SUB114475		Serum	2771
BS806212			PV4268	SDY80	7	Days	Time of initial vaccine administration		SUB114476		Serum	2771
BS806214			PV1834	SDY80	0	Days	Time of initial vaccine administration		SUB114477		Serum	2771
BS806216			PV4268	SDY80	7	Days	Time of initial vaccine administration		SUB114477		Serum	2771
BS806228			PV4269	SDY80	70	Days	Time of initial vaccine administration		SUB114480		Serum	2771
BS806230			PV1835	SDY80	1	Days	Time of initial vaccine administration		SUB114481		Serum	2771
BS806234			PV1834	SDY80	0	Days	Time of initial vaccine administration		SUB114482		Serum	2771
BS806244			PV1834	SDY80	0	Days	Time of initial vaccine administration		SUB114484		Serum	2771
BS806257			PV1835	SDY80	1	Days	Time of initial vaccine administration		SUB114487		Serum	2771
BS806266			PV1834	SDY80	0	Days	Time of initial vaccine administration		SUB114489		Serum	2771
BS806269			PV4267	SDY80	-7	Days	Time of initial vaccine administration		SUB114489		Serum	2771
BS806272			PV1835	SDY80	1	Days	Time of initial vaccine administration		SUB114490		Serum	2771
BS806275			PV4269	SDY80	70	Days	Time of initial vaccine administration		SUB114490		Serum	2771
BS806282			PV1835	SDY80	1	Days	Time of initial vaccine administration		SUB114492		Serum	2771
BS806287			PV1835	SDY80	1	Days	Time of initial vaccine administration		SUB114493		Serum	2771
BS806290			PV4269	SDY80	70	Days	Time of initial vaccine administration		SUB114493		Serum	2771
BS806292			PV1835	SDY80	1	Days	Time of initial vaccine administration		SUB114494		Serum	2771
BS806297			PV1835	SDY80	1	Days	Time of initial vaccine administration		SUB114495		Serum	2771
BS806305			PV4267	SDY80	-7	Days	Time of initial vaccine administration		SUB114497		Serum	2771
BS806326			PV4269	SDY80	70	Days	Time of initial vaccine administration		SUB114501		Serum	2771
BS806334			PV4268	SDY80	7	Days	Time of initial vaccine administration		SUB114503		Serum	2771
BS806346			PV4269	SDY80	70	Days	Time of initial vaccine administration		SUB114506		Serum	2771
BS806353			PV4268	SDY80	7	Days	Time of initial vaccine administration		SUB114508		Serum	2771
BS806354			PV4267	SDY80	-7	Days	Time of initial vaccine administration		SUB114508		Serum	2771
BS806355			PV4269	SDY80	70	Days	Time of initial vaccine administration		SUB114508		Serum	2771
BS806358			PV4268	SDY80	7	Days	Time of initial vaccine administration		SUB114509		Serum	2771
BS806361			PV1834	SDY80	0	Days	Time of initial vaccine administration		SUB114510		Serum	2771
BS806362			PV1835	SDY80	1	Days	Time of initial vaccine administration		SUB114510		Serum	2771
BS806363			PV4268	SDY80	7	Days	Time of initial vaccine administration		SUB114510		Serum	2771
BS806365			PV4269	SDY80	70	Days	Time of initial vaccine administration		SUB114510		Serum	2771
BS806368			PV4268	SDY80	7	Days	Time of initial vaccine administration		SUB114511		Serum	2771
BS807762	Cryopreserved PBMCs were thawed, washed twice and the number of viable cells enumerated with an automated FACS based instrument (Millipore). A portion of the PBMCs were examined by flow cytometry using CD19, CD20, CD27, CD21, CD10 and CD95 or CD19, CD20, IgM, IgD, IgG and IgA for immunophenotyping of B cell markers and normalization of B cell numbers		PV1834	SDY80	0	Days	Time of initial vaccine administration		SUB114456		PBMC	2771
BS807766	Cryopreserved PBMCs were thawed, washed twice and the number of viable cells enumerated with an automated FACS based instrument (Millipore). A portion of the PBMCs were examined by flow cytometry using CD19, CD20, CD27, CD21, CD10 and CD95 or CD19, CD20, IgM, IgD, IgG and IgA for immunophenotyping of B cell markers and normalization of B cell numbers		PV1834	SDY80	0	Days	Time of initial vaccine administration		SUB114475		PBMC	2771
BS807768	Cryopreserved PBMCs were thawed, washed twice and the number of viable cells enumerated with an automated FACS based instrument (Millipore). A portion of the PBMCs were examined by flow cytometry using CD19, CD20, CD27, CD21, CD10 and CD95 or CD19, CD20, IgM, IgD, IgG and IgA for immunophenotyping of B cell markers and normalization of B cell numbers		PV4268	SDY80	7	Days	Time of initial vaccine administration		SUB114510		PBMC	2771
BS807773	Cryopreserved PBMCs were thawed, washed twice and the number of viable cells enumerated with an automated FACS based instrument (Millipore). A portion of the PBMCs were examined by flow cytometry using CD19, CD20, CD27, CD21, CD10 and CD95 or CD19, CD20, IgM, IgD, IgG and IgA for immunophenotyping of B cell markers and normalization of B cell numbers		PV1834	SDY80	0	Days	Time of initial vaccine administration		SUB114467		PBMC	2771
BS807777	Cryopreserved PBMCs were thawed, washed twice and the number of viable cells enumerated with an automated FACS based instrument (Millipore). A portion of the PBMCs were examined by flow cytometry using CD19, CD20, CD27, CD21, CD10 and CD95 or CD19, CD20, IgM, IgD, IgG and IgA for immunophenotyping of B cell markers and normalization of B cell numbers		PV1834	SDY80	0	Days	Time of initial vaccine administration		SUB114512		PBMC	2771
BS807805	Cryopreserved PBMCs were thawed, washed twice and the number of viable cells enumerated with an automated FACS based instrument (Millipore). A portion of the PBMCs were examined by flow cytometry using CD19, CD20, CD27, CD21, CD10 and CD95 or CD19, CD20, IgM, IgD, IgG and IgA for immunophenotyping of B cell markers and normalization of B cell numbers		PV4268	SDY80	7	Days	Time of initial vaccine administration		SUB114483		PBMC	2771
BS807823	Cryopreserved PBMCs were thawed, washed twice and the number of viable cells enumerated with an automated FACS based instrument (Millipore). A portion of the PBMCs were examined by flow cytometry using CD19, CD20, CD27, CD21, CD10 and CD95 or CD19, CD20, IgM, IgD, IgG and IgA for immunophenotyping of B cell markers and normalization of B cell numbers		PV4268	SDY80	7	Days	Time of initial vaccine administration		SUB114501		PBMC	2771
BS807841	Cryopreserved PBMCs were thawed, washed twice and the number of viable cells enumerated with an automated FACS based instrument (Millipore). A portion of the PBMCs were examined by flow cytometry using CD19, CD20, CD27, CD21, CD10 and CD95 or CD19, CD20, IgM, IgD, IgG and IgA for immunophenotyping of B cell markers and normalization of B cell numbers		PV1834	SDY80	0	Days	Time of initial vaccine administration		SUB114452		PBMC	2771
BS807842	Cryopreserved PBMCs were thawed, washed twice and the number of viable cells enumerated with an automated FACS based instrument (Millipore). A portion of the PBMCs were examined by flow cytometry using CD19, CD20, CD27, CD21, CD10 and CD95 or CD19, CD20, IgM, IgD, IgG and IgA for immunophenotyping of B cell markers and normalization of B cell numbers		PV4268	SDY80	7	Days	Time of initial vaccine administration		SUB114486		PBMC	2771
BS807844	Cryopreserved PBMCs were thawed, washed twice and the number of viable cells enumerated with an automated FACS based instrument (Millipore). A portion of the PBMCs were examined by flow cytometry using CD19, CD20, CD27, CD21, CD10 and CD95 or CD19, CD20, IgM, IgD, IgG and IgA for immunophenotyping of B cell markers and normalization of B cell numbers		PV1834	SDY80	0	Days	Time of initial vaccine administration		SUB114490		PBMC	2771
BS807858			PV1834	SDY80	0	Days	Time of initial vaccine administration		SUB114452		PBMC	2771
BS807881			PV1834	SDY80	0	Days	Time of initial vaccine administration		SUB114457		PBMC	2771
BS807882			PV1835	SDY80	1	Days	Time of initial vaccine administration		SUB114457		PBMC	2771
BS807887			PV1835	SDY80	1	Days	Time of initial vaccine administration		SUB114458		PBMC	2771
BS807888			PV4268	SDY80	7	Days	Time of initial vaccine administration		SUB114458		PBMC	2771
BS807900			PV4269	SDY80	70	Days	Time of initial vaccine administration		SUB114460		PBMC	2771
BS807903			PV4267	SDY80	-7	Days	Time of initial vaccine administration		SUB114461		PBMC	2771
BS807910			PV1835	SDY80	1	Days	Time of initial vaccine administration		SUB114463		PBMC	2771
BS807916			PV4268	SDY80	7	Days	Time of initial vaccine administration		SUB114464		PBMC	2771
BS807922			PV4267	SDY80	-7	Days	Time of initial vaccine administration		SUB114465		PBMC	2771
BS807942			PV4267	SDY80	-7	Days	Time of initial vaccine administration		SUB114470		PBMC	2771
BS807943			PV4269	SDY80	70	Days	Time of initial vaccine administration		SUB114470		PBMC	2771
BS807945			PV1835	SDY80	1	Days	Time of initial vaccine administration		SUB114471		PBMC	2771
BS807947			PV4269	SDY80	70	Days	Time of initial vaccine administration		SUB114471		PBMC	2771
BS807948			PV1834	SDY80	0	Days	Time of initial vaccine administration		SUB114472		PBMC	2771
BS807954			PV4267	SDY80	-7	Days	Time of initial vaccine administration		SUB114473		PBMC	2771
BS807955			PV4269	SDY80	70	Days	Time of initial vaccine administration		SUB114473		PBMC	2771
BS807979			PV4267	SDY80	-7	Days	Time of initial vaccine administration		SUB114479		PBMC	2771
BS807981			PV1834	SDY80	0	Days	Time of initial vaccine administration		SUB114481		PBMC	2771
BS808002			PV4269	SDY80	70	Days	Time of initial vaccine administration		SUB114486		PBMC	2771
BS808013			PV4267	SDY80	-7	Days	Time of initial vaccine administration		SUB114490		PBMC	2771
BS808024			PV1835	SDY80	1	Days	Time of initial vaccine administration		SUB114493		PBMC	2771
BS808026			PV1834	SDY80	0	Days	Time of initial vaccine administration		SUB114494		PBMC	2771
BS808031			PV1834	SDY80	0	Days	Time of initial vaccine administration		SUB114495		PBMC	2771
BS808033			PV4268	SDY80	7	Days	Time of initial vaccine administration		SUB114495		PBMC	2771
BS808061			PV4268	SDY80	7	Days	Time of initial vaccine administration		SUB114503		PBMC	2771
BS808063			PV4269	SDY80	70	Days	Time of initial vaccine administration		SUB114503		PBMC	2771
BS808082			PV4267	SDY80	-7	Days	Time of initial vaccine administration		SUB114510		PBMC	2771
BS808102	Cryopreserved PBMCs were thawed, washed twice and the number of viable cells enumerated with an automated FACS based instrument (Millipore). A portion of the PBMCs were examined by flow cytometry using CD19, CD20, CD27, CD21, CD10 and CD95 or CD19, CD20, IgM, IgD, IgG and IgA for immunophenotyping of B cell markers and normalization of B cell numbers		PV1834	SDY80	0	Days	Time of initial vaccine administration		SUB114466		PBMC	2771
BS808109	Cryopreserved PBMCs were thawed, washed twice and the number of viable cells enumerated with an automated FACS based instrument (Millipore). A portion of the PBMCs were examined by flow cytometry using CD19, CD20, CD27, CD21, CD10 and CD95 or CD19, CD20, IgM, IgD, IgG and IgA for immunophenotyping of B cell markers and normalization of B cell numbers		PV1834	SDY80	0	Days	Time of initial vaccine administration		SUB114476		PBMC	2771
BS808117	Cryopreserved PBMCs were thawed, washed twice and the number of viable cells enumerated with an automated FACS based instrument (Millipore). A portion of the PBMCs were examined by flow cytometry using CD19, CD20, CD27, CD21, CD10 and CD95 or CD19, CD20, IgM, IgD, IgG and IgA for immunophenotyping of B cell markers and normalization of B cell numbers		PV1834	SDY80	0	Days	Time of initial vaccine administration		SUB114462		PBMC	2771
BS808128	Cryopreserved PBMCs were thawed, washed twice and the number of viable cells enumerated with an automated FACS based instrument (Millipore). A portion of the PBMCs were examined by flow cytometry using CD19, CD20, CD27, CD21, CD10 and CD95 or CD19, CD20, IgM, IgD, IgG and IgA for immunophenotyping of B cell markers and normalization of B cell numbers		PV1834	SDY80	0	Days	Time of initial vaccine administration		SUB114455		PBMC	2771
BS808149	Cryopreserved PBMCs were thawed, washed twice and the number of viable cells enumerated with an automated FACS based instrument (Millipore). A portion of the PBMCs were examined by flow cytometry using CD19, CD20, CD27, CD21, CD10 and CD95 or CD19, CD20, IgM, IgD, IgG and IgA for immunophenotyping of B cell markers and normalization of B cell numbers		PV1834	SDY80	0	Days	Time of initial vaccine administration		SUB114467		PBMC	2771
BS808169	Cryopreserved PBMCs were thawed, washed twice and the number of viable cells enumerated with an automated FACS based instrument (Millipore). A portion of the PBMCs were examined by flow cytometry using CD19, CD20, CD27, CD21, CD10 and CD95 or CD19, CD20, IgM, IgD, IgG and IgA for immunophenotyping of B cell markers and normalization of B cell numbers		PV4269	SDY80	70	Days	Time of initial vaccine administration		SUB114479		PBMC	2771
BS808175	Cryopreserved PBMCs were thawed, washed twice and the number of viable cells enumerated with an automated FACS based instrument (Millipore). A portion of the PBMCs were examined by flow cytometry using CD19, CD20, CD27, CD21, CD10 and CD95 or CD19, CD20, IgM, IgD, IgG and IgA for immunophenotyping of B cell markers and normalization of B cell numbers		PV4267	SDY80	-7	Days	Time of initial vaccine administration		SUB114510		PBMC	2771
BS808184	Cryopreserved PBMCs were thawed, washed twice and the number of viable cells enumerated with an automated FACS based instrument (Millipore). A portion of the PBMCs were examined by flow cytometry using CD19, CD20, CD27, CD21, CD10 and CD95 or CD19, CD20, IgM, IgD, IgG and IgA for immunophenotyping of B cell markers and normalization of B cell numbers		PV4267	SDY80	-7	Days	Time of initial vaccine administration		SUB114482		PBMC	2771
BS808193	Cryopreserved PBMCs were thawed, washed twice and the number of viable cells enumerated with an automated FACS based instrument (Millipore). A portion of the PBMCs were examined by flow cytometry using CD19, CD20, CD27, CD21, CD10 and CD95 or CD19, CD20, IgM, IgD, IgG and IgA for immunophenotyping of B cell markers and normalization of B cell numbers		PV4267	SDY80	-7	Days	Time of initial vaccine administration		SUB114497		PBMC	2771
BS808202	Cryopreserved PBMCs were thawed, washed twice and the number of viable cells enumerated with an automated FACS based instrument (Millipore). A portion of the PBMCs were examined by flow cytometry using CD19, CD20, CD27, CD21, CD10 and CD95 or CD19, CD20, IgM, IgD, IgG and IgA for immunophenotyping of B cell markers and normalization of B cell numbers		PV4267	SDY80	-7	Days	Time of initial vaccine administration		SUB114471		PBMC	2771
BS808223		228_day-7	PV4267	SDY80	-7	Days	Time of initial vaccine administration		SUB114468	228.Blood.RNA-MicroArray.PV4267	RNA	2771
BS808224		229_day-7	PV4267	SDY80	-7	Days	Time of initial vaccine administration		SUB114469	229.Blood.RNA-MicroArray.PV4267	RNA	2771
BS808231		237_day-7	PV4267	SDY80	-7	Days	Time of initial vaccine administration		SUB114477	237.Blood.RNA-MicroArray.PV4267	RNA	2771
BS808238		249_day-7	PV4267	SDY80	-7	Days	Time of initial vaccine administration		SUB114486	249.Blood.RNA-MicroArray.PV4267	RNA	2771
BS808252		268_day-7	PV4267	SDY80	-7	Days	Time of initial vaccine administration		SUB114500	268.Blood.RNA-MicroArray.PV4267	RNA	2771
BS808264		284_day-7	PV4267	SDY80	-7	Days	Time of initial vaccine administration		SUB114512	284.Blood.RNA-MicroArray.PV4267	RNA	2771
BS808272		213_day7	PV4268	SDY80	7	Days	Time of initial vaccine administration		SUB114459	213.Blood.RNA-MicroArray.PV4268	RNA	2771
BS808284		231_day7	PV4268	SDY80	7	Days	Time of initial vaccine administration		SUB114471	231.Blood.RNA-MicroArray.PV4268	RNA	2771
BS808287		234_day7	PV4268	SDY80	7	Days	Time of initial vaccine administration		SUB114474	234.Blood.RNA-MicroArray.PV4268	RNA	2771
BS808292		242_day7	PV4268	SDY80	7	Days	Time of initial vaccine administration		SUB114479	242.Blood.RNA-MicroArray.PV4268	RNA	2771
BS808300		250_day7	PV4268	SDY80	7	Days	Time of initial vaccine administration		SUB114487	250.Blood.RNA-MicroArray.PV4268	RNA	2771
BS808301		251_day7	PV4268	SDY80	7	Days	Time of initial vaccine administration		SUB114488	251.Blood.RNA-MicroArray.PV4268	RNA	2771
BS808307		260_day7	PV4268	SDY80	7	Days	Time of initial vaccine administration		SUB114494	260.Blood.RNA-MicroArray.PV4268	RNA	2771
BS808308		261_day7	PV4268	SDY80	7	Days	Time of initial vaccine administration		SUB114495	261.Blood.RNA-MicroArray.PV4268	RNA	2771
BS808312		268_day7	PV4268	SDY80	7	Days	Time of initial vaccine administration		SUB114500	268.Blood.RNA-MicroArray.PV4268	RNA	2771
BS808320		283_day7	PV4268	SDY80	7	Days	Time of initial vaccine administration		SUB114511	283.Blood.RNA-MicroArray.PV4268	RNA	2771
BS808332		215_day70	PV4269	SDY80	70	Days	Time of initial vaccine administration		SUB114460	215.Blood.RNA-MicroArray.PV4269	RNA	2771
BS808348		241_day70	PV4269	SDY80	70	Days	Time of initial vaccine administration		SUB114478	241.Blood.RNA-MicroArray.PV4269	RNA	2771
BS806091			PV4268	SDY80	7	Days	Time of initial vaccine administration		SUB114451		Serum	2771
BS806092			PV4267	SDY80	-7	Days	Time of initial vaccine administration		SUB114451		Serum	2771
BS806093			PV4269	SDY80	70	Days	Time of initial vaccine administration		SUB114451		Serum	2771
BS806102			PV4267	SDY80	-7	Days	Time of initial vaccine administration		SUB114453		Serum	2771
BS806119			PV1835	SDY80	1	Days	Time of initial vaccine administration		SUB114457		Serum	2771
BS806121			PV4269	SDY80	70	Days	Time of initial vaccine administration		SUB114457		Serum	2771
BS806132			PV1834	SDY80	0	Days	Time of initial vaccine administration		SUB114460		Serum	2771
BS806138			PV1835	SDY80	1	Days	Time of initial vaccine administration		SUB114461		Serum	2771
BS806155			PV4269	SDY80	70	Days	Time of initial vaccine administration		SUB114464		Serum	2771
BS806158			PV4267	SDY80	-7	Days	Time of initial vaccine administration		SUB114465		Serum	2771
BS806160			PV1834	SDY80	0	Days	Time of initial vaccine administration		SUB114466		Serum	2771
BS806166			PV1835	SDY80	1	Days	Time of initial vaccine administration		SUB114467		Serum	2771
BS806173			PV4267	SDY80	-7	Days	Time of initial vaccine administration		SUB114468		Serum	2771
BS808360		256_day70	PV4269	SDY80	70	Days	Time of initial vaccine administration		SUB114491	256.Blood.RNA-MicroArray.PV4269	RNA	2771
BS808362		259_day70	PV4269	SDY80	70	Days	Time of initial vaccine administration		SUB114493	259.Blood.RNA-MicroArray.PV4269	RNA	2771
BS808366		265_day70	PV4269	SDY80	70	Days	Time of initial vaccine administration		SUB114498	265.Blood.RNA-MicroArray.PV4269	RNA	2771
BS808368		268_day70	PV4269	SDY80	70	Days	Time of initial vaccine administration		SUB114500	268.Blood.RNA-MicroArray.PV4269	RNA	2771
BS807743	Cryopreserved PBMCs were thawed, washed twice and the number of viable cells enumerated with an automated FACS based instrument (Millipore). A portion of the PBMCs were examined by flow cytometry using CD19, CD20, CD27, CD21, CD10 and CD95 or CD19, CD20, IgM, IgD, IgG and IgA for immunophenotyping of B cell markers and normalization of B cell numbers		PV4268	SDY80	7	Days	Time of initial vaccine administration		SUB114500		PBMC	2771
BS807746	Cryopreserved PBMCs were thawed, washed twice and the number of viable cells enumerated with an automated FACS based instrument (Millipore). A portion of the PBMCs were examined by flow cytometry using CD19, CD20, CD27, CD21, CD10 and CD95 or CD19, CD20, IgM, IgD, IgG and IgA for immunophenotyping of B cell markers and normalization of B cell numbers		PV4268	SDY80	7	Days	Time of initial vaccine administration		SUB114474		PBMC	2771
BS807755	Cryopreserved PBMCs were thawed, washed twice and the number of viable cells enumerated with an automated FACS based instrument (Millipore). A portion of the PBMCs were examined by flow cytometry using CD19, CD20, CD27, CD21, CD10 and CD95 or CD19, CD20, IgM, IgD, IgG and IgA for immunophenotyping of B cell markers and normalization of B cell numbers		PV4267	SDY80	-7	Days	Time of initial vaccine administration		SUB114504		PBMC	2771
BS807757	Cryopreserved PBMCs were thawed, washed twice and the number of viable cells enumerated with an automated FACS based instrument (Millipore). A portion of the PBMCs were examined by flow cytometry using CD19, CD20, CD27, CD21, CD10 and CD95 or CD19, CD20, IgM, IgD, IgG and IgA for immunophenotyping of B cell markers and normalization of B cell numbers		PV1834	SDY80	0	Days	Time of initial vaccine administration		SUB114508		PBMC	2771
BS953285			PV1834	SDY80	0	Days	Time of initial vaccine administration		SUB114480		Serum	2771
BS953287			PV1834	SDY80	0	Days	Time of initial vaccine administration		SUB114485		Serum	2771
BS953291			PV1834	SDY80	0	Days	Time of initial vaccine administration		SUB114504		Serum	2771
BS953306			PV6192	SDY80	28	Days	Time of initial vaccine administration		SUB114463		Serum	2771
BS953311			PV6192	SDY80	28	Days	Time of initial vaccine administration		SUB114469		Serum	2771
BS953329			PV6192	SDY80	28	Days	Time of initial vaccine administration		SUB114490		Serum	2771
BS953336			PV6192	SDY80	28	Days	Time of initial vaccine administration		SUB114498		Serum	2771
BS630809	Before vaccine		PV1834	SDY80	0	Days	Time of initial vaccine administration		SUB114465		RNA	2771
BS630818	Before vaccine		PV1834	SDY80	0	Days	Time of initial vaccine administration		SUB114474		RNA	2771
BS630825	Before vaccine		PV1834	SDY80	0	Days	Time of initial vaccine administration		SUB114481		RNA	2771
BS630828	Before vaccine		PV1834	SDY80	0	Days	Time of initial vaccine administration		SUB114484		RNA	2771
BS630830	Before vaccine		PV1834	SDY80	0	Days	Time of initial vaccine administration		SUB114486		RNA	2771
BS630831	Before vaccine		PV1834	SDY80	0	Days	Time of initial vaccine administration		SUB114487		RNA	2771
BS630843	Before vaccine		PV1834	SDY80	0	Days	Time of initial vaccine administration		SUB114499		RNA	2771
BS630846	Before vaccine		PV1834	SDY80	0	Days	Time of initial vaccine administration		SUB114502		RNA	2771
BS630850	Before vaccine		PV1834	SDY80	0	Days	Time of initial vaccine administration		SUB114506		RNA	2771
BS630853	Before vaccine		PV1834	SDY80	0	Days	Time of initial vaccine administration		SUB114509		RNA	2771
BS630868	After vaccine		PV1835	SDY80	1	Days	Time of initial vaccine administration		SUB114461		RNA	2771
BS630872	After vaccine		PV1835	SDY80	1	Days	Time of initial vaccine administration		SUB114465		RNA	2771
BS630875	After vaccine		PV1835	SDY80	1	Days	Time of initial vaccine administration		SUB114468		RNA	2771
BS630887	After vaccine		PV1835	SDY80	1	Days	Time of initial vaccine administration		SUB114480		RNA	2771
BS630890	After vaccine		PV1835	SDY80	1	Days	Time of initial vaccine administration		SUB114483		RNA	2771
BS630895	After vaccine		PV1835	SDY80	1	Days	Time of initial vaccine administration		SUB114488		RNA	2771
BS630901	After vaccine		PV1835	SDY80	1	Days	Time of initial vaccine administration		SUB114494		RNA	2771
BS630903	After vaccine		PV1835	SDY80	1	Days	Time of initial vaccine administration		SUB114496		RNA	2771
BS630911	After vaccine		PV1835	SDY80	1	Days	Time of initial vaccine administration		SUB114504		RNA	2771
BS630915	After vaccine		PV1835	SDY80	1	Days	Time of initial vaccine administration		SUB114508		RNA	2771
BS630916	After vaccine		PV1835	SDY80	1	Days	Time of initial vaccine administration		SUB114509		RNA	2771
BS806191			PV1835	SDY80	1	Days	Time of initial vaccine administration		SUB114472		Serum	2771
BS806194			PV4269	SDY80	70	Days	Time of initial vaccine administration		SUB114472		Serum	2771
BS806202			PV4268	SDY80	7	Days	Time of initial vaccine administration		SUB114474		Serum	2771
BS806213			PV4269	SDY80	70	Days	Time of initial vaccine administration		SUB114476		Serum	2771
BS806218			PV1834	SDY80	0	Days	Time of initial vaccine administration		SUB114478		Serum	2771
BS806220			PV4268	SDY80	7	Days	Time of initial vaccine administration		SUB114478		Serum	2771
BS806221			PV4267	SDY80	-7	Days	Time of initial vaccine administration		SUB114478		Serum	2771
BS806239			PV1834	SDY80	0	Days	Time of initial vaccine administration		SUB114483		Serum	2771
BS806250			PV4267	SDY80	-7	Days	Time of initial vaccine administration		SUB114485		Serum	2771
BS806261			PV1834	SDY80	0	Days	Time of initial vaccine administration		SUB114488		Serum	2771
BS806268			PV4268	SDY80	7	Days	Time of initial vaccine administration		SUB114489		Serum	2771
BS806286			PV1834	SDY80	0	Days	Time of initial vaccine administration		SUB114493		Serum	2771
BS806295			PV4269	SDY80	70	Days	Time of initial vaccine administration		SUB114494		Serum	2771
BS806304			PV4268	SDY80	7	Days	Time of initial vaccine administration		SUB114497		Serum	2771
BS806307			PV1834	SDY80	0	Days	Time of initial vaccine administration		SUB114498		Serum	2771
BS806312			PV1834	SDY80	0	Days	Time of initial vaccine administration		SUB114499		Serum	2771
BS806317			PV1834	SDY80	0	Days	Time of initial vaccine administration		SUB114500		Serum	2771
BS806321			PV4269	SDY80	70	Days	Time of initial vaccine administration		SUB114500		Serum	2771
BS806323			PV1835	SDY80	1	Days	Time of initial vaccine administration		SUB114501		Serum	2771
BS806335			PV4267	SDY80	-7	Days	Time of initial vaccine administration		SUB114503		Serum	2771
BS806337			PV4267	SDY80	-7	Days	Time of initial vaccine administration		SUB114504		Serum	2771
BS806357			PV1835	SDY80	1	Days	Time of initial vaccine administration		SUB114509		Serum	2771
BS806370			PV4269	SDY80	70	Days	Time of initial vaccine administration		SUB114511		Serum	2771
BS807776	Cryopreserved PBMCs were thawed, washed twice and the number of viable cells enumerated with an automated FACS based instrument (Millipore). A portion of the PBMCs were examined by flow cytometry using CD19, CD20, CD27, CD21, CD10 and CD95 or CD19, CD20, IgM, IgD, IgG and IgA for immunophenotyping of B cell markers and normalization of B cell numbers		PV4268	SDY80	7	Days	Time of initial vaccine administration		SUB114465		PBMC	2771
BS807778	Cryopreserved PBMCs were thawed, washed twice and the number of viable cells enumerated with an automated FACS based instrument (Millipore). A portion of the PBMCs were examined by flow cytometry using CD19, CD20, CD27, CD21, CD10 and CD95 or CD19, CD20, IgM, IgD, IgG and IgA for immunophenotyping of B cell markers and normalization of B cell numbers		PV1834	SDY80	0	Days	Time of initial vaccine administration		SUB114482		PBMC	2771
BS807795	Cryopreserved PBMCs were thawed, washed twice and the number of viable cells enumerated with an automated FACS based instrument (Millipore). A portion of the PBMCs were examined by flow cytometry using CD19, CD20, CD27, CD21, CD10 and CD95 or CD19, CD20, IgM, IgD, IgG and IgA for immunophenotyping of B cell markers and normalization of B cell numbers		PV1834	SDY80	0	Days	Time of initial vaccine administration		SUB114464		PBMC	2771
BS807807	Cryopreserved PBMCs were thawed, washed twice and the number of viable cells enumerated with an automated FACS based instrument (Millipore). A portion of the PBMCs were examined by flow cytometry using CD19, CD20, CD27, CD21, CD10 and CD95 or CD19, CD20, IgM, IgD, IgG and IgA for immunophenotyping of B cell markers and normalization of B cell numbers		PV1834	SDY80	0	Days	Time of initial vaccine administration		SUB114453		PBMC	2771
BS807819	Cryopreserved PBMCs were thawed, washed twice and the number of viable cells enumerated with an automated FACS based instrument (Millipore). A portion of the PBMCs were examined by flow cytometry using CD19, CD20, CD27, CD21, CD10 and CD95 or CD19, CD20, IgM, IgD, IgG and IgA for immunophenotyping of B cell markers and normalization of B cell numbers		PV4268	SDY80	7	Days	Time of initial vaccine administration		SUB114484		PBMC	2771
BS807830	Cryopreserved PBMCs were thawed, washed twice and the number of viable cells enumerated with an automated FACS based instrument (Millipore). A portion of the PBMCs were examined by flow cytometry using CD19, CD20, CD27, CD21, CD10 and CD95 or CD19, CD20, IgM, IgD, IgG and IgA for immunophenotyping of B cell markers and normalization of B cell numbers		PV4268	SDY80	7	Days	Time of initial vaccine administration		SUB114491		PBMC	2771
BS807833	Cryopreserved PBMCs were thawed, washed twice and the number of viable cells enumerated with an automated FACS based instrument (Millipore). A portion of the PBMCs were examined by flow cytometry using CD19, CD20, CD27, CD21, CD10 and CD95 or CD19, CD20, IgM, IgD, IgG and IgA for immunophenotyping of B cell markers and normalization of B cell numbers		PV4268	SDY80	7	Days	Time of initial vaccine administration		SUB114512		PBMC	2771
BS807840	Cryopreserved PBMCs were thawed, washed twice and the number of viable cells enumerated with an automated FACS based instrument (Millipore). A portion of the PBMCs were examined by flow cytometry using CD19, CD20, CD27, CD21, CD10 and CD95 or CD19, CD20, IgM, IgD, IgG and IgA for immunophenotyping of B cell markers and normalization of B cell numbers		PV1834	SDY80	0	Days	Time of initial vaccine administration		SUB114487		PBMC	2771
BS807843	Cryopreserved PBMCs were thawed, washed twice and the number of viable cells enumerated with an automated FACS based instrument (Millipore). A portion of the PBMCs were examined by flow cytometry using CD19, CD20, CD27, CD21, CD10 and CD95 or CD19, CD20, IgM, IgD, IgG and IgA for immunophenotyping of B cell markers and normalization of B cell numbers		PV1834	SDY80	0	Days	Time of initial vaccine administration		SUB114486		PBMC	2771
BS807857			PV4269	SDY80	70	Days	Time of initial vaccine administration		SUB114451		PBMC	2771
BS807859			PV1835	SDY80	1	Days	Time of initial vaccine administration		SUB114452		PBMC	2771
BS807863			PV1834	SDY80	0	Days	Time of initial vaccine administration		SUB114453		PBMC	2771
BS807865			PV4268	SDY80	7	Days	Time of initial vaccine administration		SUB114453		PBMC	2771
BS807877			PV1835	SDY80	1	Days	Time of initial vaccine administration		SUB114456		PBMC	2771
BS807894			PV4267	SDY80	-7	Days	Time of initial vaccine administration		SUB114459		PBMC	2771
BS807897			PV1835	SDY80	1	Days	Time of initial vaccine administration		SUB114460		PBMC	2771
BS807904			PV4269	SDY80	70	Days	Time of initial vaccine administration		SUB114461		PBMC	2771
BS807913			PV4269	SDY80	70	Days	Time of initial vaccine administration		SUB114463		PBMC	2771
BS807918			PV4269	SDY80	70	Days	Time of initial vaccine administration		SUB114464		PBMC	2771
BS807927			PV4267	SDY80	-7	Days	Time of initial vaccine administration		SUB114467		PBMC	2771
BS807930			PV1835	SDY80	1	Days	Time of initial vaccine administration		SUB114468		PBMC	2771
BS807946			PV4267	SDY80	-7	Days	Time of initial vaccine administration		SUB114471		PBMC	2771
BS807963			PV1835	SDY80	1	Days	Time of initial vaccine administration		SUB114476		PBMC	2771
BS807964			PV4267	SDY80	-7	Days	Time of initial vaccine administration		SUB114476		PBMC	2771
BS807966			PV1834	SDY80	0	Days	Time of initial vaccine administration		SUB114477		PBMC	2771
BS807973			PV4268	SDY80	7	Days	Time of initial vaccine administration		SUB114478		PBMC	2771
BS807984			PV1834	SDY80	0	Days	Time of initial vaccine administration		SUB114482		PBMC	2771
BS807989			PV1834	SDY80	0	Days	Time of initial vaccine administration		SUB114483		PBMC	2771
BS807990			PV1835	SDY80	1	Days	Time of initial vaccine administration		SUB114483		PBMC	2771
BS807994			PV1834	SDY80	0	Days	Time of initial vaccine administration		SUB114485		PBMC	2771
BS808011			PV4269	SDY80	70	Days	Time of initial vaccine administration		SUB114488		PBMC	2771
BS808015			PV1834	SDY80	0	Days	Time of initial vaccine administration		SUB114491		PBMC	2771
BS808017			PV4267	SDY80	-7	Days	Time of initial vaccine administration		SUB114491		PBMC	2771
BS808035			PV4269	SDY80	70	Days	Time of initial vaccine administration		SUB114495		PBMC	2771
BS808043			PV1834	SDY80	0	Days	Time of initial vaccine administration		SUB114498		PBMC	2771
BS808051			PV4268	SDY80	7	Days	Time of initial vaccine administration		SUB114500		PBMC	2771
BS808054			PV1834	SDY80	0	Days	Time of initial vaccine administration		SUB114502		PBMC	2771
BS808067			PV4267	SDY80	-7	Days	Time of initial vaccine administration		SUB114504		PBMC	2771
BS808072			PV4267	SDY80	-7	Days	Time of initial vaccine administration		SUB114506		PBMC	2771
BS808079			PV4267	SDY80	-7	Days	Time of initial vaccine administration		SUB114508		PBMC	2771
BS808088			PV1834	SDY80	0	Days	Time of initial vaccine administration		SUB114512		PBMC	2771
BS808095	Cryopreserved PBMCs were thawed, washed twice and the number of viable cells enumerated with an automated FACS based instrument (Millipore). A portion of the PBMCs were examined by flow cytometry using CD19, CD20, CD27, CD21, CD10 and CD95 or CD19, CD20, IgM, IgD, IgG and IgA for immunophenotyping of B cell markers and normalization of B cell numbers		PV1834	SDY80	0	Days	Time of initial vaccine administration		SUB114457		PBMC	2771
BS808103	Cryopreserved PBMCs were thawed, washed twice and the number of viable cells enumerated with an automated FACS based instrument (Millipore). A portion of the PBMCs were examined by flow cytometry using CD19, CD20, CD27, CD21, CD10 and CD95 or CD19, CD20, IgM, IgD, IgG and IgA for immunophenotyping of B cell markers and normalization of B cell numbers		PV4267	SDY80	-7	Days	Time of initial vaccine administration		SUB114495		PBMC	2771
BS808106	Cryopreserved PBMCs were thawed, washed twice and the number of viable cells enumerated with an automated FACS based instrument (Millipore). A portion of the PBMCs were examined by flow cytometry using CD19, CD20, CD27, CD21, CD10 and CD95 or CD19, CD20, IgM, IgD, IgG and IgA for immunophenotyping of B cell markers and normalization of B cell numbers		PV1834	SDY80	0	Days	Time of initial vaccine administration		SUB114450		PBMC	2771
BS808111	Cryopreserved PBMCs were thawed, washed twice and the number of viable cells enumerated with an automated FACS based instrument (Millipore). A portion of the PBMCs were examined by flow cytometry using CD19, CD20, CD27, CD21, CD10 and CD95 or CD19, CD20, IgM, IgD, IgG and IgA for immunophenotyping of B cell markers and normalization of B cell numbers		PV1834	SDY80	0	Days	Time of initial vaccine administration		SUB114478		PBMC	2771
BS808119	Cryopreserved PBMCs were thawed, washed twice and the number of viable cells enumerated with an automated FACS based instrument (Millipore). A portion of the PBMCs were examined by flow cytometry using CD19, CD20, CD27, CD21, CD10 and CD95 or CD19, CD20, IgM, IgD, IgG and IgA for immunophenotyping of B cell markers and normalization of B cell numbers		PV1834	SDY80	0	Days	Time of initial vaccine administration		SUB114470		PBMC	2771
BS808139	Cryopreserved PBMCs were thawed, washed twice and the number of viable cells enumerated with an automated FACS based instrument (Millipore). A portion of the PBMCs were examined by flow cytometry using CD19, CD20, CD27, CD21, CD10 and CD95 or CD19, CD20, IgM, IgD, IgG and IgA for immunophenotyping of B cell markers and normalization of B cell numbers		PV1834	SDY80	0	Days	Time of initial vaccine administration		SUB114482		PBMC	2771
BS808143	Cryopreserved PBMCs were thawed, washed twice and the number of viable cells enumerated with an automated FACS based instrument (Millipore). A portion of the PBMCs were examined by flow cytometry using CD19, CD20, CD27, CD21, CD10 and CD95 or CD19, CD20, IgM, IgD, IgG and IgA for immunophenotyping of B cell markers and normalization of B cell numbers		PV1834	SDY80	0	Days	Time of initial vaccine administration		SUB114507		PBMC	2771
BS808152	Cryopreserved PBMCs were thawed, washed twice and the number of viable cells enumerated with an automated FACS based instrument (Millipore). A portion of the PBMCs were examined by flow cytometry using CD19, CD20, CD27, CD21, CD10 and CD95 or CD19, CD20, IgM, IgD, IgG and IgA for immunophenotyping of B cell markers and normalization of B cell numbers		PV1834	SDY80	0	Days	Time of initial vaccine administration		SUB114510		PBMC	2771
BS808160	Cryopreserved PBMCs were thawed, washed twice and the number of viable cells enumerated with an automated FACS based instrument (Millipore). A portion of the PBMCs were examined by flow cytometry using CD19, CD20, CD27, CD21, CD10 and CD95 or CD19, CD20, IgM, IgD, IgG and IgA for immunophenotyping of B cell markers and normalization of B cell numbers		PV4267	SDY80	-7	Days	Time of initial vaccine administration		SUB114464		PBMC	2771
BS808164	Cryopreserved PBMCs were thawed, washed twice and the number of viable cells enumerated with an automated FACS based instrument (Millipore). A portion of the PBMCs were examined by flow cytometry using CD19, CD20, CD27, CD21, CD10 and CD95 or CD19, CD20, IgM, IgD, IgG and IgA for immunophenotyping of B cell markers and normalization of B cell numbers		PV1834	SDY80	0	Days	Time of initial vaccine administration		SUB114473		PBMC	2771
BS808168	Cryopreserved PBMCs were thawed, washed twice and the number of viable cells enumerated with an automated FACS based instrument (Millipore). A portion of the PBMCs were examined by flow cytometry using CD19, CD20, CD27, CD21, CD10 and CD95 or CD19, CD20, IgM, IgD, IgG and IgA for immunophenotyping of B cell markers and normalization of B cell numbers		PV4267	SDY80	-7	Days	Time of initial vaccine administration		SUB114508		PBMC	2771
BS808176	Cryopreserved PBMCs were thawed, washed twice and the number of viable cells enumerated with an automated FACS based instrument (Millipore). A portion of the PBMCs were examined by flow cytometry using CD19, CD20, CD27, CD21, CD10 and CD95 or CD19, CD20, IgM, IgD, IgG and IgA for immunophenotyping of B cell markers and normalization of B cell numbers		PV4268	SDY80	7	Days	Time of initial vaccine administration		SUB114485		PBMC	2771
BS808199	Cryopreserved PBMCs were thawed, washed twice and the number of viable cells enumerated with an automated FACS based instrument (Millipore). A portion of the PBMCs were examined by flow cytometry using CD19, CD20, CD27, CD21, CD10 and CD95 or CD19, CD20, IgM, IgD, IgG and IgA for immunophenotyping of B cell markers and normalization of B cell numbers		PV4267	SDY80	-7	Days	Time of initial vaccine administration		SUB114454		PBMC	2771
BS808201	Cryopreserved PBMCs were thawed, washed twice and the number of viable cells enumerated with an automated FACS based instrument (Millipore). A portion of the PBMCs were examined by flow cytometry using CD19, CD20, CD27, CD21, CD10 and CD95 or CD19, CD20, IgM, IgD, IgG and IgA for immunophenotyping of B cell markers and normalization of B cell numbers		PV4267	SDY80	-7	Days	Time of initial vaccine administration		SUB114493		PBMC	2771
BS808204	Cryopreserved PBMCs were thawed, washed twice and the number of viable cells enumerated with an automated FACS based instrument (Millipore). A portion of the PBMCs were examined by flow cytometry using CD19, CD20, CD27, CD21, CD10 and CD95 or CD19, CD20, IgM, IgD, IgG and IgA for immunophenotyping of B cell markers and normalization of B cell numbers		PV4267	SDY80	-7	Days	Time of initial vaccine administration		SUB114486		PBMC	2771
BS808215		215_day-7	PV4267	SDY80	-7	Days	Time of initial vaccine administration		SUB114460	215.Blood.RNA-MicroArray.PV4267	RNA	2771
BS808219		222_day-7	PV4267	SDY80	-7	Days	Time of initial vaccine administration		SUB114464	222.Blood.RNA-MicroArray.PV4267	RNA	2771
BS808233		244_day-7	PV4267	SDY80	-7	Days	Time of initial vaccine administration		SUB114481	244.Blood.RNA-MicroArray.PV4267	RNA	2771
BS808235		246_day-7	PV4267	SDY80	-7	Days	Time of initial vaccine administration		SUB114483	246.Blood.RNA-MicroArray.PV4267	RNA	2771
BS808245		259_day-7	PV4267	SDY80	-7	Days	Time of initial vaccine administration		SUB114493	259.Blood.RNA-MicroArray.PV4267	RNA	2771
BS808250		265_day-7	PV4267	SDY80	-7	Days	Time of initial vaccine administration		SUB114498	265.Blood.RNA-MicroArray.PV4267	RNA	2771
BS808253		270_day-7	PV4267	SDY80	-7	Days	Time of initial vaccine administration		SUB114501	270.Blood.RNA-MicroArray.PV4267	RNA	2771
BS808289		236_day7	PV4268	SDY80	7	Days	Time of initial vaccine administration		SUB114476	236.Blood.RNA-MicroArray.PV4268	RNA	2771
BS808290		237_day7	PV4268	SDY80	7	Days	Time of initial vaccine administration		SUB114477	237.Blood.RNA-MicroArray.PV4268	RNA	2771
BS808297		247_day7	PV4268	SDY80	7	Days	Time of initial vaccine administration		SUB114484	247.Blood.RNA-MicroArray.PV4268	RNA	2771
BS808313		270_day7	PV4268	SDY80	7	Days	Time of initial vaccine administration		SUB114501	270.Blood.RNA-MicroArray.PV4268	RNA	2771
BS808331		213_day70	PV4269	SDY80	70	Days	Time of initial vaccine administration		SUB114459	213.Blood.RNA-MicroArray.PV4269	RNA	2771
BS808333		217_day70	PV4269	SDY80	70	Days	Time of initial vaccine administration		SUB114461	217.Blood.RNA-MicroArray.PV4269	RNA	2771
BS808335		222_day70	PV4269	SDY80	70	Days	Time of initial vaccine administration		SUB114464	222.Blood.RNA-MicroArray.PV4269	RNA	2771
BS806112			PV4267	SDY80	-7	Days	Time of initial vaccine administration		SUB114455		Serum	2771
BS806113			PV4269	SDY80	70	Days	Time of initial vaccine administration		SUB114455		Serum	2771
BS806124			PV4268	SDY80	7	Days	Time of initial vaccine administration		SUB114458		Serum	2771
BS806131			PV4269	SDY80	70	Days	Time of initial vaccine administration		SUB114459		Serum	2771
BS806154			PV4267	SDY80	-7	Days	Time of initial vaccine administration		SUB114464		Serum	2771
BS806162			PV4268	SDY80	7	Days	Time of initial vaccine administration		SUB114466		Serum	2771
BS806177			PV4268	SDY80	7	Days	Time of initial vaccine administration		SUB114469		Serum	2771
BS806189			PV4269	SDY80	70	Days	Time of initial vaccine administration		SUB114471		Serum	2771
BS808356		250_day70	PV4269	SDY80	70	Days	Time of initial vaccine administration		SUB114487	250.Blood.RNA-MicroArray.PV4269	RNA	2771
BS808361		257_day70	PV4269	SDY80	70	Days	Time of initial vaccine administration		SUB114492	257.Blood.RNA-MicroArray.PV4269	RNA	2771
BS808364		261_day70	PV4269	SDY80	70	Days	Time of initial vaccine administration		SUB114495	261.Blood.RNA-MicroArray.PV4269	RNA	2771
BS807734	Cryopreserved PBMCs were thawed, washed twice and the number of viable cells enumerated with an automated FACS based instrument (Millipore). A portion of the PBMCs were examined by flow cytometry using CD19, CD20, CD27, CD21, CD10 and CD95 or CD19, CD20, IgM, IgD, IgG and IgA for immunophenotyping of B cell markers and normalization of B cell numbers		PV4268	SDY80	7	Days	Time of initial vaccine administration		SUB114458		PBMC	2771
BS807739	Cryopreserved PBMCs were thawed, washed twice and the number of viable cells enumerated with an automated FACS based instrument (Millipore). A portion of the PBMCs were examined by flow cytometry using CD19, CD20, CD27, CD21, CD10 and CD95 or CD19, CD20, IgM, IgD, IgG and IgA for immunophenotyping of B cell markers and normalization of B cell numbers		PV1834	SDY80	0	Days	Time of initial vaccine administration		SUB114503		PBMC	2771
BS807752	Cryopreserved PBMCs were thawed, washed twice and the number of viable cells enumerated with an automated FACS based instrument (Millipore). A portion of the PBMCs were examined by flow cytometry using CD19, CD20, CD27, CD21, CD10 and CD95 or CD19, CD20, IgM, IgD, IgG and IgA for immunophenotyping of B cell markers and normalization of B cell numbers		PV1834	SDY80	0	Days	Time of initial vaccine administration		SUB114468		PBMC	2771
BS807756	Cryopreserved PBMCs were thawed, washed twice and the number of viable cells enumerated with an automated FACS based instrument (Millipore). A portion of the PBMCs were examined by flow cytometry using CD19, CD20, CD27, CD21, CD10 and CD95 or CD19, CD20, IgM, IgD, IgG and IgA for immunophenotyping of B cell markers and normalization of B cell numbers		PV1834	SDY80	0	Days	Time of initial vaccine administration		SUB114510		PBMC	2771
BS807759	Cryopreserved PBMCs were thawed, washed twice and the number of viable cells enumerated with an automated FACS based instrument (Millipore). A portion of the PBMCs were examined by flow cytometry using CD19, CD20, CD27, CD21, CD10 and CD95 or CD19, CD20, IgM, IgD, IgG and IgA for immunophenotyping of B cell markers and normalization of B cell numbers		PV4268	SDY80	7	Days	Time of initial vaccine administration		SUB114508		PBMC	2771
BS953286			PV6192	SDY80	28	Days	Time of initial vaccine administration		SUB114480		Serum	2771
BS953296			PV6192	SDY80	28	Days	Time of initial vaccine administration		SUB114453		Serum	2771
BS953305			PV6192	SDY80	28	Days	Time of initial vaccine administration		SUB114462		Serum	2771
BS953315			PV6192	SDY80	28	Days	Time of initial vaccine administration		SUB114473		Serum	2771
BS953318			PV6192	SDY80	28	Days	Time of initial vaccine administration		SUB114476		Serum	2771
BS953324			PV6192	SDY80	28	Days	Time of initial vaccine administration		SUB114484		Serum	2771
BS953332			PV6192	SDY80	28	Days	Time of initial vaccine administration		SUB114493		Serum	2771
BS953341			PV6192	SDY80	28	Days	Time of initial vaccine administration		SUB114505		Serum	2771
BS630794	Before vaccine		PV1834	SDY80	0	Days	Time of initial vaccine administration		SUB114450		RNA	2771
BS630795	Before vaccine		PV1834	SDY80	0	Days	Time of initial vaccine administration		SUB114451		RNA	2771
BS630802	Before vaccine		PV1834	SDY80	0	Days	Time of initial vaccine administration		SUB114458		RNA	2771
BS630810	Before vaccine		PV1834	SDY80	0	Days	Time of initial vaccine administration		SUB114466		RNA	2771
BS630823	Before vaccine		PV1834	SDY80	0	Days	Time of initial vaccine administration		SUB114479		RNA	2771
BS630834	Before vaccine		PV1834	SDY80	0	Days	Time of initial vaccine administration		SUB114490		RNA	2771
BS630837	Before vaccine		PV1834	SDY80	0	Days	Time of initial vaccine administration		SUB114493		RNA	2771
BS630848	Before vaccine		PV1834	SDY80	0	Days	Time of initial vaccine administration		SUB114504		RNA	2771
BS630851	Before vaccine		PV1834	SDY80	0	Days	Time of initial vaccine administration		SUB114507		RNA	2771
BS630852	Before vaccine		PV1834	SDY80	0	Days	Time of initial vaccine administration		SUB114508		RNA	2771
BS630857	After vaccine		PV1835	SDY80	1	Days	Time of initial vaccine administration		SUB114450		RNA	2771
BS630860	After vaccine		PV1835	SDY80	1	Days	Time of initial vaccine administration		SUB114453		RNA	2771
BS630864	After vaccine		PV1835	SDY80	1	Days	Time of initial vaccine administration		SUB114457		RNA	2771
BS630865	After vaccine		PV1835	SDY80	1	Days	Time of initial vaccine administration		SUB114458		RNA	2771
BS630871	After vaccine		PV1835	SDY80	1	Days	Time of initial vaccine administration		SUB114464		RNA	2771
BS630876	After vaccine		PV1835	SDY80	1	Days	Time of initial vaccine administration		SUB114469		RNA	2771
BS630879	After vaccine		PV1835	SDY80	1	Days	Time of initial vaccine administration		SUB114472		RNA	2771
BS630880	After vaccine		PV1835	SDY80	1	Days	Time of initial vaccine administration		SUB114473		RNA	2771
BS630885	After vaccine		PV1835	SDY80	1	Days	Time of initial vaccine administration		SUB114478		RNA	2771
BS630886	After vaccine		PV1835	SDY80	1	Days	Time of initial vaccine administration		SUB114479		RNA	2771
BS630910	After vaccine		PV1835	SDY80	1	Days	Time of initial vaccine administration		SUB114503		RNA	2771
BS806190			PV1834	SDY80	0	Days	Time of initial vaccine administration		SUB114472		Serum	2771
BS806210			PV1834	SDY80	0	Days	Time of initial vaccine administration		SUB114476		Serum	2771
BS806219			PV1835	SDY80	1	Days	Time of initial vaccine administration		SUB114478		Serum	2771
BS806227			PV4268	SDY80	7	Days	Time of initial vaccine administration		SUB114480		Serum	2771
BS806240			PV1835	SDY80	1	Days	Time of initial vaccine administration		SUB114483		Serum	2771
BS806271			PV1834	SDY80	0	Days	Time of initial vaccine administration		SUB114490		Serum	2771
BS806279			PV4267	SDY80	-7	Days	Time of initial vaccine administration		SUB114491		Serum	2771
BS806288			PV4268	SDY80	7	Days	Time of initial vaccine administration		SUB114493		Serum	2771
BS806339			PV1834	SDY80	0	Days	Time of initial vaccine administration		SUB114505		Serum	2771
BS807770	Cryopreserved PBMCs were thawed, washed twice and the number of viable cells enumerated with an automated FACS based instrument (Millipore). A portion of the PBMCs were examined by flow cytometry using CD19, CD20, CD27, CD21, CD10 and CD95 or CD19, CD20, IgM, IgD, IgG and IgA for immunophenotyping of B cell markers and normalization of B cell numbers		PV4268	SDY80	7	Days	Time of initial vaccine administration		SUB114492		PBMC	2771
BS807788	Cryopreserved PBMCs were thawed, washed twice and the number of viable cells enumerated with an automated FACS based instrument (Millipore). A portion of the PBMCs were examined by flow cytometry using CD19, CD20, CD27, CD21, CD10 and CD95 or CD19, CD20, IgM, IgD, IgG and IgA for immunophenotyping of B cell markers and normalization of B cell numbers		PV1834	SDY80	0	Days	Time of initial vaccine administration		SUB114501		PBMC	2771
BS807793	Cryopreserved PBMCs were thawed, washed twice and the number of viable cells enumerated with an automated FACS based instrument (Millipore). A portion of the PBMCs were examined by flow cytometry using CD19, CD20, CD27, CD21, CD10 and CD95 or CD19, CD20, IgM, IgD, IgG and IgA for immunophenotyping of B cell markers and normalization of B cell numbers		PV4268	SDY80	7	Days	Time of initial vaccine administration		SUB114480		PBMC	2771
BS807799	Cryopreserved PBMCs were thawed, washed twice and the number of viable cells enumerated with an automated FACS based instrument (Millipore). A portion of the PBMCs were examined by flow cytometry using CD19, CD20, CD27, CD21, CD10 and CD95 or CD19, CD20, IgM, IgD, IgG and IgA for immunophenotyping of B cell markers and normalization of B cell numbers		PV4268	SDY80	7	Days	Time of initial vaccine administration		SUB114455		PBMC	2771
BS807804	Cryopreserved PBMCs were thawed, washed twice and the number of viable cells enumerated with an automated FACS based instrument (Millipore). A portion of the PBMCs were examined by flow cytometry using CD19, CD20, CD27, CD21, CD10 and CD95 or CD19, CD20, IgM, IgD, IgG and IgA for immunophenotyping of B cell markers and normalization of B cell numbers		PV1834	SDY80	0	Days	Time of initial vaccine administration		SUB114470		PBMC	2771
BS807809	Cryopreserved PBMCs were thawed, washed twice and the number of viable cells enumerated with an automated FACS based instrument (Millipore). A portion of the PBMCs were examined by flow cytometry using CD19, CD20, CD27, CD21, CD10 and CD95 or CD19, CD20, IgM, IgD, IgG and IgA for immunophenotyping of B cell markers and normalization of B cell numbers		PV4268	SDY80	7	Days	Time of initial vaccine administration		SUB114490		PBMC	2771
BS807822	Cryopreserved PBMCs were thawed, washed twice and the number of viable cells enumerated with an automated FACS based instrument (Millipore). A portion of the PBMCs were examined by flow cytometry using CD19, CD20, CD27, CD21, CD10 and CD95 or CD19, CD20, IgM, IgD, IgG and IgA for immunophenotyping of B cell markers and normalization of B cell numbers		PV1834	SDY80	0	Days	Time of initial vaccine administration		SUB114460		PBMC	2771
BS807825	Cryopreserved PBMCs were thawed, washed twice and the number of viable cells enumerated with an automated FACS based instrument (Millipore). A portion of the PBMCs were examined by flow cytometry using CD19, CD20, CD27, CD21, CD10 and CD95 or CD19, CD20, IgM, IgD, IgG and IgA for immunophenotyping of B cell markers and normalization of B cell numbers		PV1834	SDY80	0	Days	Time of initial vaccine administration		SUB114498		PBMC	2771
BS807836	Cryopreserved PBMCs were thawed, washed twice and the number of viable cells enumerated with an automated FACS based instrument (Millipore). A portion of the PBMCs were examined by flow cytometry using CD19, CD20, CD27, CD21, CD10 and CD95 or CD19, CD20, IgM, IgD, IgG and IgA for immunophenotyping of B cell markers and normalization of B cell numbers		PV1834	SDY80	0	Days	Time of initial vaccine administration		SUB114484		PBMC	2771
BS807837	Cryopreserved PBMCs were thawed, washed twice and the number of viable cells enumerated with an automated FACS based instrument (Millipore). A portion of the PBMCs were examined by flow cytometry using CD19, CD20, CD27, CD21, CD10 and CD95 or CD19, CD20, IgM, IgD, IgG and IgA for immunophenotyping of B cell markers and normalization of B cell numbers		PV1834	SDY80	0	Days	Time of initial vaccine administration		SUB114461		PBMC	2771
BS807848			PV1834	SDY80	0	Days	Time of initial vaccine administration		SUB114450		PBMC	2771
BS807852			PV4269	SDY80	70	Days	Time of initial vaccine administration		SUB114450		PBMC	2771
BS807854			PV1835	SDY80	1	Days	Time of initial vaccine administration		SUB114451		PBMC	2771
BS807856			PV4267	SDY80	-7	Days	Time of initial vaccine administration		SUB114451		PBMC	2771
BS807860			PV4268	SDY80	7	Days	Time of initial vaccine administration		SUB114452		PBMC	2771
BS807866			PV4267	SDY80	-7	Days	Time of initial vaccine administration		SUB114453		PBMC	2771
BS807867			PV4269	SDY80	70	Days	Time of initial vaccine administration		SUB114453		PBMC	2771
BS807868			PV1834	SDY80	0	Days	Time of initial vaccine administration		SUB114454		PBMC	2771
BS807870			PV4268	SDY80	7	Days	Time of initial vaccine administration		SUB114454		PBMC	2771
BS807876			PV1834	SDY80	0	Days	Time of initial vaccine administration		SUB114456		PBMC	2771
BS807878			PV4268	SDY80	7	Days	Time of initial vaccine administration		SUB114456		PBMC	2771
BS807884			PV4267	SDY80	-7	Days	Time of initial vaccine administration		SUB114457		PBMC	2771
BS807885			PV4269	SDY80	70	Days	Time of initial vaccine administration		SUB114457		PBMC	2771
BS807890			PV4269	SDY80	70	Days	Time of initial vaccine administration		SUB114458		PBMC	2771
BS807905			PV1834	SDY80	0	Days	Time of initial vaccine administration		SUB114462		PBMC	2771
BS807909			PV1834	SDY80	0	Days	Time of initial vaccine administration		SUB114463		PBMC	2771
BS807917			PV4267	SDY80	-7	Days	Time of initial vaccine administration		SUB114464		PBMC	2771
BS807920			PV1835	SDY80	1	Days	Time of initial vaccine administration		SUB114465		PBMC	2771
BS807934			PV1834	SDY80	0	Days	Time of initial vaccine administration		SUB114469		PBMC	2771
BS807935			PV1835	SDY80	1	Days	Time of initial vaccine administration		SUB114469		PBMC	2771
BS807938			PV4269	SDY80	70	Days	Time of initial vaccine administration		SUB114469		PBMC	2771
BS807940			PV1835	SDY80	1	Days	Time of initial vaccine administration		SUB114470		PBMC	2771
BS807944			PV1834	SDY80	0	Days	Time of initial vaccine administration		SUB114471		PBMC	2771
BS807957			PV4268	SDY80	7	Days	Time of initial vaccine administration		SUB114474		PBMC	2771
BS807958			PV4267	SDY80	-7	Days	Time of initial vaccine administration		SUB114474		PBMC	2771
BS807967			PV1835	SDY80	1	Days	Time of initial vaccine administration		SUB114477		PBMC	2771
BS807968			PV4268	SDY80	7	Days	Time of initial vaccine administration		SUB114477		PBMC	2771
BS807971			PV1834	SDY80	0	Days	Time of initial vaccine administration		SUB114478		PBMC	2771
BS807975			PV4269	SDY80	70	Days	Time of initial vaccine administration		SUB114478		PBMC	2771
BS807982			PV4268	SDY80	7	Days	Time of initial vaccine administration		SUB114481		PBMC	2771
BS807999			PV1835	SDY80	1	Days	Time of initial vaccine administration		SUB114486		PBMC	2771
BS808028			PV4268	SDY80	7	Days	Time of initial vaccine administration		SUB114494		PBMC	2771
BS808032			PV1835	SDY80	1	Days	Time of initial vaccine administration		SUB114495		PBMC	2771
BS808034			PV4267	SDY80	-7	Days	Time of initial vaccine administration		SUB114495		PBMC	2771
BS808099	Cryopreserved PBMCs were thawed, washed twice and the number of viable cells enumerated with an automated FACS based instrument (Millipore). A portion of the PBMCs were examined by flow cytometry using CD19, CD20, CD27, CD21, CD10 and CD95 or CD19, CD20, IgM, IgD, IgG and IgA for immunophenotyping of B cell markers and normalization of B cell numbers		PV1834	SDY80	0	Days	Time of initial vaccine administration		SUB114477		PBMC	2771
BS808115	Cryopreserved PBMCs were thawed, washed twice and the number of viable cells enumerated with an automated FACS based instrument (Millipore). A portion of the PBMCs were examined by flow cytometry using CD19, CD20, CD27, CD21, CD10 and CD95 or CD19, CD20, IgM, IgD, IgG and IgA for immunophenotyping of B cell markers and normalization of B cell numbers		PV1834	SDY80	0	Days	Time of initial vaccine administration		SUB114461		PBMC	2771
BS808116	Cryopreserved PBMCs were thawed, washed twice and the number of viable cells enumerated with an automated FACS based instrument (Millipore). A portion of the PBMCs were examined by flow cytometry using CD19, CD20, CD27, CD21, CD10 and CD95 or CD19, CD20, IgM, IgD, IgG and IgA for immunophenotyping of B cell markers and normalization of B cell numbers		PV4267	SDY80	-7	Days	Time of initial vaccine administration		SUB114503		PBMC	2771
BS808124	Cryopreserved PBMCs were thawed, washed twice and the number of viable cells enumerated with an automated FACS based instrument (Millipore). A portion of the PBMCs were examined by flow cytometry using CD19, CD20, CD27, CD21, CD10 and CD95 or CD19, CD20, IgM, IgD, IgG and IgA for immunophenotyping of B cell markers and normalization of B cell numbers		PV1834	SDY80	0	Days	Time of initial vaccine administration		SUB114502		PBMC	2771
BS808138	Cryopreserved PBMCs were thawed, washed twice and the number of viable cells enumerated with an automated FACS based instrument (Millipore). A portion of the PBMCs were examined by flow cytometry using CD19, CD20, CD27, CD21, CD10 and CD95 or CD19, CD20, IgM, IgD, IgG and IgA for immunophenotyping of B cell markers and normalization of B cell numbers		PV1834	SDY80	0	Days	Time of initial vaccine administration		SUB114506		PBMC	2771
BS808146	Cryopreserved PBMCs were thawed, washed twice and the number of viable cells enumerated with an automated FACS based instrument (Millipore). A portion of the PBMCs were examined by flow cytometry using CD19, CD20, CD27, CD21, CD10 and CD95 or CD19, CD20, IgM, IgD, IgG and IgA for immunophenotyping of B cell markers and normalization of B cell numbers		PV4267	SDY80	-7	Days	Time of initial vaccine administration		SUB114483		PBMC	2771
BS808148	Cryopreserved PBMCs were thawed, washed twice and the number of viable cells enumerated with an automated FACS based instrument (Millipore). A portion of the PBMCs were examined by flow cytometry using CD19, CD20, CD27, CD21, CD10 and CD95 or CD19, CD20, IgM, IgD, IgG and IgA for immunophenotyping of B cell markers and normalization of B cell numbers		PV1834	SDY80	0	Days	Time of initial vaccine administration		SUB114508		PBMC	2771
BS808150	Cryopreserved PBMCs were thawed, washed twice and the number of viable cells enumerated with an automated FACS based instrument (Millipore). A portion of the PBMCs were examined by flow cytometry using CD19, CD20, CD27, CD21, CD10 and CD95 or CD19, CD20, IgM, IgD, IgG and IgA for immunophenotyping of B cell markers and normalization of B cell numbers		PV1834	SDY80	0	Days	Time of initial vaccine administration		SUB114500		PBMC	2771
BS808167	Cryopreserved PBMCs were thawed, washed twice and the number of viable cells enumerated with an automated FACS based instrument (Millipore). A portion of the PBMCs were examined by flow cytometry using CD19, CD20, CD27, CD21, CD10 and CD95 or CD19, CD20, IgM, IgD, IgG and IgA for immunophenotyping of B cell markers and normalization of B cell numbers		PV1834	SDY80	0	Days	Time of initial vaccine administration		SUB114453		PBMC	2771
BS808185	Cryopreserved PBMCs were thawed, washed twice and the number of viable cells enumerated with an automated FACS based instrument (Millipore). A portion of the PBMCs were examined by flow cytometry using CD19, CD20, CD27, CD21, CD10 and CD95 or CD19, CD20, IgM, IgD, IgG and IgA for immunophenotyping of B cell markers and normalization of B cell numbers		PV4267	SDY80	-7	Days	Time of initial vaccine administration		SUB114478		PBMC	2771
BS808189	Cryopreserved PBMCs were thawed, washed twice and the number of viable cells enumerated with an automated FACS based instrument (Millipore). A portion of the PBMCs were examined by flow cytometry using CD19, CD20, CD27, CD21, CD10 and CD95 or CD19, CD20, IgM, IgD, IgG and IgA for immunophenotyping of B cell markers and normalization of B cell numbers		PV4267	SDY80	-7	Days	Time of initial vaccine administration		SUB114450		PBMC	2771
BS808216		217_day-7	PV4267	SDY80	-7	Days	Time of initial vaccine administration		SUB114461	217.Blood.RNA-MicroArray.PV4267	RNA	2771
BS808222		227_day-7	PV4267	SDY80	-7	Days	Time of initial vaccine administration		SUB114467	227.Blood.RNA-MicroArray.PV4267	RNA	2771
BS808236		247_day-7	PV4267	SDY80	-7	Days	Time of initial vaccine administration		SUB114484	247.Blood.RNA-MicroArray.PV4267	RNA	2771
BS808243		256_day-7	PV4267	SDY80	-7	Days	Time of initial vaccine administration		SUB114491	256.Blood.RNA-MicroArray.PV4267	RNA	2771
BS808247		261_day-7	PV4267	SDY80	-7	Days	Time of initial vaccine administration		SUB114495	261.Blood.RNA-MicroArray.PV4267	RNA	2771
BS808255		273_day-7	PV4267	SDY80	-7	Days	Time of initial vaccine administration		SUB114503	273.Blood.RNA-MicroArray.PV4267	RNA	2771
BS808265		200_day7	PV4268	SDY80	7	Days	Time of initial vaccine administration		SUB114450	200.Blood.RNA-MicroArray.PV4268	RNA	2771
BS808273		215_day7	PV4268	SDY80	7	Days	Time of initial vaccine administration		SUB114460	215.Blood.RNA-MicroArray.PV4268	RNA	2771
BS808274		217_day7	PV4268	SDY80	7	Days	Time of initial vaccine administration		SUB114461	217.Blood.RNA-MicroArray.PV4268	RNA	2771
BS808275		218_day7	PV4268	SDY80	7	Days	Time of initial vaccine administration		SUB114462	218.Blood.RNA-MicroArray.PV4268	RNA	2771
BS808280		227_day7	PV4268	SDY80	7	Days	Time of initial vaccine administration		SUB114467	227.Blood.RNA-MicroArray.PV4268	RNA	2771
BS808281		228_day7	PV4268	SDY80	7	Days	Time of initial vaccine administration		SUB114468	228.Blood.RNA-MicroArray.PV4268	RNA	2771
BS808296		246_day7	PV4268	SDY80	7	Days	Time of initial vaccine administration		SUB114483	246.Blood.RNA-MicroArray.PV4268	RNA	2771
BS808298		248_day7	PV4268	SDY80	7	Days	Time of initial vaccine administration		SUB114485	248.Blood.RNA-MicroArray.PV4268	RNA	2771
BS808299		249_day7	PV4268	SDY80	7	Days	Time of initial vaccine administration		SUB114486	249.Blood.RNA-MicroArray.PV4268	RNA	2771
BS808303		254_day7	PV4268	SDY80	7	Days	Time of initial vaccine administration		SUB114490	254.Blood.RNA-MicroArray.PV4268	RNA	2771
BS808310		265_day7	PV4268	SDY80	7	Days	Time of initial vaccine administration		SUB114498	265.Blood.RNA-MicroArray.PV4268	RNA	2771
BS808318		281_day7	PV4268	SDY80	7	Days	Time of initial vaccine administration		SUB114509	281.Blood.RNA-MicroArray.PV4268	RNA	2771
BS808322		200_day70	PV4269	SDY80	70	Days	Time of initial vaccine administration		SUB114450	200.Blood.RNA-MicroArray.PV4269	RNA	2771
BS808323		201_day70	PV4269	SDY80	70	Days	Time of initial vaccine administration		SUB114451	201.Blood.RNA-MicroArray.PV4269	RNA	2771
BS808329		209_day70	PV4269	SDY80	70	Days	Time of initial vaccine administration		SUB114457	209.Blood.RNA-MicroArray.PV4269	RNA	2771
BS808337		226_day70	PV4269	SDY80	70	Days	Time of initial vaccine administration		SUB114466	226.Blood.RNA-MicroArray.PV4269	RNA	2771
BS808338		227_day70	PV4269	SDY80	70	Days	Time of initial vaccine administration		SUB114467	227.Blood.RNA-MicroArray.PV4269	RNA	2771
BS808339		228_day70	PV4269	SDY80	70	Days	Time of initial vaccine administration		SUB114468	228.Blood.RNA-MicroArray.PV4269	RNA	2771
BS806086			PV4268	SDY80	7	Days	Time of initial vaccine administration		SUB114450		Serum	2771
BS806097			PV4267	SDY80	-7	Days	Time of initial vaccine administration		SUB114452		Serum	2771
BS806099			PV1834	SDY80	0	Days	Time of initial vaccine administration		SUB114453		Serum	2771
BS806104			PV1834	SDY80	0	Days	Time of initial vaccine administration		SUB114454		Serum	2771
BS806108			PV4269	SDY80	70	Days	Time of initial vaccine administration		SUB114454		Serum	2771
BS806110			PV1835	SDY80	1	Days	Time of initial vaccine administration		SUB114455		Serum	2771
BS806118			PV1834	SDY80	0	Days	Time of initial vaccine administration		SUB114457		Serum	2771
BS806122			PV1834	SDY80	0	Days	Time of initial vaccine administration		SUB114458		Serum	2771
BS806142			PV1834	SDY80	0	Days	Time of initial vaccine administration		SUB114462		Serum	2771
BS806143			PV1835	SDY80	1	Days	Time of initial vaccine administration		SUB114462		Serum	2771
BS806144			PV4268	SDY80	7	Days	Time of initial vaccine administration		SUB114462		Serum	2771
BS806145			PV4267	SDY80	-7	Days	Time of initial vaccine administration		SUB114462		Serum	2771
BS806159			PV4269	SDY80	70	Days	Time of initial vaccine administration		SUB114465		Serum	2771
BS806165			PV1834	SDY80	0	Days	Time of initial vaccine administration		SUB114467		Serum	2771
BS806170			PV1834	SDY80	0	Days	Time of initial vaccine administration		SUB114468		Serum	2771
BS806174			PV4269	SDY80	70	Days	Time of initial vaccine administration		SUB114468		Serum	2771
BS806178			PV4267	SDY80	-7	Days	Time of initial vaccine administration		SUB114469		Serum	2771
BS808354		247_day70	PV4269	SDY80	70	Days	Time of initial vaccine administration		SUB114484	247.Blood.RNA-MicroArray.PV4269	RNA	2771
BS808363		260_day70	PV4269	SDY80	70	Days	Time of initial vaccine administration		SUB114494	260.Blood.RNA-MicroArray.PV4269	RNA	2771
BS808367		267_day70	PV4269	SDY80	70	Days	Time of initial vaccine administration		SUB114499	267.Blood.RNA-MicroArray.PV4269	RNA	2771
BS808370		272_day70	PV4269	SDY80	70	Days	Time of initial vaccine administration		SUB114502	272.Blood.RNA-MicroArray.PV4269	RNA	2771
BS808375		280_day70	PV4269	SDY80	70	Days	Time of initial vaccine administration		SUB114508	280.Blood.RNA-MicroArray.PV4269	RNA	2771
BS807733	Cryopreserved PBMCs were thawed, washed twice and the number of viable cells enumerated with an automated FACS based instrument (Millipore). A portion of the PBMCs were examined by flow cytometry using CD19, CD20, CD27, CD21, CD10 and CD95 or CD19, CD20, IgM, IgD, IgG and IgA for immunophenotyping of B cell markers and normalization of B cell numbers		PV4268	SDY80	7	Days	Time of initial vaccine administration		SUB114476		PBMC	2771
BS807742	Cryopreserved PBMCs were thawed, washed twice and the number of viable cells enumerated with an automated FACS based instrument (Millipore). A portion of the PBMCs were examined by flow cytometry using CD19, CD20, CD27, CD21, CD10 and CD95 or CD19, CD20, IgM, IgD, IgG and IgA for immunophenotyping of B cell markers and normalization of B cell numbers		PV4267	SDY80	-7	Days	Time of initial vaccine administration		SUB114457		PBMC	2771
BS807753	Cryopreserved PBMCs were thawed, washed twice and the number of viable cells enumerated with an automated FACS based instrument (Millipore). A portion of the PBMCs were examined by flow cytometry using CD19, CD20, CD27, CD21, CD10 and CD95 or CD19, CD20, IgM, IgD, IgG and IgA for immunophenotyping of B cell markers and normalization of B cell numbers		PV1834	SDY80	0	Days	Time of initial vaccine administration		SUB114500		PBMC	2771
BS807758	Cryopreserved PBMCs were thawed, washed twice and the number of viable cells enumerated with an automated FACS based instrument (Millipore). A portion of the PBMCs were examined by flow cytometry using CD19, CD20, CD27, CD21, CD10 and CD95 or CD19, CD20, IgM, IgD, IgG and IgA for immunophenotyping of B cell markers and normalization of B cell numbers		PV1834	SDY80	0	Days	Time of initial vaccine administration		SUB114502		PBMC	2771
BS953284			PV6192	SDY80	28	Days	Time of initial vaccine administration		SUB114479		Serum	2771
BS953295			PV6192	SDY80	28	Days	Time of initial vaccine administration		SUB114452		Serum	2771
BS953298			PV6192	SDY80	28	Days	Time of initial vaccine administration		SUB114455		Serum	2771
BS953299			PV6192	SDY80	28	Days	Time of initial vaccine administration		SUB114456		Serum	2771
BS953302			PV6192	SDY80	28	Days	Time of initial vaccine administration		SUB114459		Serum	2771
BS953308			PV6192	SDY80	28	Days	Time of initial vaccine administration		SUB114466		Serum	2771
BS953327			PV6192	SDY80	28	Days	Time of initial vaccine administration		SUB114488		Serum	2771
BS953334			PV6192	SDY80	28	Days	Time of initial vaccine administration		SUB114495		Serum	2771
BS953337			PV6192	SDY80	28	Days	Time of initial vaccine administration		SUB114499		Serum	2771
BS953342			PV6192	SDY80	28	Days	Time of initial vaccine administration		SUB114506		Serum	2771
BS953347			PV6192	SDY80	28	Days	Time of initial vaccine administration		SUB114511		Serum	2771
